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Association of Cardiorespiratory Fitness and Adiposity with Inflammatory
Biomarkers in Young Adults
August, 2014
Abstract

Background
Low grade systemic inflammation plays a key role in atherosclerosis, and C-reactive
protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor- alpha (TNF-a),
markers of systemic inflammation, are associated with cardiovascular events and
adiposity. Cardiorespiratory fitness has shown health benefits by reducing circulating
levels of inflammatory markers. However, it remains uncertain whether the negative
association between cardiorespiratory fitness and inflammatory biomarkers is due to
cardiorespiratory fitness itself or results from lower levels of adiposity. Moreover, the
evidence examining the interaction between cardiorespiratory fitness and adiposity in
inflammation in young adults is lacking.

Purpose
The aims of this study were to (1) determine the strength of the associations of
cardiorespiratory fitness and adiposity (body mass index [BMI], waist circumference
[WC]) with circulating levels of plasma hs-CRP, IL-6, and TNF-a; and (2) test the
moderating effect of adiposity on the strength of the association between
cardiorespiratory fitness and circulating levels of plasma hs-CRP, IL-6, and TNF -a.

Methods
A cross-sectional study was conducted with 88 young adults aged 20-34 years without
diagnosed diseases. A submaximal treadmill walking test was used to assess

v

cardiorespiratory fitness. BMI and WC were measured to assess adiposity. The hs-CRP,
IL-6 and TNF-a were assayed and were log10-transformed. For aim one, a separate
multiple regression analysis was conducted with each ofhs-CRP, IL-6, and TNF-a as
dependent variables and adjusted for confounders. Analysis of covariance (ANCOVA)
was used and adjusted for confounders for aim two. Confounding variables tested were
sex, ethnicity, oral contraceptive use, and education level.

Results
Aiml: Cardiorespiratory fitness was not significantly associated with log1ohs-CRP after
adjustment for BMI or WC and confounders. Cardiorespiratory fitness was not
significantly associated with log 10IL-6 after adjustment for BMI and confounders.
However, cardiorespiratory fitness was significantly and negatively associated with
log10IL-6 after adjustment for WC and confounders (Model adjusted R2 =.273,p < .0001;

p = -.341, t = -1.995,p =.049). Aim 2: Cardiorespiratory fitness X

BMI or we interaction

was not significantly associated with log10hs-CRP after adjustment for confounders.
Similarly, cardiorespiratory fitness x BMI interaction was not significantly associated
with log10IL-6 after adjustment for confounders. However, cardiorespiratory fitness

x

WC interaction was significantly associated with log10IL-6 after adjustment for
confounders (Model adjusted R2 = .258,p < .0001; partial eta2 =.056, F = 4.730,p =
.033). There were no associations of cardiorespiratory fitness, adiposity, and log10TNF-a.

Conclusions
In young adults, higher cardiorespiratory fitness is significantly associated with lower
levels of IL-6, particularly in young adults with central adiposity. Further studies are
warranted to determine if experimentally induced increases in cardiorespiratory fitness

Vl

reduce inflammatory markers in young adults. Longitudinal studies are needed to
understand the underlying inflammatory mechanisms related to interaction between
cardiorespiratory fitness and adiposity, and its influence on cardiovascular disease risk in
young adults.
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Summary of Study
The dissertation consists of the proposal, two manuscripts reporting study results,
and appendixes. The proposal consists of specific aims, research strategy, facilities/
resources/ consultants, and human subject concerns. Two manuscripts are included:
manuscript 1. Anthropometric Adiposity Measures and Inflammatory Biomarkers in
Adolescents and Young Adults: A Systematic Review and manuscript 2. Association of
Cardiorespiratory Fitness and Adiposity with Inflammatory Biomarkers in Young Adults:
dissertation.
Manuscript 1 is the systematic review on the associations between anthropometric
adiposity measures (BMI, WC, WHR, WHtR, and BF%) and inflammatory biomarkers
(CRP, IL-6, and TNF -a) in adolescents and young adults. This review found that
anthropometric adiposity measures are positively associated with CRP in adolescents and
young adults. However, anthropometric adiposity measures and IL-6 and TNF-a in
adolescents and young adults is inconclusive. Additional studies are needed to identify
the strength and patterns of association of anthropometric adiposity measures with CRP,
IL-6 and TNF-a.
Manuscript 2 is a dissertation study. This cross-sectional study is to ( 1) determine
the strength of the associations of cardiorespiratory fitness and adiposity (body mass
index [BMI], waist circumference [WC]) with circulating levels of plasma hs-CRP, IL-6,
and TNF -a; and (2) test the moderating effect of adiposity on the strength of the
association between cardiorespiratory fitness and circulating levels of plasma hs-CRP,
IL-6, and TNF-a. This study found that in young adults, higher cardiorespiratory fitness
is significantly associated with lower levels of IL-6, particularly in young adults with
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central adiposity. Further studies are warranted to determine if experimentally induced
increases in cardiorespiratory fitness reduce inflammatory markers in young adults.
Appendices include study protocols, IRB approval letters and human subject
concerns. Curriculum vitae constitute the final section of the dissertation.
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Abstract
Purpose: The proposed study is to investigate the association of cardiorespiratory fitness
(CRF) and adiposity with inflammatory biomarkers in healthy young adults. Specific
aims are ( 1) to determine· the strength of the association between CRF levels with
circulating levels of plasma high sensitivity C-reactive protein (hs-CRP), interleukin-6
(IL-6), and tumor necrosis factor- alpha (TNF-a); (2) to determine the strength of the
association between adiposity levels and circulating levels of plasma hs-CRP, IL-6, and
TNF-a; and (3) to test the moderating effect of adiposity on the strength of the

association between CRF levels and circulating levels of plasma hs-CRP, IL-6, and TNF-

a.
Significance: Atherosclerotic cardiovascular disease is a significant public health
concern. Low grade chronic vascular inflammation plays a key role in atherosclerosis.
CRF has shown health benefits by reducing circulating levels of inflammatory markers.
However, it is uncertain whether the beneficial effect of CRF derives from the CRF itself
or from inadequate adjustment for adiposity. Moreover, the evidence examining adiposity
as a modifier of this association in young adults is lacking.

Methods: A cross-sectional analytic design will be conducted to achieve the three
specific aims. Participants will be recruited through flyers and emails. Inclusion criteria
include young adults aged 20-34 years old, healthy (without diagnosis of disease), being
capable of completing the CRF testing, and not using any hormonal therapy. After
screening for eligibility, 88 participants will be enrolled and they will be scheduled for a
data collection session. Data will be collected on each participant through CRF testing,
anthropometric measurement and blood sampling of inflammatory biomarkers in one
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session at the University of Texas Health Science Center at Houston School of Nursing.
CRF will be estimate by a submaximal treadmill test and adiposity will be assessed by
body mass index and waist circumference. Inflammatory markers will be measured by
enzyme-linked immunosorbent assay (ELISA). Separate analyses will be conducted with
each of the inflammatory markers (hs-CRP, IL-6, and TNF-a) as the dependent variable

in multiple linear regression for aims one and two. Multiple linear regression models,
with interaction terms (CRF x BMI) (CRF x waist circumference) will be addressed to
assess aim three.

Nursing Implications: This information provides more accurate evaluation and
interpretation of inflammatory biomarkers in clinical practice as related to CRF and
adiposity. Additionally, these finding will be useful in understanding the physiological
mechanisms ofCRF, adiposity, and inflammatory biomarkers, which contributes to
decreased atherosclerosis risk. Lastly, these findings will be useful in in planning
preventive strategies to reduce low-grade chronic inflammation in obese as well as
healthy weight young adults, which in turn delay the progression of atherosclerosis and
reduce the risk of CVD events.
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Specific Aims
Chronic, low-grade vascular inflammation plays a key role in the initiation and
progression of atherosclerosis (Packard & Libby, 2008). C-reactive protein (hs-CRP),
interleukin-6 {IL-6), and tumor necrosis factor-a. (TNF-a.) have been documented as the
major inflammatory markers associated with atherosclerotic progression and events
(Packard & Libby, 2008). It has demonstrated that atherosclerotic lesions begin early in
life albeit clinical manifestations are not observed until symptoms occur in later life
(Loria et al., 2007).
Cardiorespiratory fitness (CRF) has shown health benefits in reducing circulating
levels of inflammatory markers, but it is still uncertain whether there is a definitive link
between CRF and inflammatory biomarkers in healthy young adults (Hamer, 2007).
There is also evidence that adiposity might be a factor attenuating the link of CRF with
low grade inflammation (Hamer, 2007). However, no previous studies have examined the
interplay of CRF and adiposity on inflammatory biomakers in healthy young adults.
In this proposed study, the principal investigator (PI) will examine the associations of
CRF and adiposity with inflammatory biomarkers and the interaction of CRF and
adiposity on inflammatory biomarkers in healthy young adults aged 20 to 34 years.
Adiposity is defined as body mass index (BMI) and waist circumference in this study.
The PI will pursue the main purpose of this study through three specific aims as follows:

Aiml. To determine the strength of the association between CRF levels with
circulating levels of plasma hs-CRP, IL-6, and TNF-a.. Hypothesis: Higher levels
of CRF will be related to lower levels of circulating plasma hs-CRP, IL-6, and
TNF-a..
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Aim2. To determine the strength of the association between adiposity levels and
circulating levels of plasma hs-CRP, IL-6, and TNF-a. Hypothesis: 2a. Higher
levels ofBMI will be related to higher levels of circulating plasma hs-CRP, IL-6,
and TNF-a. 2b. Higher levels of waist circumference will be related to higher
levels of circulating plasma hs-CRP, IL-6, and TNF-a.

Aim3. To test the moderating effect of adiposity on the strength of the association
between CRF levels and circulating levels of plasma hs-CRP, IL-6, and TNF-a.
Hypothesis: 3a. Individuals with higher levels of BMI and higher levels of CRF
will have lower levels of circulating plasma hs-CRP, IL-6, and TNF-a compared
with individuals with higher levels ofBMI and lower levels ofCRF. 3b.
Individuals with higher waist circumference and higher levels of CRF will have
lower levels of circulating plasma hs-CRP, IL-6, and TNF-a compared with
individuals with higher waist circumference and lower levels of CRF.
For public health strategies and improvements of cardiovascular health, the
proposed work is innovative in that it will test the central hypothesis that young adults
with higher levels of CRF will have lower levels of inflammatory markers than those
with lower levels of CRF, even among individuals who have greater adiposity as
measured by BMI and waist circumference. Additionally, understanding the interplay of
CRF, adiposity and inflammatory markers is of great importance because it will
contribute to more accurate evaluation and interpretation of inflammatory markers in
clinical practice. Finally, these findings will be useful in planning interventions to reduce
low-grade chronic inflammation in obese as well as healthy weight young adults, which
in turn may delay the progression of atherosclerosis and reduce the risk of CVD.
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Research Strategy
Significance
Atherosclerotic cardiovascular disease (CVD) is a significant public health burden
in the United States (Go et al., 2013). Atherosclerosis, a systemic disease process in
which amassment of plaque builds up in the arterial wall, is the major underlying cause of
the clinical CVD and CVD events (Go et al., 2013; Libby et al, 2009). It has been
demonstrated that low-grade systemic vascular inflammation plays a pivotal role in the
initiation and progression of atherosclerosis (Libby et al., 2009) by impairing endothelial
function (Hansson, 2005; Ferri et al., 2007). Among the many inflammatory biomarkers,
hs-CRP, IL-6, and TNF-a are well-recognized markers of inflammation in relation to
atherogenesis (Calabro, Golia, & Yeh, 2009; Haddy et al., 2003). Hs-CRP, a primitive
acute phase inflammatory protein, is secreted by the liver in reaction to IL-6 and has been
demonstrated to be represented in atherosclerotic plaque (Clearfield, 2005; Wilson, Ryan,
& Boyle, 2006). The "high sensitivity (hs )" term means "the measurement of CRP in
serum or plasma sample using immunoassay methods with sufficient sensitivity" in
asymptomatic individuals (Bajpai, Goyal, & Sperling, 2010, p.191 ). IL-6 is a proinflammatory cytokine and produced by fibroblasts, endothelial cells, monocytes, and
adipose tissue (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer, 2009). IL-6 plays an
important role in controlling hepatic production of inflammatory proteins, including hsCRP and fibrinogen (Antuna-Puente, Feve, Fellahi, & Bastard, 2008). TNF-a, a proinflammatory cytokine, is secreted by macrophages, lymphocyte, and adipose tissue
(Petersen & Pedersen, 2005). TNF-a activates the production ofiL-6 in adipose tissue
and blood mononuclear cells (Petersen & Pedersen, 2005).

9
Although clinical symptoms of atherosclerotic CVD, such as chest pain or
discomfort, shortness of breath or fatigue, numbness, and blurred vision are not
commonly detected until adulthood it is a progressive atherosclerotic process that occurs
early in life and has clinical indications, including acute coronary syndrome and acute
stroke usually later in life (Loria et al., 2007; Frank et al., 2010). Hence, young adults
could be a main target for preventive endeavors, such as individual's health behaviors
because these efforts might minimize or delay atherosclerotic process, which could
eventually decrease the incidence of clinical CVD throughout middle and older adulthood
(Loria et al., 2007).
CRF refers to the health-related component of physical fitness (Caspersen, Powell,
& Christenson, 1985). CRF defined as "the ability to perform large muscle, dynamic,
moderate-to-high intensity exercise for prolong periods of time" (American College of
Sports Medicine [ACSM], 2010b, p.71). CRF is "an individual's capacity of the
cardiovascular, respiratory, and muscle systems to supply oxygen during sustained
physical activity" (ACSM, 2010a, p.3).1t has reported that higher levels ofCRF are
closely related to higher levels of habitual physical activity (Blair et al., 1995). The "gold
standard" or criterion measure of CRF is maximal oxygen uptake (V02max) (ACSM,
201 0). The VO 2max reflects the capacity of the heart, lungs, and blood to deliver oxygen
to the working muscles during dynamic exercise involving large muscle mass (Heyward,
2010). The V02max commonly estimates either a maximal or submaximal exercise test.
CRF in this study will be estimated by using a submaximal treadmill walking protocol
because maximal exercise testing is not always feasible or practical in the health and
research settings (Heyward, 201 0). Additionally, maximal exercise testing with analysis
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of expired gases requires expensive laboratory equipment, considerable amount time,
trained personnel and possible physician oversight. Further, there is considerable
participant burden, associated safety considerations, and obtaining a valid estimate
requires participant motivation (Heyward, 201 0). The selected submaximal treadmill
walking test protocol will utilize individual's heart rate (HR) response to submaximal
treadmill work rates to estimate V02max (Ebbeling et al., 1991). It has reported that CRF
is inversely associated with CRP in young adults (Kuo, Yen, Chen, Yu, & Bean, 2007;
Williams et al., 2005). However, it is remain uncertain whether an inverse association
between CRF and inflammatory biomarkers is due to the health benefits of CRF or results
from changes in adiposity (Harmer, 2007).
Adiposity is defmed as "the quality or state of being fat" (Merriam-Webster

Dictionary). The adiposity is a synonym for obesity or fatness (Merriam-Webster
Dictionary). Adiposity has been assessed by anthropometric measures in public health
and clinical practices. Adiposity in this study will be assessed by BMI and waist
circumference (WC). BMI (kg/m2 ) has been recommended for the identification of
measuring body fat (WHO, 2000) and the most widely accepted measures of overall
adiposity (Stevens, McClain, & Truesdale, 2008); however, BMI does not differentiate
fat mass from bone and muscle mass and does not provide any information on the
distribution of body fat, particularly central body fat (Stevens, McClain, & Truesdale,
2008). Thus, WC will be assessed for measuring central adiposity (Stevens, McClain, &
Truesdale, 2008). A growing body of evidence has supported that there is positive
association of adiposity with inflammatory biomarkers (Park, Park, & Yu, 2005; Wang,
Reed, Goli, & Goswarni, 2011). However, there is not enough evidence to identify the

11

strength and patterns of association of anthropometric adiposity measures with CRP, IL-6
and TNF-a.
Although there is evidence that CRF is inversely associated with inflammatory
biomarkers (Hamer, 2007), it is still under debate whether the beneficial effect of CRF
derives from the CRF itself or from inadequate adjustment for adiposity (Hamer, 2007),
which adiposity also may influence in inflammatory processes (Rocha & Libby, 2009).
More importantly, only two studies have examined the association of CRF and CRP in
young adults over the past decade (Kuo et al., 2007; Williams, Milne, Hancox, & Poulton,
2005). One study measured CRP using a low sensitivity CRP assay, which may
underestimate the strength of the association between CRF and inflammation (Williams
et al., 2005). The other study was population-based study, which included study
participants with CVD risk factors, such as hypertension, diabetes and current smokers or
participants with anti-inflammatory or CVD medications (Kuo et al., 2007), thus, the
findings cannot be generalized to healthy young adults. Neither study examined adiposity
as moderator of the association between inflammation and CRF, and what extent that
adiposity influences the association between CRF and inflammation. Furthermore, these
two previous studies only focused on CRP as a biomarker of inflammation. It is essential
to investigate other inflammatory markers, such as IL-6 and TNF-a in order to better
understand inflammatory processes in relation to adiposity and CRF. Therefore, this
proposed study is significant as it will provide data on the role of adiposity as a
moderator of the strength of the association between CRF and three inflammatory
biomarkers. This will fill an important gap in knowledge. Figure 1 shows a schematic
diagram of the conceptual framework and specific aims of this proposed study.
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The proposed study is significant as it will
(1) Provide a basis for more accurate interpretation and evaluation of inflammatory
biomarkers in clinical settings as related to CRF and adiposity assessment.
(2) Contribute a better understanding inflammatory process in relation to CRF and
adiposity in a young adult population.
(3) Provide knowledge for the design of preventive strategies to reduce low
grade chronic inflammation in obese as well as healthy weight young adults, which
inturn may delay the progression of atherosclerosis risk and reduce the risk of CVD.

Cardiorespiratory
Fitness (Walking
treadmiU test)

Adiposity
(BMI, \VC)

Aim2

Inflammatory
biomarkers (BS-CRP,
ll...-6, Th"F-a)

Cardiorespiratory
Fitness x Adiposity

Figure 1. Conceptual framework for cardiorespiratory fitness, adiposity and
Inflammatory biomarkers In young adults
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Innovation
The proposed study is innovative in that it will
(1) No previous studies have examined the interplay ofCRF and adiposity on
inflammatory makers in young adults.
(2) Be one of the few studies that assessed CRF in young adults without known
diagnosis of disease using a single-stage submaximal treadmill walking test in
community setting.
(3) Provide CRF levels, adiposity levels and plasma inflammatory biomarkers levels
not only hs-CRP but it also IL-6 and TNF-a in young adults. To our knowledge,
this is the first study to include IL-6 and TNF-a in relation to CRF in healthy
young adults. There is limited data on these variables in young adults. This
information will expand scientific knowledge on the inflammatory mechanisms
related to CRF and adiposity, which may contribute to atherosclerosis risk in this
population.

Approach
Preliminary study.
Effects of exercise intervention on inflammatory markers in healthy young and
middle aged adults: A systematic review. The PI conducted a systematic review of
effects of exercise interventions on inflammatory markers in healthy young and middle
aged adults (Park &Meininger). The aim of this systematic review was to assess the
effects of exercise interventions on circulating levels of inflammatory markers CRP, IL-6,
and TNF -a in healthy young and middle aged adults. Method of this study was that
Medline and PubMed databases were searched for studies published between 1966 and
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July 2011 using keywords related to "exercise", "C-reactive protein", "interleukin-6",
and "tumor necrosis factor-alpha". Inclusion criteria were (a) randomized controlled trials
(RCTs), (b) exercise interventions with a minimum duration of 4 weeks, and (c)
participants' ages 18 to 65 years old. Main findings were as follows: Of 1,490 identified
publications, 93 were retrieved for detailed evaluation and 8 met inclusion criteria. Of 6
RCTs on CRP, 1 study reported decreased CRP (P<0.05) in aerobic exercise. Of3 RCTs
on IL-6, 1study showed decreased IL-6 (P~0.02) in aerobic exercise. Of 4 RCTs on 1NFa, 1 study reported elevated TNF-a (P<0.05) in aerobic exercise among females, and 1

study demonstrated decreased 1NF-a (P<O.Ol) in high-intensity aerobic exercise. The
evidence supporting the effects of exercise interventions on CRP, IL-6 and TNF-a is
sparse and inconsistent, and degree of adiposity was not considered. Further research is
needed on the potential role of body fat as it relates to the effects of exercise and CR
fitness on inflammatory biomarkers.

Anthropometric adiposity measures and inflammatory biomarkers in
adolescents and young adults: A systematic review. The purpose of the systematic
review was to determine the associations between anthropometric adiposity measures
(BMI, WC, WHR, WHtR, and BF%) and inflammatory biomarkers (CRP, IL-6, and
TNF-a) in healthy adolescents and young adults without a known diagnosis of diseases.

Method of this study was that MEDLINE (from 1946 to June 08, 2012), CINAHL (from
1995 to June 08, 2012), and SCOPUS (from 1960 to June 08, 2012) using keywords
related to anthropometric adiposity measures;"body mass index,"" waist circumference,"
and inflammatory biomarkers; "C-reactive protein", "interleukin-6", and "tumor necrosis
factor-alpha". Inclusion criteria were (1) adolescents and young adults aged 13 to 40
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years; (2) investigated the association between at least one anthropometric adiposity
measures and CRP, IL-6, and/or TNF-a; (3) anthropometric adiposity measured by BMI,
WC, WHR, WHtR, and/or body percentage assessing a skinfold thickness; (4) eRP, IL-6,
and TNF-a levels measured by blood; ( 5) if cross-sectional data from the same study
cohort was published in more than one studies, then only results from the report that most
directly evaluated the association of anthropometric adiposity and inflammation was
included; (6) all types of research designs; (7) reported in an original study; (8) no
country restriction; and (9) published study in English language. Exclusion criteria were:
(1) adolescent and young adults with diagnosed diseases and infectious diseases; (2)
pregnant women; (3) reported adiposity measured only by DEXA or MRI; (4) reported a
review or an editorial article; and ( 5) reported in an abstract. Main findings were as
follows: Of3,714 identified publications, 166 full text studies were retrieved for detailed
evaluation and 27 met inclusion criteria. The main findings of the systematic review
showed that there was significant and positive association of anthropometric adiposity
measured by both total adiposity and central adiposity (BMI, we, WHtR, WHR, and
BF%) with CRP in adolescents and young adults in 23 studies (96%) (p < 0.05) and there
was no significant association in adolescents in one study (4%). The findings of the
review in the associations between anthropometric adiposity measures (BMI, we, WHR,
and BF%) with IL-6 and TNF-a in adolescents and young adults remained inconsistent.
Further research is needed to focus on the interplay of diet, physical activity, or weight
loss with eRP, IL-6 and TNF-a for developing appropriate and effective lifestyle
modification in reducing circulating levels of CRP, IL-6 and TNF-a and in preventing
further development of atherosclerotic CVD and acute CVD events in later life.
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Methods
Research design. The proposed cross-sectional analytic study is designed to
achieve three specific aims. After screening for eligibility, health young adults 20-34
years old will be enrolled. Data will be collected on each participant through CRF testing,
anthropometric measurement and blood sampling of inflammatory biomarkers in one
session at the University of Texas Health Science Center at Houston (UTHSC-H) School
ofNursing (SON).

Participants and setting. The target population for this study is healthy young
adults aged 20 to 34 years residing in Houston, a large metropolitan city and with an
ethnically diverse population in southeast Texas. Adults can be divided into young
adulthood (the 20s and 30s), middle adulthood (the 40s and 50s), and later adulthood (age
60 or 65 and up) based on developmental periods in the human lifespan (Craig & Dunn,
201 0). The focus of this study is on young adults aged 20 to 34 without a known
diagnosis of diseases because women's menopause occurs after age of 40 to 45 and
perimenopause typically begins several years before menopause. A sample of the
population will be accessed using non-probability quota sampling approach in the area of
UTHSC-H.

Sample size. Sample size was estimated based on a multiple linear regression
model, regression coefficient (R2 ) with interactions using nQuery Advisor version 7.0
(nQuery, Saugus, MA). The estimated sample size was 88 subjects to detect a medium
effect size (0.059 ~ R2 < 0.138) according to Jacob Cohen (1998), a power of80%, and
an alpha level of 0.050 for a two-tailed test. With a sample size of 88, the interaction of
adiposity and CRF would be stated by at p < 0.05 if the change in R2 with the addition of
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the interaction term were as lower at 0.069. To address possible attrition up to 20%, 110
participants will be recruited. Since there were no previous studies to estimate for the
interaction term, the PI chose the medium (R2 ) of 0.069 for interactions for a multiple
linear regression model in this study.

Inclusion and exclusion criteria. Inclusion criteria are (1) young adults age 20-34
years; (2) healthy (defined as "not currently having acute or chronic diseases" as
specified in exclusion criteria); (3) capable of completing the CRF test and there is no
minimal or maximal value for vo2

max

as long as participants are physically able to do

CRF testing safely (ACSM, 2010a; ACSM, 2010b); and (4) able to speak and read
English. Exclusion criteria are as follows in both males and females: (1) currently nonsmoker or smoking cessation greater than 1year because smoking status may increase hsCRP, IL-6 and possibly certain cytokine receptors antagonists (O'Connor et al., 2009); (2)
alcohol dependence or regular consumption of more than 7 servings per week because
alcohol intake alters inflammatory biomarkers (O'Connor et al., 2009 ); (3) acute
infections, including a current or recent influenza illness, recent flu shot recipients, acute
respiratory infection within 2 weeks; (4) dental infection and problem within 2 weeks; ( 5)
CVD, such as hypertension, heperlipidemia and diabetes mellitus type I or II; (6)
rheumatoid arthritis and immune disorders because of the possible alteration of
inflammatory markers; (7) history of inflammatory bowel disease, such as Crohn' s
disease and ulcerative colitis; (8) recent surgery within 1 month; (9) currently taking
medications, such as hormone replacement therapy, antihypertensive medications, allergy
shots or systemic corticosteroids, aspirin, statin, and selective serotonin uptake inhibitors
(SSRis), and anti-inflammatory medications, all of which may impact levels of
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circulatory inflammatory biomarkers (O'Connor et al., 2009); (10) history of orthopedic
injury in the past and limitations due to the musculoskeletal demands of CRF test (11)
other medical conditions and medications that would increase inflammatory markers and
would prohibit CRF test; and (12) the maximum hs-CRP cut off point will be set at 10.0
mg/L which may have potentially reflected inflammation due to sepsis and an acute
infection or other inflammatory conditions (Pearson et al., 2003). For females, inclusion
criteria are as follows: (1) self-reported menstrual cycle length of24-35 days during the 2
months before entering the study; and (2) self-reported without a menstrual period at the
time of data collection because menses may impact increased levels of CRP (Gaskins et
al., 2012). Exclusion criteria are as follows: (1) natural or surgical menopausal status; (2)
use of hormone replacement therapy (HRT); (3) not currently or recently (past 6 months)
pregnant status; (4) not currently or recently (past 2 months) lactating females because
breast feeding may influence CRP (Williams, Williams & Poulton, 2006); (5) history of
gynecologic problems, such as fibroids, endometriosis, or polycystic ovary syndrome
because these gynecologic problems have been reported to increase CRP (EscobarMorreale, Luque-Ramirez, & Gonzalez, 2011); (6) hormonal contraception use within the
past three months , such as hormone patch and vaginal ring methods; and (7) IUDs with
hormones and Depo-Provera within the past 12 months, which of all may increase
inflammatory biomarkers (Gaskins et al., 2011; O'Connor et al., 2009). Those taking oral
contraceptives will not be excluded from the study, but data on this variable will be
collected so that it can be included as a covariate in the analysis.

Setting for data collection. The data will be collected by the PI at the Center for
Nursing Research, and a biological sciences laboratory in the UTHSC-H SON. Data
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collection will be performed in a CRF study room in the UTHSC-H SON. The room will
be maintained between 68 and 76 degrees Fahrenheit, with a humidity level between 20
to 60 percent using a room temperature thermometer (Q-Track IAQ monitor, TSI
Incorporated, Shoreview, MN) throughout the data collection period based on the
Occupational Safety and Health Administration recommendations (2003).

Recruitment of subject and data collection procedure. Participants will be
recruited by posting fliers in the UTHSC-H and surrounding communities ofUTHSC-H
as well as by sending e-mails to students and employees of the UTHSC-H. The
recruitment will begin from the end ofNovember 2012 through December 2013. Time
frame of project activity is provided (Appendix F). A flyer and email will describe the
need for healthy young adult volunteers, age 20-34 years, of all fitness and weight levels.
The flyers will include a very brief description of the study, and will provide the PI's
phone number and e-mail address for further information (Appendix A). If participants
are interested in the study, they will contact the Pl. The PI will provide detailed
information on the study, including the purpose of the study, study procedures, data
collection plan, and potential risks and benefits. During a telephone interview, the PI will
screen participant's eligibility. When participants meet the inclusion criteria and they
show an interest in participating in the study, they will be scheduled to attend a data
collection session in the UTHSC-H SON. For preparation of data collection, participants
will be instructed (1) not to eat after 8 pm the night or 12 hours before the testing; (2) not
to do strenuous exercise, consume alcohol, or use anti-inflammatory drugs 24 hours prior
to blood sampling; (3) to arrive at the UTHSC-H SON bioscience laboratory between
8am and 10 am; (4) to wear comfortable exercise-type clothing; (5) to avoid tobacco and
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caffeine 3 hours prior to test; (6) to consume plenty of fluids; and (7) to obtain an
adequate amount of sleep the night before the test (ACSM a, 2010; ACSM b, 2010).
Because inflammatory markers are elevated during menstruation, women participants
will be scheduled for a day when they are not menstruating (Gaskins et al., 2011).
Before collecting the data, informed consent will be obtained by the PI. The PI will
thoroughly explain and will clarify any information on this study. After obtaining
informed consent, each participant will complete an interview guided pre-assessment
health questionnaire (ACSM a, 2010). The questionnaire was designed to identify
whether the participants are safe to test for CRF (ACSM a, 201 0). If the participant will
not be safe to perform CRF testing, he or she will be excluded such as high blood
pressure, short of breath, chest pain, heart palpitation, heart murmur, fainting, back pain
and intermittent leg pain. Once the participant is eligible to perform CRF testing, the
eligible participant's blood test will be collected between Sam and lOam. After collecting
blood samples, anthropometric characteristics (height, weight and waist circumference)
will be measured. A light snack and water will be provided. After a brief resting period,
the PI will conduct CRF testing. The CRF test will take 20-30 minutes of walking on the
treadmill including warm-up and cool down stages. Participants who complete all
procedures will be compensated with a $10 gift card. All procedures will be conducted by
the PI. The results of CRF levels, body anthropometric measurements and levels of
inflammatory markers will be released for participants who show an interest in knowing
their results. Procedures for obtaining informed consent and all protocols will be
approved by the Committee for the Protection of Human Subjects at the UTHSC-H.
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Instruments.
Demographic characteristics. The PI will complete pre-assessment questionnaire
regarding demographic and health-related information, lifestyle, and activity levels from
participant's self-report. The pre-assessment questionnaire was developed by ACSM
(2010a).The demographic information includes information on age, gender, ethnicity,
marital status, and education. Age, gender, ethnicity and education will be described
participants' characteristics and be used as covariates in the multiple regression analysis.
Assessment of CRF. CRF will be assessed by a single-stage submaximal
treadmill walking test (SSTWT). The SSTWTwas developed by Ebbeling et al. (1991)
for estimating V02max of low-risk, healthy adults 20 to 50 years. The SSTWT was
validated by correlating the indirectly estimated V02max based on individual's walking
speed, heart rate (HR), age and sex and the directly measured respiratory gas exchange
(V02max) in the cross-validation group (N = 22) (Ebbeling et al., 1991). A correlation (r)
of .96 was reported, with multiple correlation (R2) of .86 (SEE= 4.85 ml· kg- 1·mim- 1)
(Ebbeling et al., 1991 ).
Single-stage submaximal treadmill walking test protocol. The SSTWT consisted
of a 4-minute warm-up stage, 4-minute workload stage, and a 2- 5minute cooldown stage.
The treadmill will be calibrated before CRF test to ensure the accuracy of the test. Prior
to beginning the SSTWT, participants will be familiarized with the treadmill (Precor 956i,
Precor, Inc., Woodinville, WA), including a visual demonstration in order to maximize
participant safety.
In the first warm-up stage, participants will walk on the treadmill for a 4-minute
at 0% incline and a walking speed (2.0 to 4.5 mph) that brings the HR to between 50%
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and 70% beats per minute (bpm) age-predicted maximal HR by the Pl. In workload stage,
the treadmill incline will increase to 5% at the same speed for a 4-to 5-minute. Following
a workload stage, the participants will complete a cooldown stage at a slow walk and 0%
incline for a 2-5minute. Resting BP and HR using the oscillometric technique (HEM907SL, Omron Healthcare, Inc., Bannockburn, IL) will be assessed prior to a warm-up
stage, twice and after a cool-down stage one time. If the participant's resting blood
pressure ~ 130/90 mmHg or resting HR ~ 100 per minute, the participant will not be
allowed to have a SSTWT. Polar HR (Vintage NV model, Polar CIC, Inc., Port
Washington, NY) will be recorded during the SSTWT protocol and the Borg Ratings of
Perceived Exertion scale (RPE) will be documented at the end of the warm-up stage and
the workload stage. The Borg Scale takes into account a participant's fitness level. It
matches how hard he or she feels he or she is working with numbers from 6 (very, very
light) to 20 (very, very hard) (Borg, 1970). Steady-state HR defines as a HR within± 5
bpm during the last 2minute of the workload stage.
The main outcome of the CRF test will be estimated maximal oxygen uptake
(V02max). The SSTWT prediction equation will be used to estimate V02max based on
age, sex, walking speed (mph), and steady-state HR.
Estimated V02 max (ml·kg-1·min-1) = 15.1 +21.8 (speed in mph)- 0.327 (steady
state HR in bpm)- 0.263 (speed x age in years)+ 0.00504 (SS HR in bpm age in
years)+ 5.98 (sex; female= 0, male= 1)

Assessment of adiposity. Adiposity will be assessed using BMI and waist
circumference. BMI will be calculated by dividing the participant's weight in kilograms
by the height in meters squared (kg/m2). Height will be measured without shoes to the
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nearest 0.1 em using a wall-mounted stadiometer (Accustat, Genentech Inc.). Weight will
be measured to the nearest 1/4th lb with a calibrated balance beam scale. Height and
weight will be measured with minimal clothing and without shoes and hats (NHANES,
2010). Waist circumference (WC) is a measure of the degree of central of body fat. WC
will be measured to the nearest 0.1 em using a flexible, nonstrectchable tape. The tape
measure will be placed just above the uppermost lateral border of the right ilium crest and
will be extended around the waist in a horizontal plane (NHANES, 201 0).

Measurement ofhs-CRP, IL-6, and TNF-a. Prior to blood sample collection, the
PI will ascertain that the participant is comfortable with instructions and procedures for
collecting blood sample. A 10 ml fasting blood will be collected from an antecubital vein
into two vacutainers containing ethylene diamine tetra acetic acid (EDTA) vacutainers by
the PI. After collecting two EDTA vacutainers, the blood samples will be transported to
the Bioscience Laboratory in the UTHSC-H SON on dry ice pellets with ice designed for
frozen temperature to maintain that temperature. The blood samples will be immediately
centrifuged at 1,630 relative centrifugal force (ret) at -4°C for 30 minutes
(Centrifuge5810R, Eppendorf AG Hamburg, Germany). After centrifugation, plasma
samples will be divided into eight aliquots. Each cryo-tube will be labeled in numerical
order of the participant study identification, date, year, and stored at -80°C for up to a
maximum of one year.
Plasma hs-CRP will be determined by a sandwich ELISA (Alpco C-reactive
protein (hs-CRP), EIA, Salem, N.H., USA). Plasma hs-CRP will present in milligram per
liter (mg/L). Intra- and inter-assay coefficients of variation are less than 2%. Plasma IL-6
concentration will be measured using the BIOSOURCE Enzyme Amplified Sensitivity
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Immunoassay (EASIA) kit (BioSource, Nivelles, Belgium). Plasma TNF-a will be
quantified using a solid phase sandwich ELISA (ALPCO Diagnostics). Plasma IL-6 and

TNF-a will be represent in pictogram per milliliter (pg/ml). Plates of biomarkers will be
read on a microplate reader using absorbance (Bioteck instruments Inc., Winooski, VT).
WorkOut™ software (version 2.5, Perkin Elmer Life and Analytical Sciences) will be
used for analyzing assay results. Intra- and inter-assay coefficients of variation will be
below 10%. All inflammatory biomarkers will be assayed at the Bioscience Laboratory at
the UTHSC-H SON for this study.

Data Analysis
Statistical analyses will be performed by using statistical software SPSS version
22.0 (SPSS Inc., Chicago, IL). Descriptive statistics will be used to summarize
characteristics of study participants, including mean, standard deviation, frequency and
percentage. For continuous variables, histograms, box plots, and normality probability
plot will be used to identify normality of distribution, outliers, and missing data.
Appropriate transformations will be performed where necessary. All analyses will be
two-tailed and P-value < 0.05 will be considered statistically significant.
Separate analysis will be conducted with each of the inflammatory markers (hs-CRP, IL6, and TNF-a) as the dependent variable in multiple linear regression analysis for aim 1:
the strength of the association between CRF and inflammatory biomarkers, and the aim 2:
the strength of the association between adiposity and inflammatory biomarkers. Analyses
for aim 1 and 2 will be adjusted for possible confounders including age, sex, ethnicity
and education.
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Aiml. To determine the strength of the association between CRF levels with
circulating levels of plasma hs-CRP, IL-6, and TNF-a. Hypothesis: Higher levels of CRF
will be related to lower levels of circulating plasma hs-CRP, IL-6, and TNF-a.

Aim2. To determine the strength of the association between adiposity levels and
circulating levels of plasma hs-CRP, IL-6, and TNF-a. Hypothesis: 2a. Higher levels of
BMI will be related to higher levels of circulating plasma hs-CRP, IL-6, and TNF-a. 2b.
Higher levels of waist circumference will be related to higher levels of circulating plasma
hs-CRP, IL-6, and TNF-a.
Multiple linear regression models, with interaction terms (CRF x BMI) (CRF x
waist circumference) will be examined to assess aim 3: the moderating effect of adiposity
(moderator) on the strength of the association ofCRF (independent variable) with
inflammatory biomarkers (dependent variable). Analyses for aim 3 will be adjusted for
possible confounders including age, gender, ethnicity and education.

Aim3. To test the moderating effect of adiposity on the strength of the association
between CRF levels and circulating levels of plasma hs-CRP, IL-6, and TNF-a.
Hypothesis: 3a. Individuals with higher levels of BMI and higher levels of CRF will have
lower levels of circulating plasma hs-CRP, IL-6, and TNF-a compared with individuals
with higher levels ofBMI and lower levels ofCR fitness. 3b. Individuals with higher
waist circumference and higher levels of CRF will have lower levels of circulating
plasma hs-CRP, IL-6, and TNF-a compared with individuals with higher waist
circumference and lower levels of CRF.
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Limitations
Firstly, a weakness of this study is the difficulty of establishing causal
relationships from data collected in a cross-sectional time frame. Secondly, a nonprobability sampling method in a university setting will limit generalization of the
findings of this study. In spite of these limitations, the findings will provide important
knowledge about inflammatory markers in young adults and will be used for designing
longitudinal studies and interventions to improve cardiovascular health in this target
population.

Facilities/Resources/Consultants
Center for Nursing Research for CR fitness and bioscience laboratory for
handling and analyzing inflammatory biomarkers at the UTHSC-H SON are available for
the conduct of this project. Additionally, statisticians to assist with data management and
analysis are available. Lastly, fitness experts at UTHSC-H Recreation Center and School
of Public Health are available for consultation.

Human Subjects Concerns
Protection of human subjects. Protection of human subjects' rights will be
assured with obtaining appropriate approval from the University of Texas Health Science
Center at Houston Committee for Protection of Human Subjects (UTHSC-H CPS). The
PI will be trained on Collaborative Institutional Training Initiative (CITI) and iRIS. The
PI will thoroughly explain the purpose and overall procedure of the study, and potential
benefits and risks of participating in the study prior to obtaining informed consent.
Participants will be informed that if they are unwilling to participate in this study, they
can withdraw at any time. Participants will be allowed and encouraged to ask any
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questions regarding the study before completing the informed consent process with a
signature. No data will be collected before informed consent. Information regarding
protection of privacy and confidentiality, and how the data will be handled with
confidentiality will be provided to the participants.

Potential benefits and risk of the proposed study to the subjects. Participants
may benefit from learning about physical inactivity, body fatness and weight as related to
risk for cardiovascular disease. Participants will be informed of potential discomforts and
risks as related to CR fitness and blood sampling. With regards to blood test, participants
may feel some pain and have a bruise at the needle site. There might be a risk for
developing an infection at the needle site but this is rare. In relation to CR fitness,
participants may feel some discomforts during and after fitness test. These include
dizziness and fainting but these effects are rare. The trained professional is available to
assist with unusual situations that may arise. If participants are interested in their results,
they will be received a copy of their results.

Data and safety monitoring plan. The PI will be responsible for monitoring and
managing data safety and analysis procedures. Each participant will be given a study
identification number. Forms and documents will be kept separate from the data file and
kept in a locked cabinet. Data files and blood samples will be coded by the study
identification numbers. Confidentiality of the data will be assured through coding
systems without specific participant's identifiers. Protected data will be entered into a
double password protected computer database with restricted access to the system.

Inclusion of minorities, women, and children. The target population of this
proposed study is healthy young adults aged 20-34 years. This study population will
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include diverse ethnic groups, such as African American, Asian, and Hispanic. This study
will exclude children, adolescents, elderly, and pregnant women.
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Abstract
Background
Overweight and obesity are major risk factors for cardiovascular disease (CVD)
morbidity and mortality. Low- grade chronic inflammation may be a mediating factor in
the association of overweight and obesity with development of atherosclerosis and higher
risk for CVD and CVD events. C-reactive protein (CRP), interleukin-6 (IL-6), and tumor
necrosis factor-alpha (TNF-a.) are well-recognized markers of inflammatory response to
atherosclerosis.

Purpose
The purpose of the systematic review was to determine the associations between
anthropometric adiposity measures (BMI, WC, WHR, WHtR, and BF%) and
inflammatory biomarkers (CRP, IL-6, and TNF-a.) in adolescents and young adults.

Methods
The electronic databases Ovid MEDLINE, CINAHL, and SCOPUS were searched for
studies published between 1946 and July 2013. Inclusion criteria were (a) adolescents
and young adults aged 13 to 40 years without a known diagnosis of diseases (b)
examined the association between at least one anthropometric adiposity measures and
CRP, IL-6, and /or TNF-a., and (c) published study in English language.

Results
Of 4,876 identified publications, 176 were retrieved for detailed evaluation and 28 met
inclusion criteria. There is a significant and positive association between anthropometric
adiposity measured by total and central adiposity (BMI, WC, WHtR, WHR, and BF%)
and CRP in adolescents and young adults in 22 out of 23 studies (96%). Findings of
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anthropometric adiposity measures (BMI, WC, WHR, and BF%) and IL-6 and TNF-a in
adolescents and young adults remain inconclusive. No single anthropometric adiposity
measures in adolescents and young adults would appear to be superior in relation to CRP,
IL-6 and TNF-a.

Conclusions
The evidence supports that anthropometric adiposity measures are positively associated
with CRP in adolescents and young adults. However, anthropometric adiposity measures
and IL-6 and TNF-a in adolescents and young adults is inconclusive. Additional studies
are needed to identify the strength and patterns of association of anthropometric adiposity
measures with CRP, IL-6 and TNF-a. Further studies are needed to identify sex and
ethnicity differences in the association of anthropometric adiposity measures and
inflammatory biomarkers.

Keywords: body mass index; waist circumference; waist to hip ratio; waist to height
ratio; body fat percentage; c-reactive protein; interlukin-6; tumor necrosis factor-a;
adolescents; young adults
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Anthropometric Adiposity Measures and Inflammatory Biomarkers in Adolescents and
Young Adults: A Systematic Review
Atherosclerosis is a systemic disease process in which accumulation of plaque
builds up in the arterial wall and a main pathophysiological determinant of clinical
cardiovascular events, morbidity and mortality (Go et al., 2013 ). It has been shown that
chronic, low-grade inflammation plays an important role in the initiation and progression
of atherosclerosis by impairing endothelial function (Libby, Ridker, & Hansso~ 2009;
Widlansky, Gokce, Keaney, & Vita, 2003). The endothelial dysfunction promotes
development, progression, and clinical expression of atherosclerosis, such as an acute
atherosclerotic event (Bucdkley, Rongwei, Freeman, Rogers, & Helfand, 2009; Packard
& Libby, 2008; Wildansky et al., 2003). C-reactive protein (CRP), interleukin-6 (IL-6),

and tumor necrosis factor-a (TNF-a) are well-recognized biomarkers of inflammation in
relation to atherogenesis (Libby et al., 2009). CRP, a primitive acute phase inflammatory
protein, plays an essential role in innate immune response and inflammatory processes
(Wilson, Ryan, & Boyle, 2006). CRP is primarily produced in the liver and is synthesized
by hepatocytes in response to inflammatory cytokines, mainly IL-6 (Wilson et al., 2006).
IL-6 is a pro-inflammatory cytokine that play a major role in the acute phase response in
relation to infection and is produced by various cells, such as fibroblasts, endothelial
cells, monocytes, and adipocytes (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer,
2009). The important role of IL-6 is controlling hepatic production of inflammatory
proteins, including CRP (Schuett et al., 2009). TNF-a is a pro-inflammatory cytokine that
is secreted by various cells, such as macrophages, lymphocyte, and adipocytes (Petersen
& Pedersen, 2005).
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The prevalence of overweight and obesity is a significant public health problem
worldwide, and it has grown substantially over the past few decades (Lobstein, Baur, &
Uauy, 2004; World Health Organization [WHO], 2012). It is estimated that worldwide
obesity has more than doubled since 1980 (WHO, 2012). Overweight and obesity are
considered major risk factors for cardiovascular disease (CVD) mortality and morbidity
(Roger et al., 2012; WHO, 2012). The underlying mechanisms for the relationship of
overweight and obesity with CVD have not been fully elucidated. A growing body of
evidence indicates that chronic inflammation may be a mediating factor in the association
of obesity with development of atherosclerosis (Mathieu, Lemieux & Depres, 2010;
Rocha & Libby, 2009; Wang & Nakayama, 2010). More specifically, excess adipose
tissue induces pro-inflammatory cytokines, including IL-6 and TNF-a (Calabro et al.,
2009) which precipitate the release ofCRP from the liver (Wang & Nakayama, 2010;
Yudkin, Stheouwer, Emeis & Coppack, 1999). In this way, obesity itself promotes
inflammatory process which induces endothelial dysfunction and plaque formation, thus
contributing atherosclerosis and higher risk for future CVD and CVD events (McGill,
McMahan, Herderick et al., 2002; Meyers & Gokce, 2007; Ikeoka, Mader, & Pieber,
2010).
Albeit clinical symptoms related to atherosclerosis, such as chest pain or
discomfort, shortness of breath or fatigue, numbness, and blurred vision commonly are
not detected in adolescents and young adults, atherosclerotic changes in the vessel wall
already begin early in life, and these changes progress and predispose to the development
of atherosclerotic CVD and acute CVD events in middle-aged and older adult populations
(Jarvisalo et al., 2002). In addition, the growing overweight and obesity in adolescents
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and young adults accelerate atherosclerotic inflammatory processes (McGill, McMahan,
Herderick et al., 2002; Rocha & Libby, 2009). Therefore, knowledge of inflammatory
biomarkers in relation to adiposity in adolescents and young adults may lead to new
avenues to deter atherosclerotic processes that increase the risk of atherosclerotic CVD
and acute CVD events in middle and older adults.
Although dual-energy x-ray absorptiometry (DEXA), computed tomography
(CT), magnetic resonance imaging (MRI), and underwater weighing are more precise and
reliable measures of adiposity, these require greater cost and are not feasible in routine
public health and clinical practices (Stevens et al., 2008). For these reasons, adiposity has
been assessed by anthropometric measures (Body mass index [BMI], body fat percentage
[BF%], waist circumference [WC], waist to hip ratio [WHR], and waist to height ratio
[WHtR]) in public health and clinical practices. BMI is the most widely used
anthropometric measure and is calculated as body weight in kilograms divided by height
in meters squared (kg/m2 ) (Cornier et al., 2011). BF%, which can be estimated from
measurement of skinfold thickness or bioelectrical impedance, is also used for assessing
fat mass, or adiposity, as a proportion of total body mass (Stevens, McClain, &
Truesdale, 2008). BMI and BF% are measures of total adiposity whereas WC, WHR, and
WHtR are measures of central adiposity (Cornier et al., 2011). WC has been measured in
different ways. The National Institutes of Health National Heart, Lung, and Blood
Institute (HNHLB) (2000), currently recommends using an inelastic tape in a horizontal
plane at the end of normal expiration in United States for the measurement of WC. The
WHO (2011) recommends the use of the midpoint between the lower margin of the last
palpable rib and the top of the iliac crest. WHR is the circumference of the waist divided
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by the circumference of the hip and has been used for assessing body fat distribution
(Cornier et al., 2011). Hip circumference is measured at the level of the widest portion of
the buttocks (Cornier et al., 2011; WHO, 2011). WHtR is the circumference of the waist
divided by the height (Cornier et al., 2011).
To date, there is only one systematic review and meta-analysis addressing the
obesity and CRP in various populations (Choi, Joseph, & Pilote, 2012); however, this
review only focused on the CRP as a biomarker of inflammation. It is important to
evaluate other inflammatory markers, such as IL-6 and TNF-a in order to better
understand inflammatory processes in relation to anthropometric total and central
adiposity measures. Therefore, the purpose of the systematic review was to determine the
associations between anthropometric adiposity measures (BMI, WC, WHR, WHtR, and
BF%) and inflammatory biomarkers (CRP, IL-6, and TNF-a) in adolescents and young
adults without a known diagnosis of diseases. The goal of this systematic is to provide
better understanding of the evidence linking anthropometric adiposity measures with
inflammatory processes in young individuals free of co-morbidities. This review may
provide an insight for early intervention strategies, such as a lifestyle modification and
weight loss for improving long-term outcomes of reducing inflammation as related to
adiposity. Additionally, this systemic review identifies gaps in current knowledge and
provides future directions for research and practice.

Methods
Literature Search
A systematic literature search was conducted to identify potentially relevant
studies examining the association between anthropometric adiposity measures and
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circulating levels ofCRP, IL-6, and TNF-a in adolescents and young adults. The
electronic databases Ovid MEDLINE (from 1946 to July 03, 2013), CINAHL (from 1995
to July 05, 2013), and SCOPUS (from 1960 to July 05, 2013) were searched. Reference
lists of articles that met the inclusion criteria were searched manually for any additional
studies. Search terms included Medical Subject Headings (MeSH) and keywords related
to anthropometric adiposity measures ("body mass index,"" waist circumference,"
"abdominal obesity," "abdominal adiposity," "abdominal diameter," "waist to hip ratio,"
"waist to height ratio," "skinfold thickness," "body fat percentage," "body fat
distribution," "body composition"); inflammatory markers ("inflammation," "C-reactive
protein", "interleukin-6","tumor necrosis factor-alpha"); and "adolescent," "teen,"
"university student," "college student," and "young adult." Each category of variables
was combined with each population using the "OR" Boolean operator. The variables and
population were then combined using the ''AND" Boolean operator. Literature searches
were limited to the English language and human subjects. The process of the search
strategy is shown in Figure 1.

Inclusion and Exclusion Criteria
Inclusion criteria were: ( 1) adolescents and young adults aged 13 to 40 years; (2)
investigated the association between at least one anthropometric adiposity measures and
CRP, IL-6, and/or TNF-a; (3) anthropometric adiposity measured by BMI, WC, WHR,
WHtR, and/or body fat percentage assessing a skinfold thickness or bioelectrical
impedance ; (4) CRP, IL-6, and TNF -a levels measured from blood samples; (5) all types
of research designs; (6) an original study; (7) no country restriction; and (8) published
study in English language. Exclusion criteria were: (1) adolescent and young adults with
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diagnosed diseases and infectious diseases; (2) pregnant women; (3) adiposity measured
only by DEXA or MRI; (4) a review or an editorial article; and (5) an abstract.

Data Extraction and Synthesis
This review extracted year of publication, country, participants, setting, design,
study period, anthropometric measures, measures ofCRP, IL-6 and TNF-a., results,
analysis and significance of the association, and adjustment of covariates (Table 1 and
Table 2). Mean, range, and proportion of age, sex, ethnicity, BMI, and sample size were
reported. The statistical analyses and significance of associations or correlations between
anthropometric adiposity measures and CRP, IL-6 and TNF-a for each study were
presented as odds ratios, correlation coefficients, and/or regression coefficients with pvalue and 95% confidence interval if original studies were reported in this way. If the
results of the studies were not reported in this way, the study findings were summarized
for this review. Due to variation in growth rates, hormonal changes and pubertal stage of
adolescents and young adults, the two groups were considered separately in this review.

Study Quality Assessment
Study method and quality were assessed using an evaluation checklist, which was
developed by the first author based on the guidelines for assessing observational studies
(Pocock et al., 2004; von Elm et al., 2007; Zaccai, 2004). This evaluation checklist
included 11 questions to evaluate the main issues and potential biases related to design,
sampling, setting, measurements, analyses, and peer-review of each study (Table 3 and
Table 4). Each item was scored as "Yes=1," "No=O," and "Not reported=O", allowing the
range of the score to be 0 to 11.
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Results
Study Selection
As can be seen in Figure 2, a total of 4,876 studies were found from the Ovid
MEDLINE, CINAHL, SCOPUS databases, and manual search of references. Of these,
264 studies were identified by title and abstract. After the removal of duplicates, 176
relevant studies remained for further detailed evaluation of the full text. Of the 176
studies, 139 studies were excluded: 61 were not relevant to the research questions; 42
studies were excluded for not meeting the criteria of age 13-40 years; 27 did not report
associations or correlations between anthropometric adiposity measures and
inflammatory markers; in four studies adiposity was measured by only DEXA or MRI;
and in two studies participants had diagnosed diseases. In addition, two studies were
excluded since dependent variables were not related to inflammatory biomarkers (CRP,
IL-6, and TNF-a). Three cross-sectional studies were excluded due to same data from the
same study cohort were collected. Four studies were a review or editorial and two studies
reported an abstract only. Lastly, one systematic review and meta-analysis was excluded
(Choi, Joseph & Pilote, 2013). Thus, 28 studies were included in this systematic review.
The specific search strategies are illustrated in Figure 2.

Study Characteristics
Of 28 studies, six were conducted in United States, 17 were conducted in
Australia, Egypt, Germany, Spain, Brazil, Italy, United Kingdom, Columbia, Finland,
and New Zealand, and five studies were conducted in Korea, China, Philippines and
India. Age of participants ranged from 13 to 39 years. The studies enrolled a total of
15,862 participants; 4,859 adolescents and 11,003 young adults. Sample size ranged from
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30 to 3,289 per study. Of the 28 studies, five studies consisted of males only (Jung et al.,
2008; Vikram et al., 2006; Bo, Raspo, Morra, Isaia et al., 2004; Bo, Raspo, Morra,
Cassader et al., 2004; Perez et al., 2003), four studies consisted of females only (ElWakkad et al., 2013; Serrano et al., 2010; Brydon et al., 2008; Morrison et al., 2011), and
19 studies consisted of both males and females . Of the 28 studies, nine studies reported
participant's ethnicity (Huang et al., 2011; Jung et al., 2008; Khan et al., 2010; Moon et
al., 2004; Petty et al., 201 0; Brydon et al., 2008; Mills et al., 2008; Morrison et al., 2011;
Wang, Christoffel et al., 2011 ).
For study design, only one out of28 studies had a prospective design (Khan et al.,
201 0), whereas the other remaining 27 studies used cross sectional designs. Although the
data of the two studies were from the same study cohort (McDade et al., 2009; McDade
et al., 2011), this review included these two studies because the outcomes of the
inflammatory biomarkers are different; One study focused on CRP only (McDade et al.,
2009) and the other study examined IL-6 only (McDade et al., 2011).
Of the 28 studies, nine studies analyzed data combining both males and females
(Herder et al., 2007; Khan et al., 2010; Martinez-Gomez et al., 2010; Moon et al., 2004;
Hermsdorff et al., 2011; McDade et al., 2009; McDade et al., 2011; Mills et al., 2008;
Orri et al., 201 0). Eight studies conducted a separate analysis for males and females
(Denney-Wilson et al., 2008; Huang et al., 2011; Petty et al., 201 0; Wang et al., 2011;
Wamber et al., 2006; Nazmi et al., 2008; Raitakari et al., 2005; Williams et al., 2002).
Two studies reported data for a combined analysis for males and females as well a
separate analysis for males and females (Hermsdorff et al., 2012; Wang, Reed et al.,
2011 ). In addition, none of the studies reflected ethnic influences or ethnic differences in
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the association between anthropometric adiposity and inflammatory biomarkers in this
review. Two studies reported ethnicity, but they did not determine the association
between anthropometric adiposity and inflammatory biomarkers (Khan et al., 201 0;
McDade et al., 2011 ). The association between adiposity and inflammatory biomarkers
was analyzed using odds ratio, Pearson coefficient, Spearman coefficient, or regression
coefficient. The detailed characteristics of each study were summarized in Table 1 and
Table 2.

Anthropometric Adiposity Measures
Anthropometric adiposity was assessed by BMI, WC, WHR, WHtR, and BF. The
BF (mm) or (%) was examined by sum of skinfold thickness using a skinfold caliper or
by bioelectrical impedance. Of the total 28 studies, 24 studies included two or more
anthropometric measures; two studies used BMI only (Khan et al., 2010; McDade et al.,
2011); one study used WC only (Jung et al., 2008); and one study used BF% only
(Hermsdorff et al., 20 12). Twenty six studies considered adiposity as a continuous
variable and two studies analyzed adiposity as a categorical variable (Denney-Wilson et
al., 2008; Nazmi et al., 2008). Of these two studies, one study categorized BMI into nonobese, overweight and obesity based on the International Obesity Task Force and the
United Kingdom Child Growth Foundation Charts (Denney-Wilson et al., 2008) and the
other study categorized BMI into WHO recommendation: < 18.5kg/m2
(underweight),18.5-24.9 kg/m2 (normal), 25.0-29.9 kg/m2 (overweight), and 30kg/m2
(obese) (Nazmi et al., 2008) (Table 1 and Table 2).
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Measurement of CRP, IL-6 and TNF-a
CRP was measured using diverse immunoassay tests. Five studies used enzymelinked immunosorbent assay (ELIZA), 5 studies used immune-turbidimetry, 2 studies
used high-sensitivity immunoassay, 2 studies used automated DPC immulite
chemiluminescent immunoassay, and other studies used ultrasensitive assay, high
sensitive-monoclonal antibody assay, latex enhanced immune-turbidometry, sandwich
immunoassay, high sensitivity-Denka-Seiken assay, high sensitivity-latex enhanced
immune-nephelometric assay and Cardio high sensitivity-CRP assay. For IL-6, 6 studies
used ELIZA, and other studies used high sensitivity-human cytokine, and high
sensitivity-multiplex immunoassay. For TNF-a, 4 studies used ELIZA. Of the 28 studies,
21 studies have an overnight fast.

Study Quality Assessment
None of the studies met all of the evaluation quality criteria. Of the 28 studies,
eight studies met high quality ( 10 out of 11 ); eight studies met nine out of 11; six studies
met eight out of 11; five studies met seven out 11; and one studies met low quality (six
out of 11 ). Of the 28 studies, 25 studies reported study designs either in method section,
discussion or limitation section. Of the 28 studies, 10 studies did not specify inclusion
and exclusion criteria, and only one study reported a sample size estimate (Nazmi et al.,
2008). Of the 28 studies, six studies (Jung et al., 2009; Bo et al., 2004; Mills et al., 2008;
Morrison et al., 2011; Orri et al., 201 0; Raitakari et al., 2005) did not report how
anthropometric adiposity was measured in detail and three studies (Hennsdorff et al.,
20 12; Hennsdorff et al., 2011; McDade et al., 2009) provided protocols and guidelines on
the measurements of anthropometric adiposity in their reference section (Table 3, Table
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4). Of the 28 studies, 12 adjusted for covariates in data analysis. Covariates included age,
gender, ethnicity, lipids, family income, physical activity, pubertal status, and
homeostasis model assessment of insulin resistance (HOMA-IR) in adolescent studies,
whereas, age, gender, smoking status, physical activity, skin color, family income, years
of education were included in young adult studies.

Associations of Anthropometric Adiposity Measures with Inflammation in
Adolescents
Thirteen studies identified associations between anthropometric adiposity
measures (BMI, WC, WHR, WHtR, and BF) and inflammatory biomarkers (CRP, IL-6,
and TNF-a) in adolescents. The descriptive values on anthropometric adiposity measures
(BMI, WC, WHR, WHtR, and BF) and inflammatory biomarkers (CRP, IL-6, and TNFa) were reported in Table 1.

Anthropometric adiposity and CRP. Of these 13 studies, 10 studies examined
the association of anthropometric adiposity measures and CRP levels (Denney-Wilson et
al., 2008; Huang et al., 2011; Jung et al., 2009; Khan, Rieder, Cohen, Coupey, &
Wildman, 201 0; Martinez-Gomez et al., 201 0; Petty et al., 201 0; Serrano et al., 201 0;
Vikram et al., 2006; Wang, Christoffel et al., 2011; Warnberg et al., 2006). Of the 10
studies, nine studies found significantly positive associations between one or more
anthropometric adiposity measures (BMI, WC, WHR, WHtR, and BF) and CRP
(Denney-Wilson et al., 2008; Huang et al., 2011; Jung et al., 2009; Khan, Rieder, Cohen,
Coupey, & Wildman, 201 0; Martinez-Gomez et al., 201 0; Petty et al., 201 0; Vikram et
al., 2006; Wang, Christoffel et al., 2011; Warnberg et al., 2006). However, one study did
not find any significant association ofBMI and WC with CRP (Petty et al., 2010). Of the
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nine studies, five studies included males and females separately (Denney-Wilson et al.,
2008; Huang et al., 2011; Petty et al., 201 0; Wang, Christoffel et al., 2011; Wamberg et
al., 2006). Of the five studies, four studies revealed that there were significantly positive
associations between two and more anthropometric adiposity measures (BMI, WC,
WHtR, and BF) and CRP in both males and females (Denney-Wilson et al., 2008; Huang
et al., 2011; Wang, Christoffel et al., 2011; Wamberg et al., 2006). However, one study
revealed that there were significantly positive associations ofBMI and WC with CRP
only for females but not males (Petty et al., 201 0).

Anthropometric adiposity and IL-6. Of these 13 studies, three studies
determined associations of anthropometric adiposity measures (BMI, WC, and BF) and
IL-6levels (Herder et al., 2007; Martinez-Gomez et al., 2010; Petty et al., 2010). Only
one study revealed that there were significantly positive associations between
anthropometric adiposity measures (BMI and WC) and IL-6levels (Herder et al., 2007).
In contrast, the remaining two studies revealed that no significant association between
anthropometric adiposity measures and IL-6 (Martinez-Gomez et al., 201 0; Petty et al.,
201 0). Of the three studies, only one study included a separate analysis for males and
females (Petty et al., 201 0). This study found that there were no significant associations
ofBMI and WC with IL-6 in males or females (Petty et al., 2010).

Anthropometric adiposity and TNF-a. Of these 13 studies, three examined
associations of anthropometric adiposity measures (BMI, WC, WHR, and BF) and TNFa. Two studies found that there were significant positive associations of BMI, WC, and
WHR with TNF-a (El-Wakkad et al., 2013; Moon et al., 2004). However, one study did
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not find significant associations ofBMI and WC with TNF-a (Herder et al., 2007). None
of these studies included sex differences.

Association of Anthropometric Adiposity Measures and Inflammation in Young
Adults
Fifteen studies found associations between anthropometric measures (BMI, WC,
WHR, WHtR, and BF) and inflammatory biomarkers (CRP, IL-6, and TNF-a) in young
adults. The descriptive values on anthropometric adiposity measures (BMI, WC, WHR,
WHtR, and BF) and inflammatory biomarkers (CRP, IL-6, and TNF-a) were reported in
Table 2.

Anthropometric adiposity and CRP. Of the 15 studies, 13 studies determined
the association of anthropometric adiposity measures and eRP (Bo, Raspo, Morra,
eassader, et al., 2004; Bo, Raspo, Morra, Isaia, et al., 2004; Hermsdorff et al., 2012;
Hermsdorff, Zulet, Puchau, & Martinez, 20 II; McDade et al., 2009; Mills et al., 2008;
Morrison et al., 2011; Nazmi et al., 2008; Orri, Carter, & Howington, 2010; Perez et al.,
2003; Raitakari et al., 2005; Wang, Reed, Goli, & Goswami, 2011; Williams et al., 2002).
All of the 13 studies found that there were significant positive associations between one
or more anthropometric adiposity measures (BMI, we, WHR, and BF) and CRP. Of the
13 studies, five studies included a sex differences (Hermsdorff et al., 2012; Nazmi et al.,
2008; Raitakari et al., 2005; Wang, Reed et al., 2011; Williams et al., 2002). Of the five
studies, four found that there were significantly positive associations between two or
more anthropometric adiposity measures (BMI, we, WHR, and BF) and eRP in both
males and females (Hermsdorff et al., 2012; Nazmi et al., 2008; Raitakari et al., 2005;
Williams et al., 2002). However, remaining one study showed that there were significant
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positive associations ofBMI and BF% with CRP in females but not males (Wang, Reed
et al., 2011 ).

Anthropometric adiposity and IL-6. Of these 15 studies, five studies focused on
associations between anthropometric adiposity measures (BMI, WC, WHR, and BF%)
and IL-6. Of the five studies, four reported a significant positive associations between
one or more anthropometric adiposity measures (BMI, WHR, and BF%) and IL-6
(Brydon et al., 2008; Hermsdoff et al., 2011; McDade et al., 2011; Mills et al., 2008).
However, one study did not find significant associations of BMI and BF% with IL-6
(Wang, Reed et al., 2011 ). Of the five studies, sex differences were examined only in one
study, in which no significant associations of BMI and BF% with IL-6 in either males or
females were found (Wang, Reed et al., 2011).

Anthropometric adiposity and TNF-a. Of these 15 studies, only one study
examined associations between anthropometric adiposity measures (BMI and BF%) and
TNF-a (Wang, Reed et al., 2011). The study did not find significant associations ofBMI
and BF% with TNF-a (Wang, Reed et al., 2011 ). In sex differences, the study did not
find significant associations ofBMI and BF% with TNF-a in either males or females
(Wang, Reed et al., 2011).

Discussion
Synthesis of Main Findings and Knowledge
The major finding of this systematic review is that there is a significant and
positive association between anthropometric adiposity measured by total and central
adiposity (BMI, WC, WHtR, WHR, and BF%) and CRP in adolescents and young adults
in 22 out of 23 studies (96%). These positive associations are consistent with the findings
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of a previous review on the positive association between abdominal adiposity and CRP in
adults (Brooks et al., 201 0) and a previous systematic review and meta-analysis on
obesity and CRP in various populations (Choi, Joseph, & Pilote, 2012). In addition,
elevated circulating levels of CRP were found in obese participants when compared with
non-obese counterparts, which supported evidence for an association of obesity and CRP
(Denney-Wilson et al., 200; Nazmi et al., 2008) (p < 0.05). The finding of a significant
association between obesity and CRP is in agreement with previous results showing that
weight loss was associated with a decline in circulating levels ofCRP in obese
individuals aged 20 to 46 years (Esposito et al., 2003) and systematic review (Selvin,
Paynter, & Erlinger, 2007) which provide additional supportive evidence for a link of
obesity and CRP. Only one study did not indicate.any significant associations between
the anthropometric measures (BMI, WC, WHR, and BF%) and CRP in female
adolescents in Brazil (Serrano et al., 201 0). This study did not report detailed information
about the measurement of CRP assay and coefficients of variation (CV), and did not
discuss any limitations regarding the fmdings.
The present systematic review examined additional inflammatory biomarkers,
including IL-6 and TNF-a and anthropometric adiposity. The findings of the review in
the associations between anthropometric adiposity measures (BMI, WC, WHR, and
BF%) with IL-6 from eight studies and TNF-a from four studies in adolescents and
young adults have shown inconsistent results. Of the eight studies of IL-6, five studies
revealed significant positive associations (p < 0.05) in adolescents (Herder et al., 2007)
and young adults (Brydon et al., 2008; Hermsdoff et al., 2011; McDade et al., 2011; Mills
et al., 2008), whereas three studies showed no significant associations in adolescents
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(Martinez-Gomez et al., 2010; Petty et al., 2010) and young adults (Wang, Reed et al.,
2011). Of the four studies in TNF-a, two studies revealed significantly positive
associations (p < 0.05) in adolescents (El-Wakkad et al., 2013; Moon et al., 2004) and
two studies found no significant associations in adolescents and young adults (Herder et
al., 2007; Wang et al., 2011). One of the possible reasons for the discrepancy may be due
to the different sampling strategies. For instance, some studies consisted primarily of
non-obese participants (Herder et al., 2007; Martinez-Gomez et al., 2010; Petty et al.,
201 0; Wang, Reed et al., 2011, whereas other studies had a preponderance of obese
participants (El-Wakkad et al., 2013; Moon et al., 2004). The latter might be better able
to identify an obesity-induced inflammatory association than the former. Another
possible reason for the discrepant findings may be attributable to low blood
concentrations of IL-6 and TNF-a if some studies have participants who are mostly from
a non-obese population. Of studies showing the positive association of anthropometric
measures with CRP, IL-6 and TNF-a in adolescents and young adults, there was no
single anthropometric adiposity measure that suggested a stronger correlation than others
with CRP, IL-6 and TNF-a in adolescents and young adults.
Sex

Sex has been reported to influence the association between anthropometric
adiposity measures and inflammatory biomarkers. For sex differences, only two studies
reported there were significant positive associations of anthropometric adiposity
measures (BMI, WC, and BF%) with CRP in female but not males (Petty et al., 2010;
Wang et al., 2011). The findings are congruent with previous systematic review and
meta-analysis showing that r for BMI and ln(CRP) was greater in women than men by
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0.24 (CI, 0.09-0.37) in adults (Choi, Joseph, & Pilote, 2012). In a previous populationbased study of middle-aged men and women, adiposity was strongly associated with
higher CRP levels in women as compared to men (Thorand et al., 2006). It could be
explained in several ways. First of all, women have more total adiposity and
subcutaneous fat than men (Lohman, 1981 ). In addition, women have higher levels of
CRP as compared to men (Khera et al., 2005). Moreover, women who take oral
contraceptives have higher levels of CRP compared with those taking a placebo
(Eilertsen et al., 2005). Furthermore, women during menses have higher levels of CRP
(median, 0.74mg/L), than CRP during the follicular phase of the menstrual cycle and
CRP during ovulation is lowest (Gaskins et al., 2011 ). In these cases, study designs could
control use of oral contraceptives as a covariate. Also, data on CRP could be collected at
times other than the menstrual phase. Thus, the associations between anthropometric
adiposity measures and inflammatory biomarkers might be modified by sex. However,
further studies are needed to identify sex differences while controlling use of oral
contraceptives and menses. None of studies determined sex differences in anthropometric
adiposity measures and IL-6 and TNF-a.
Etbnicity
For ethnicity differences, none of the studies reflected ethnic and race differences
in associations between anthropometric adiposity measures and inflammatory markers in
this review. Only two studies out of28 studies reported ethnicity, but these studies did
not determine differences by ethnicity (Khan et al., 201 0; Mills et al., 2008). Previous
systematic review and meta-analysis found that the association (r) between obesity (BMI)
and In (CRP) was greater in North Americans/Europeans than Asians by 0.15 (CI, 0-
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0.28), which indicated that ethnicity may be a potential moderator between
anthropometric adiposity measures and inflammatory markers. Therefore, information on
ethnicity should be obtained and tested as a moderating variable in the analysis of future
studies.
Study Methodological Quality
The majority of studies used a cross-sectional design, from which causality
between adiposity and inflammation could not be determined. Additionally, this crosssectional design does not allow a prospective evaluation of these associations. Ten
studies of a total of 28 studies did not address specific inclusion and exclusion criteria of
participants. Of the 10 studies, seven studies were conducted in nationally representative
samples and the participants were relatively healthy adolescents and young adults
(Denney-Wilson et al., 2008; Huang et al., 2011; Martinex-Gomez et al., 2010; McDade
et al., 2009; Morrison et al., 2011; Nazmi et al., 2008; Wang et al., 2011); however,
studies without considering inclusion and exclusion criteria had reduced internal validity.
Interestingly, most studies did not report any power calculation to justify their sample
size, although most of these studies included a large sample size and were populationbased studies. Studies conducted with a small sample size without achieving sufficient
power also may reduce generalizability and external validity.
In addition ten of these 28 studies did not report CV of the assay, so the degree of
measurement error is unknown. Moreover, one study addressed that CRP was measured
by non-high sensitive assay, which potentially could lead to underestimation of the
association of anthropometric adiposity and CRP (Williams, et al., 2002). More sensitive
biomarkers should be required to accurately detect circulating levels of the inflammation
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especially in healthy populations in order to avoid reducing internal validity.
Furthermore, the majority of studies assessed a single CRP, IL-6 and TNF-a
measurement, which may not accurately reflect long term-low grade inflammatory status.
Sixteen of the 28 studies did not report potential confounders, such as age, sex, ethnicity,
acute smoking/current smokers, and alcohol dependence for their statistical analyses
(O'Connor et al., 2009). This lack of identification and control of potential confounding
variables also reduced internal validity.

Gaps and Future Directions
In order to further advance knowledge in the area of anthropometric adiposity
measures and inflammation in adolescents and young adults, gaps are identified and
recommendations are proposed based on this review. First of all, there is not enough
evidence to arrive at the conclusion of anthropometric adiposity measures with IL-6 and
TNF-a. More evidence is required for anthropometric adiposity measures with IL-6 and
TNF-a, particularly using continuous variables for more accurate estimation of the
strength of associations. Also, stratified sampling or quota sampling strategies regarding
non-obese, overweight, and obese participants should be considered for better detection
of associations between adiposity and inflammatory processes. Secondly, of the 28
studies, ten studies included a sex breakdown and a statistical analysis was performed for
males and females separately. Of the 28 studies, four studies did not control sex either
separately or as a covariate (Moon et al., 2004; McDade et al., 2009; Mills et al., 2008;
Orri et al., 2010), and none of the studies determined ethnicity differences or influences.
Future studies should routinely obtain and assess sex and ethnicity because of the
potential impact of sex and ethnicity in the association between adiposity and
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inflammation (Choi et al., 2012; O'Connor et al., 2009). Thirdly, other important
variables, such as a smoking status, alcohol dependence, acute exercise, and selective
serotonin reuptake inhibitor (SSRI) use, which increase in inflammatory markers and
may contribute to the heterogeneous results, should be assessed, controlled and possibly
excluded (O'Connor et al., 2009), and explain how and why they chose covariates for
adjustment or exclusion criteria in order to rule out their effects on the association
between anthropometric adiposity measures and inflammation. In addition, two studies
suggested that diet and physical activity/fitness play an important role in reducing
inflammatory markers (Petty et al., 201 0; Vikram et al., 2006), thus future studies need to
focus on the interplay of diet and physical activity/fitness, and how those variables
influence the association between anthropometric adiposity measures and inflammation.
Fourthly, most studies did not provide the justification of their sample size. Future studies
should consider sufficient power calculation to justify their enough sample size or a
larger sample of both genders in order to confirm these findings. Fifthly, since there is a
limitation of cross-sectional design, the significant association between anthropometric
adiposity measures and inflammation need to be evaluated in prospective studies in
adolescents and young adults. Sixthly, most studies pointed out the use of a single
measurement of inflammatory biomarkers, which may reduce a precision to reflect a
long-term inflammatory status. Future studies should consider repeated measurements in
order to ascertain a more stable estimate of inflammatory status. Lastly, in order to
understand underlying inflammatory mechanisms in relation to anthropometric adiposity,
other inflammatory markers, such as

IL-l~'

should be investigated.
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Review Limitations
This systematic review has some limitations. First of all, since this review was
limited by studies published in English language, a reporting bias may exist. Some of the
included studies did not consider their inclusion and exclusion criteria, which may reduce
internal validity. In addition, this review only focused on indirect measures of excess
adiposity; BMI, WC, WHR, WHtR, and BF%, which has less accuracy than direct
measures, such as DEXA, CT, or MRI. Furthermore, heterogeneity of study populations
and diverse statistical analyses for associations limited the consolidation for synthesis of
main findings. The evaluation checklist for study quality assessment was developed
based on the guidelines for assessing observational studies (Atlantis & Baker, 2008;
Pocock et al., 2004; von Elm et al., 2007; Zaccai, 2003). The quality score did not
establish cutoff score to determine strong, moderate, or weak of included studies. Finally,
the populations of this review only focused on adolescents and young adults therefore the
findings could be different from middle and older adulthood due to physical and
biological changes. In spite of these limitations, findings of this review have significant
implications for assessing inflammatory biomarkers in relation to adiposity in public
health and clinical practices. More importantly, although associations between obesity
and CRP has been explored in a systematic review and meta-analysis in various
populations (Choi et al., 2012), our review included empirical literature investigating the
associations of anthropometric approach assessing adiposity measures (BMI, WC, WHR,
WHtR, and BF%) and inflammatory biomarkers, including CRP IL-6 and TNF-a in
adolescent and young adult populations.
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Conclusions
This systematic review overall identified that there are consistently positive
associations of anthropometric adiposity measures (BMI, WC, WHR, and BF%) and CRP
in adolescents and young adults without a known diagnosis of diseases. Findings of
anthropometric adiposity measures (BMI, WC, WHR, and BF%) and IL-6 and TNF-a in
adolescents and young adults remain inconclusive. No single anthropometric adiposity
measures in adolescents and young adults would appear to be superior in relation to CRP,
IL-6 and TNF-a. Further studies are needed to identify the strength and patterns of
association of anthropometric adiposity measures with CRP, IL-6 and TNF-a. Moreover,
further studies are needed to identify ethnicity differences in the association of
anthropometric adiposity measures and inflammatory biomarkers. Lastly, research is
needed to focus on the interplay of diet, physical activity/fitness, or weight loss with
CRP, IL-6 and TNF-a for developing appropriate and effective lifestyle modification in
reducing circulating levels of CRP, IL-6 and TNF -a and in preventing further
development of atherosclerotic CVD and acute CVD events in later life.
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Ovid Medline search
(1946 to July 03 2013)
1. exp Inflammation/
2. exp cytokines/ or exp interleukin-6/ or exp tumor necrosis factor-alpha/
3. exp C-Reactive Protein/
4. (crp or c-reactive or interleukin 6 or il-6 or tnf-alpha or tnf).ti,ab.
5. 1 or 2 or 3 or 4
6. exp adolescent/ or exp young adult/
7. exp young adult/
8. (aged adj2 ("24" or "25" or "26" or "27" or "28" or "29" or "30" or "31" or "32" or "33"
or "34" o_r "35" or "36" or "37" or "38" or "39" or "40")).ab.
9. (youth or adolescen* or teen* or young adult* or university student*).ti,ab.
10. 6 or 7 or 8 or 9
11. body mass index/ or (body mass or bmi).ti,ab.
12. skinfold thickness/ or skinfold*.ti,ab.
13. body fat distribution/ or adiposity/
14. body fat percentage.ti,ab. or body composition/
15. (anthropometric adiposity or anthropometric measure*). ti,ab.
16. waist to heihgt ratio/ or waist to height ratio.ti,ab.
17. waist circumference/ or abdominal obesity/ or abdominal adiposity.ti,ab. or
abdominal diameter.ti,ab.
18. waist to hip ratio/ or waist to hip ratio.ti,ab.
19.5 and 10
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20. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
21. 19 and 20
22.limit 21 to English language
2,325 articles

CINAHL search
(1995 to July 05, 2013)
S 1. ((MH "Inflammation") OR (MH "Cytokines") OR (MH "Tumor Necrosis Factor")
OR (MH 11 C-Reactive Protein") ) OR TI ( crp or c-reactive or interleukin 6 or tnf or il-6 )
OR AB ( crp or c-reactive or interleukin 6 or tnf or il-6 )
S2. ( (MH "Adolescence") OR (MH "Young Adult") ) OR TI (youth or adolescen* or
teen* or young adult* ) OR AB ( youth or adolescen* or teen* or young adult* )
S3. Sl and S2
S4. ((MH "Waist-Hip Ratio") OR (MH "Waist Circumference")) OR TI (adominal
adiposity or abdominal diameter) OR AB ( adominal adiposity or abdominal diameter)
S5. (MH "body mass index") OR TI (body mass or bmi) OR AB (body mass or bmi)
S6. (MH "Skinfold Thickness 11 ) OR TI skinfold* OR AB skinfold*
S7. (MH "Adipose Tissue Distribution") OR (MH "Adipose Tissue")
S8. TI "waist to height ratio" OR AB "waist to height ratio 11
S9. (MH "Body Composition+") OR TI body fat percentage OR AB body fat percentage
SlO. s4 or s5 or s6 or s7 or s8 or s9
S11.s3 and slO
441 articles
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SCOPUS search
(1960 to July 05, 2013)
TITLE-ABS-KEY("inflammation" OR "c-reactive protein" OR "CRP" OR "interleukin6" OR "IL-6" OR "tumor necrosis factor-alpha" OR "TNF-alpha") AND TITLE-ABSKEY("body mass index" OR " BMI" OR "skinfold thickness" OR "body fat distribution"
OR "adiposity" OR "body fat percentage" OR "waist circumference" OR "waist to hip
ratio" OR "waist to height ratio" OR "abdominal obesity" OR "abdominal adiposity")
AND TITLE-ABS-KEY("adolescent*" OR "university student*" OR "college student*"
OR "young adult*") AND (LIMIT-TO(LANGUAGE, "English"))
2, 108 articles

Figure 1. Database search strategy
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Total (X = 4,876)
Ovid MEDL~"E (N = 2,325)
CINAHL (N = 441)
SCOPUS (N = 2,108)
Manual search of references (N = 2)

1

Studies excluded on the bases oftitle and
abstract review
N=4,614

Total (X = 264)
Chid MEDLINE (N = 11 7)
CINAHL (N = 29)
SCOPUS (N = 116)
Manual references (N = 2)

1
Full text studies a.'aluated in
detail for eligibility
(X= 176)

j
Full text studies included
in re\'iew (X = 28)

Duplicates removed
N=88

Excluded Full text studies ~ = 148)
Not relevant (N = 61)
Did not meet age (13-40years) (N = 42)
No data of association or correlation (N = 27)
Adiposity measured by DEXA or MRI (N = 4)
Participants with diagnosed diseases (N = 2)
No dependent data of inflammatory marker(s) (N = 2)
Data from the same study cohort (N = 3)
Review (N = 4) and systematic review (N = 1)
No full-length studies; Abstract only (N = 2)

Figure 2. Flowchart of study selection for systematic review

Table 1

Studies reporting the association ofanthropometric adiposity and inflammatory biomarkers in adolescents
Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean:SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI,WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

DenneyWilson et
al, 2008,
Australia

To determine
the association
between
measures of
adiposity (BMI,
WC) and risk
factors for heart
disease, type2
diabetes, fatty
liver disease,
and the
clustering of risk
factors in
Australian
adolescents.

N=496
(M/F =290/206)
Age 15.4 ± 0.4y

Crosssectional

BMI (kg/m2)
nonoverweight vs.
overweight (~
25) vs.
obese(~ 30)
(International
Obesity Task
Force
Definition cut
points)

Hs-CRP (mg/L)
Plasma
Ultrasensitive
assay
Intra-assay CV
=Not reported
Inter-assay CV
=7.4%

Hs-CRP was
significantly
associated with
overweight and
obese (defined by
BMI and WC) in
both adolescent's
boys and girls
(p < 0.001).

Logistic regression
OR(95%CI)
BMI (M)
Non-overweight
I (reO (N = 210)
Overweight (N = 61)
4.7 (1.2-18.5)
Obese (N = 19)
16.6 (3.5-79.2)
WC(M)
Non-overweight
1 (reO (N = 232)
Overweight (N = 29)
3.0 (0.6-15.6)
Obese (N = 29)
12.7 (5.0-31.9)

No

BMI (M)
21.4±4.1
WC(M)
71.9 ± 9.6cm
Hs-CRP (M) (median
(IQR)): 0.4 (0.2-1.0)
mg/L
BMI (F)
21.5±3.4
WC(F)
65.8 ± 7.9cm
Hs-CRP (F) (median
(IQR) ): 0.3(0.2-1.0)
mg!L

Secondary
schools in
Sydney

Feb 2004May2004
Substudy
of the
New
South
Wales
Schools
Physical
Activity
and
Nutrition
Survey
(SPANS
2004)

WC(cm)
nonoverweight
vs.
overweight
(91st
percentile) vs.
obese (95th
percentile) (UK
Child
Growth
Foundation
Charts 1997 cut
points)
: measured at
the narrowest
point between

Cut-off level =
3.0 mg/L
> 3.0 (high)
~ 3.0 (low or
normal)
Overnight fast

BMI (F)
Non-overweight
I (reO (N = 166)
Overweight (N = 31)
6.8 (2.4-19.0)
Obese (N=9)
6.8 (1.7-27.3)
WC(F)
Non-overweight
1 (reO (N = 169)
Overweight (N = 20)
3.2 ( 1.1-9.4}_

Author,
year,
country

Purpose

Participants
(N/sexlageladiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

BF%)

Obese (N = 17)
5.3 (0.8-12.1)

the lower
costal border
and the iliac
crest
ElWakkad,
.et al.,
2013,
Egypt

To investigate
the effect of
central obesity
in obese
adolescent girls
on the
promotion of the
secretion of proinflammatory
(TNF-a, IL-lp,
leptin) and anti·
inflammatory
adiponectin (IL4, IL-5)
adiponkines in
adolescent
Egyptian girls.

N = 86 (F)
Age 13-18y
BMI > 95 percentile
Group I (N = 43)
(WHR<0.80)
WHR: mean± SE
0. 74±0.00045
TNF-a: mean ± SE
2.24±0.59 pglml
Group II (N =43)
(WHR~0.80)

WHR: mean± SE
0.89±0.017
TNF-a: mean ± SE
30.4±1.735 pglml

Students
from four
local public
schools
Cairo in
Egypt

Crosssectional
(Study
design:
not
reported)
Study
period:
not
reported

WHR: calculated
by dividing we
(em) by hip
circumference
(em).

we (em):
measured the
smaller
circumference
between the iliac
crest and first
rib.

TNF-a (pglmL)
Serum
ELISA
CV= Not reported
Sensitivity = 2.3
pglmL
Fasting not
reported

There was a
significant positive
correlation
between WHR and
TNF-a of group II.

Pearson correlation
TNF-a
WHR (~ 0.80): r =
0.559, p <0.00 1 in
group II

No

Hip (em):
measured at the
most prominent
area of the
buttocks at the
level ofthe
symphysis pubis.
Abdominal
obesity: WHR ~
0.80

-.....)

00

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean:i:SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Herder et
al, 2007,
Germany

To characterize
the pattern of
subclinical
immune
activation that is
associated with
indices of
obesity and
insulin
resistance in
youth and
analyze whether
this association
is explained by
obesity as
assessed by BMI
and we in
adolescents.

N=519
(MIF = 293/226)
Age 15.5 : 0.8y

Crosssectional

BMI (kg/m2)
we (em):
measured at a
level midway
between the
lower rib
margin and
iliac crest to
the nearest
O.Scm.

IL-6 (pglmL)
Serum
ELISA
Intra-assay CV
= 5.2%
Inter-assay CV
= 15.5%
Sensitivity
=0.08pglml

IL-6 was
significantly
associated with
both higher BMI
and higher we
(p::: 0.001).

Linear regression
p:regression coefficients
IL-6 (In-transformed)
BMI: p = 0.033
(p < 0.001)
WC:P=0.011
(p = 0.001)

Age, sex,
lipids

TNF-a (pglmL)
Serum
ELISA
Intra-assay CV
=6.7%
Inter-assay CV
=8.8%
Sensitivity
= 0.25pglml

TNF-a was not
significantly
associated with
both BMI and
WC(p=NS).

TNF-a (In-transformed)
BMI:p= -0.003
(p = 0.395;NS)
WC: p = -0.003
(p = 0.114;NS)

BMI (M)
22.4 :i: 4.3
WC(M)
78.2 ± 11.8cm
IL-6 (M): median
(IQR)
0.9 (0.6; 1.5) pglmL
TNF-a (M): ): median
(IQR):
1.8 (1.5; 2.2) pg/mL
BMI (F)
23.3 ±4.9
WC(F)
76.8 ± 10. 7cm
IL-6 (M): median
(251h; 75th percentiles)
0.9 (0.6; 1.6) pg/mL
TNF-a(M)
I. 7 ( 1.4; 2.2) pg/mL

Students
from
selected
secondary
schools for
a medical
check-up
by Public
Health
Office in
DUsseldorf

In 2005

Overnight fast

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean:!:SD),
setting/location

Huanget
alt
2011t
Australia

To detennine
whether
individual CV
risk factors have
a different
pattern of
relationships to
used
anthropometric
measures.

N = 1t149
(MIF = 604/545)
Age 14y
Caucasian
BMI (M)
21.0:!: 4.1
WC(M)
76.3 :!: 11.2cm
WHtR(M)
0.46:!: 0.07
CRP(M)
2.2 : 0.6 mmoVL
BMI (F)
21.8 ± 4.3
WC(F)
75.1: 10.4cm
WHtR(F)
0.46±0.06
CRP (F)
2.4 ± 0.6 mmoi/L

The West
Australian
pregnancy
cohort
(Raine)
study
follow-up
their
children at
age 14

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Crosssectional

BMI (kg/m2)
we (em):
measured at
umbilicus
level
WHtR

CRP (mmoVL)
Serum
Hs- monoclonal
antibody assay
Intra-assay CV
=Not reported
Inter-assay CV
= 2.1-2.6%
Overnight fast

CRP had equally
and most highly
correlated with
wet WHtRand
BMiin
adolescents. No
single
anthropometric
measures best
predicted CRP.

Stepwise linear regression
B: regression
coefficient indicates the
wnountofchangein
units of the outcome
variable (CRP) that is
associated with a single
unit change in wet
WHt~ and BMI.

Study
period:
not
reported

CRP (log)
BMI (M)
B= 0.11 (p < 0.001)
R2 =0.34

Adjustments
for
covariates

Unadjusted

B= 0.12 (p < 0.001)
R2 =0.35

Adjusted for
Aget family
income,
physical
activity

B= 0.12 (p < 0.001)
R2 = not reported

Additional
adjusted for
pubertal
staging

00
0

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean::I:SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

WHtR(M)
B= 5.55(p = 0.003)
R2 =not reported

Unadjusted

B= 4.84 (p = 0.02)
R2 = not reported

Adjusted for
Age, family
income,
physical
activity

B= 5.00 (p = 0.02)
R2 = not reported

Additional
adjusted for
pubertal
staging

WC(F)
B = 3.23 (p = 0.002)
R2 = 0.17

Unadjusted

B= 3.10 (p = 0.003)
R2 = 0.18

Adjusted for
Age, family
income,
physical
activity

00

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean:I:SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

B = 3.05 (p = 0.01)
R2 =NA

Jung et
al, 2008,
Germany

Khan et
al, 2010,
USA

To investigate
whetherWC,
BMI standard
deviation score
predict classical
and new
markers of CV
risk and diabetes
in male
Caucasian
adolescents.

N=79 (M)
Age 13-17y
Caucasian,

To examine the
association of a
five percent
change in BMI
over a six-month
time period on
levels of
traditional and
newer CVD risk
markers in a
clinical
population of
severely obese,

N = 83 (baseline)
(M/F=33/50)
Age 15.1 :1:: 2.0y
AA=47
Hispanic = 36

BMI (Median (IQR))
22.8 (20.5-30.5)
WC (Median (IQR))
81 (73-91) em
48% (n = 38) had a
we::: 9oth
Percentile
Hs-CRP (Median
(IQR))
0.60 (0.10-1.60)
mg/L

Severely obese (BMI
> 951h percentile for

age and sex)
adolescents
BMI : 42.3 :1:: 7.8
CRP (median (IQR))

Volunteers
from
Schools of
the region
of Jena,
Germany

Crosssectional
(Design:
not
reported)

we (em):
Not reported

Hs-CRP (mg/L)
Serum
ELISA
CV=Not reported
Overnight fast

we predicts hs-

CRP (mg/dL):
At baseline
Measurement site
=Not reported
Latex
enhanced
immuneturbidometry
Intra-assay CV
<5%
Inter-assay CV
=Not reported
Overnight fast

BMI directly
correlated with
CRP (p :5 0.001)
at baseline.

Bivariate correlation
(at baseline)
BMI: Spearman's
rho= 0.50 (p < 0.001)

BMI remained
significantly
associated with
CRP after
adjusting for
age, sex, and
ethnicity

Multivariates regression
(at baseline)
BMI:p=0.04
95%CI: 0.02-0.04
(p < 0.001)

CRP (p < 0.001).

Linear regression
HsCRP
WC: R2 = 0.214
(p < 0.001)

Adjustments
for
covariates

Additional
adjusted for
pubertal
staging
No

Study
period:
not
reported

A
consecutive
sampling
from
Children's
hospital
weight loss
clinic at
initial visit,
and sixmonth
At 6 month
follow up

A sixmonth
longitudin
al study

BMI (kg/m2):
At baseline

Adjusted for
age, sex,
ethnicity

00

N

Author,
year,
country

Martinez
-Gomez,
et al,
2010,
Spain

Purpose

Participants
(N/sex/age/adiposity/intlammatory
markers: mean::t:SD),
setting/location

AAand
Hispanic
adolescents.

0.5 (0.1, 1.1) mg/dL

To examine the
independent
associations of
objective
measured
physical
activity,
cardiorespirator
y fitness, and
fatness with
low-grade
inflammatory
markers in
adolescents.

N= 192
(MIF = 98/94)
Age 13-17y
BMI(M+F)
21.7 ± 3.5
we (M+F)
73.4 ± 9.4 em
BF (M+F)
33.5 ± 12.1 mm
CRP(M+F)
0. 7 ::t: 1.3 mg/dL
IL-6 (M+F)
16.6 ± 28.6 pg/mL

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Analysis and significance

Adjustments
for
covariates

(p = 0.001) at
baseline.

N=50

A subsample
from the
AFINOS
surveillanc
e study:
volunteer
adolescents
in the
region of
Madrid

Results

Crosssectional
November
2007February
2008

BMI (kg/m2):
6 month follow up

CRP (mg/dL):
6 month follow up

At 6 month follow
up, comparison of
changes in CRP
level with change
in BMI, there was
a significant (p =
0.05for trend)
between the three
groups of BMI
change.

At 6 month follow up
CRP (mg/dL) changes:
median (IQR)
~ 5% BMI increase
0.1 (0, 0.5) (N = 8)
BMI within 5%
0 (-0.2, 0.2) (N = 32)
~ 5% BMI decrease
0 (-0.4, 0) (N = 10)
(p = 0.05: for trend)

Not reported

BMI (kg/m2)
we (em):
Not reported
BF (mm)
measured by
sum of six
SFs (triceps,
biceps,
subscapular,
suprailiac,
thigh, calf)
using skinfold
caliper

CRP (mg!L)
Serum
Immunoturbidimetry
CV= Not reported

BMI, WC and BF
were significantly
associated with
CRP (p < 0.001).

Partial correlations
CRP (log)
BMI: r = 0.250
(p < 0.001)
WC: r=0.301
(p < 0.001)
BF: r=0.236
(p < 0.001)

Adjusted for
age, sex, and
pubertal
status

IL-6 {pg/mL)
Serum
Hs-Human
Cytokine
MILLIPLEX
MAP kit
CV= Not reported

BMI, WC, and BF
were not
significant
association with
IL-6.

IL-6 (square-roottransformed)
BMI: r = -0.014
(p=NS)
WC: r=0.031
(p=NS)
BF: r = 0.050 (p = NS)

Overnight fast

00

w

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, we,
WHR, WHtR,

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Multiple regression
CRP (log)
BF: P= 0.241
(p = 0.002)
R2 =0.040
IL-6 (square-roottransformed)
BF: p = -0.016
(p = 0.842)
R2 = 0.005

Adjusted for
age, sex,
pubertal
status, and
HOMA-IR

Linear correlation
BMI: r = 0.346
(p < 0.005)
WC:r=0.525
(p < 0.001)

No

BF%)

Moon et
al, 2004,
South
Korea

To evaluate the
relationship
between serum
TNF-a, its
receptors, and
metabolic
syndrome
components and
anthropometric
indices in obese
and non-obese
Asian
adolescents.

N=71
(MIF =26/45)
Age 15-16y
Asian
Non-obese (BMI <
23): N= 32
(MIF = 14/25)
BMI 20.6 :!: 0.86
we 74.83 :1: 3.96 em
Obese (BMI>25)
:N=39
(MIF = 12/20)
BMI 29.44 ±2.92
we 93.83 :!:5.55 em
using Asia- Pacific
criteria
of obesity
TNF-a was not
reported

Sampling/
setting/loca
tion were
not
reported

Crosssectional
Study
period:
Not
reported

BMI {kg/m2)
we (em):
measured
midway
between the
lowest rib
margin and the
iliac crest at
the end of
gentle
expiration

TNF-a {pg/mL)
Serum
ELISA
Intra-assay CV
<7%
Inter-assay CV
<9%
Sensitivity
= 3pg/ml
Overnight fast

The serum TNF -a
concentration
was positively
correlated with
both the BMI (p
< 0.005) and we
(p < 0.001).

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Petty et
at, 2010,
USA

To examine the
sex-specific
association of
adiposity
variables with
five
inflammation
markers: IL-6,
leptin, CRP,
adiponectin, and
MCPl inAA
adolescents.

N= 166
(M/F =78/88)
Age 14-19y
AA

Crosssectional

BMI {kg/m2)
WC(cm):
measured with
thin clothing on,
at the midpoint
between the
lowest rib and
the iliac crest.

Hs-CRP (uglmL)
Plasma
ELISA
Inter-assay CV
<7.0%
Intra-assay CV
<8.3%

In males, CRP and
IL-6 were not
significantly
associated with
BMiand we.

Partial correlations
CRP (M) (log)
BMI: r= 0.179
(p=NS)
WC: r=0.173 (p=NS)
IL-6(M) (log)
BMI: r= 0.130
(p=NS)
WC: r = 0.093 (p = NS)

Adjusted for
age

In females, CRP
was significantly
associated with
BMI (p < 0.01)
and we (p<
0.001), whereas
IL-6 was
not significantly
associated with
BMiandWC.

CRP (F) (log)
BMI: r = 0.442
(p < 0.01)
WC: r=0.447
(p < 0.001)
IL-6(F) (log)
BMI: r= 0.164
(p=NS)
WC: r = 0.155 (p = NS)

CRPwasnot
correlated with
BMI, WC, WHR,
and BF (%).

Pearson correlation
CRP (positive values)
BMI: r = -0.056
(p = 0.823)
WC: r= -0.05
(p = 0.845)
WHR: r=-0.144
(p = 0.569)
BF%: r= 0.112

BMI(M)
24.35 ±4.7
WC(M)
80.32 ::1: 11.43 em
CRP(M)
1.01±1.8 uglmL
IL-6 (M)
1.29 :!: 1.3 pglmL

AA
volunteers
in local
public high
schools in
the
Augusta
Richmond
Country

June
2006-July
2008

IL-6 (pglmL)
Plasma
ELISA
Intra-assay CV
<7.8%
Inter-assay CV
<9.6%

BMI (F)
26.16::1:6.6
WC(F)
78.46:!: 11.34 em
CRP (F)
1.27±1.8 ug/mL
IL-6 (F)
1.80 :1: 1.7 pglmL

Serrano
et at,
2010,
Brazil

To evaluate
body
composition,
anthropometric
changes,
biochemical and
clinical
characteristics
of female

N = 113 {F)
Age 14-18y
BMI 22.90 :1: 4.1
we 71.01 ::1: 7.78 em
WHR 0.80 ::1: 0.04
BF 28.72:!: 5.14%
CRP 3.572 :1: 3. 732
mg/dL

Non-fasting

Public
schools in
Vic;osa,
Minas
Gerais

Crosssectional
Study
period:
Not
reported

BMI (kg/m2)
WC(cm):
measured at
the minimum
circumference
between the
iliac crest and
the rib cage
WHR(cmlcm)

CRP (mgldL)
Site, assay, and
CV=Not
reported
Overnight fast

No

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflam matory
markers: mean±SD),
setting/location

Design,
study
period

adolescents.

Vikram
et al,
2006,
India

To examine the
association of
serum hs-CRP
with fasting
insulin and
insulin
resistance in
urban adolescent
and young adult
males in north
India.

Anthropometric
adiposity
measures
(BMI,WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

BF%:
measured
by
bioelectrical
impedance
Hip (em):
measured at the
maximum
protuberance of
the buttocks
N=324(M)
Age 14-25y
BMI 20.1 ± 3.5
we 70.7 ± 7.8 em
WHR 0.82 ± 0.04
CRP (Geometric
mean (95%CI))
0.63 (0.56-0.71)
J.lg/mL

Participants
selected
randomly
from
schools and
colleges in
southwest
New Delhi,
multistage
cluster
sampling

Crosssectional
In 20012003

BMI (kg/m2)
we (em):
measured
midway
between the
iliac crest and
the lower-most
margin of the
ribs
WHR
BF%:
measured by
bioelectrical
impedance
Hip (em):
measured at the
maximum
circumference of
the buttocks,
subject standing
with feet placed
together

Analysis and significance

Adjustments
for
covariates

(p = 0.659)

Hs-CRP (J.lg/mL)
Serum
ELISA
Intra-assay CV
= 1.7%
Inter-assay CV
=3.3%
Overnight fast

Hs-CRP levels
correlated
significantly with
BMI, WC,and
WHR (p < 0.05).

Pearson correlation
Hs-CRP (log)
BMI:r=O.I4
(p < 0.01)
WC: r = 0.17 ( P < 0.01)
WHR: r=0.16
(p<O.Ol)
BF%: r = 0.07 (p = NS)

No

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean:I:SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI,WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Wanget
al, 2011,
China

To examine the
impact of
pubertal
development,
gender, and
adiposity
distribution on
CRP levels in
adolescent
twins.

N = 1,180
(M/F = 632/548)
Age 13-21y
Asian

Crosssectional

BMI {kg/m2)
WC(cm):
measured at
the level of the
umbilicus to
the nearest
millimeter

CRP (mg/L)
Plasma
Sandwich
Immunoassay
Intra-assay CV
<5.1%
Inter-assay
=Not reported
Fasting: Not
reported

BMI and WC were
linearly
associated with
log (CRP) levels
both males and
females
(p < 0.05).

Linear regression
P:coefficient
CRP (log)
BMI (M): p = 0.23
(p < 0.0001)
Partial r = 0.05 16
we (M): p= 0.22
(p < 0.0001)
Partial r = 0.0366

Adjusted for
active/passive
smoking,
Tanner stage,
and age

BMI (M)
18.7:1:2.3
WC(M)
68.4:1:6.1 em
CRP (M) (Median
(IQR))

0.85 (0.39-1.80) mg/L
BMI (F)
19.8:1:2.4
WC(F)
66.1 :1:6.3 em
CRP (M) (Median
(IQR))

0.75 (0.34-1.72) mg/L

Large
community
-based
Chinese
twin cohort
inAnging,
China

In 20052006

BMI (F): p= 0.31
(p< 0.0001)
Partial r = o.0665
we (F): p= 0.31
(p < 0.0001)
Partial r = o.o788

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/intlammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Hs-eRP (mg!L)
Serum
Immunoturbidimetry
Intra-assay ev
=Not reported
Inter-assay CV
<2%
Overnight fast

Hs-eRPwas
significantly
correlated with
BMI, we. and
BF (sum of 6 SF
Thicknesses)
(p < 0.05).

Partial correlation
In eRP (M)
BMI: r = 0.268
(p = 0.01)
We:r=0.226
(p = 0.01)
WHR: r = 0.107
(p=NS)
BF: r=0.280
(p = 0.01)

Adjusted for
age and
Tanner stage

BF%)

Wamber
et al,
2006,
Spain

To establish the
possible
relations of
serum
inflammatory
proteins with
body fat
estimates and
body fat
distribution in
an apparently
healthy Spanish
adolescent
population.

N::::472
(MIF :::: 248/224)

Age 13-18.5y
BMI (M) <25
BMI 20.13 ± 2.06
we 70.60:!: 5.16 em
WHR 0.81 :1: 0.04
BF 57.88 ± 18.74mm
BMI (M);:::25
BMI 26.50:1:2.99
we 86.99:1:8.34 em
WHR 0.85 ± 0.05
BF 118.97 ±
36.43mm
BMI (F) <25
BMI 20.42 ± 1. 75
we 68.90:1:5.61 em
WHR 0. 75 ± 0.05
BF 88.47 ± 20.96mm
BMI (F);::: 25
BMI 26.95 ± 3.67
we 81.27 ± 8.79 em
WHR 0. 79 ± 0.07
BF 141.94 ±
33.57mm

Multiplestep
random
sampling
and then by
random
selection of
classrooms
from public
and private
schools in
each city,
and then
stratified
by age and
sex: the
multicenter
AVENA
study

Crosssectional
In 20002002

BMI (kg/m2)
we (em):
Measured
midway
between the
lowest rib
margin and the
iliac crest after
gentle
expiration
WHR
BF(mm)
:6SF
(triceps,
biceps,
subscapular,
suprailiac,
thigh and calf)
Hip (em):
measured at the
point yielding
the maximum
circumference
over the buttocks

In eRP (F)
BMI: r = 0.265
(p = 0.01)
We: r=0.220
(p = 0.01)
WHR: r = 0.004
(p=NS)
BF: r=0.274
(p = 0.01)

Abbreviations: N, number; M, male; F, female; BMI, body mass index; we, waist circumference; WHR, waist to hip ratio; WHtR, waist to height ratio; BF, body fat; eRP, creactive protein; hs, high sensitivity: IL-6, interleukin 6; TNF-a, tumor necrosis factor alpha; ELISA, enzyme-linked immunosorbent assay; RIA, radioimmunoassay; y, year; ev =
coefficient of variation; OR, Odds Ratio; ei, confidence interval; NA, not applicable; NS, not significance; CV, cardiovascular; evn, cardiovascular disease; HOMA-IR,
homeostasis model assessment of insulin resistance; SF, skinfold; ref, reference; AA, African American; log, log transformed (logarithmically transformed); IQR, interquartile
range
00
00

Table 2

Studies reporting the association ofanthropometric adiposity and inflammatory biomarkers in young adults
Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean:I::SD),
setting/location

Design,
study
period

Anthropometric
adiposity/obesity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers (CRP, IL6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Bo,
Raspo,
Morra,
lsaia et
al, 2004,
Italy

To investigate
the
relationships
between body
fat, CRP levels
and metabolic
variables in
healthy, nonobese sons of
patients
affected
by MS.

N = 85 (M)
Age 31.5::1:: 7.5y

Crosssectional

BMI (kglml)
we (em):
measured
midway
between the
lower margin
of the last rib
and the iliac
crest
WHR
Hip (em):
measured around
the pelvis at the
point of
maximum
buttock
protrusion

CRP (mg/L)
Plasma
HSimmunoassay
with a
monoclonal
antibody coated
with
polystyrene
particles
CV=Not
reported
Overnight fast

CRP levels were
significantly
associated with
the measures of
obesity (BMI,
WCand WHR)
(p < 0.001) in
healthy, nonobese sons of MS
patients.

Univariate linear
regression
CRP (log)
BMI: r = 0.525
(p < 0.0001)
WC: r=0.617
(p < 0.0001)
WHR: r = 0.486
(p < 0.0001)

No

BMI 23.8 ± 3.5
we 86.8 :I: 9.9 em
WHR0.9:1::0.l
CRP (Median (IQR))
0.65 (0.25-1.02) mg/L

Healthy,
non-obese
without
overt MS
from
among the
sons ofMS
patient at
the Lipid
Clinic of
the
Department
of
Geriatrics
of a
University
teaching
hospital in
Turin

Study
period:
not
reported

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Bo,
Raspo,
Morra,
Cassader
et al,
2004,
Italy

To evaluate
whether body fat
is an
independent
predictor of hsCRP levels in
healthy, young
adult non-obese
subjects.

N= 87 (M)
Age 30± 3.5y
Healthy, non-obese
young adults

Crosssectional

BMI (kg/m2)
WC(cm):
Not reported
WHRandhip:
Not reported

Hs-CRP (mg/L)
Plasma
HSimmunoassay
with a
monoclonal
antibody coated
with
polystyrene
particles
CV= Not reported
Overnight fasting

Hs-CRP level was
strongly
associated with
BMI, WCand
WHR
(p < 0.001).

Univariate linear
regression
CRP (log)
BMI: p = 0.147
(p < 0.001)
WC:p=0.061
(p < 0.001)
WHR: p = 7.454
(p < 0.001)

No

Brydon
et al.,
2008,
UK

To investigate
the relationship
between
measures of
adiposity and
cytokine, CV
and
neuroendocrine
response to
stress in healthy
young women.

N = 67 (F)
Age 21.3y
(18-25y)
White: 66. 7%,
Non-white:
33.3%

BMI (kg/m2)
WC(cm):
measured
midway between
the lowest rib
and iliac crest
BF%:
measured by
bioelectrical
impedance
and %fat was
calculated as
fat wt divided
by total body
wt (fat+ lean)
at baseline

IL-6 (pg/mL):
At baseline
Plasma
ELISA
Intra-assay CV
=5.3%
Inter-assay CV
=9.2%
Non-fasting

IL-6 was
significantly
related to BF%,
and BMI at
baseline.

Partial correlation
(at baseline)
BMI: r = 0.31 (p < 0.05)
WC: r = 0.17 (p = NS)
BF%:r=0.28
(p < 0.05)

Adjusted for
age, ethnicity,
and smoking
status

BMI 24.1 ± 3.5
we 86.8 ± 9.9 em
WHR0.9±0.1
CRP (Median (IQR))
0.65 (0.25-1.02)mg/dL

BMI 23.2 ± 3.1
we 70.3 ± 7.9 em
BF 25.7 :1: 5.4%
IL-6 0. 71 ± 0.4 pglmL

Volunteers
of young
adults men
of the
hospital
staff at the
Lipid
Clinic of
the
Department
of
Geriatrics
of a
University
teaching
hospital in
Turin.
Volunteers
of healthy
females in
the
University
College
London

Study
period:
Not
reported

Crosssectional
Study
period:
Not
reported

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean:I::SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Herms do
rffetal.,
2012,
Brazil
and
Spain

To assess the
potential
contribution of
gender, body fat
distribution, and
their interactions
to some
inflammatory
marker
concentrations
(CRP,
complement
factor 3 (C3 ),
and
ceruloplasmin
(Cp) in young
adults.

N=317
(MIF = 122/195)
Age: 22±3y
(18-35y)

Crosssectional

BF%: estimated
by the equations
using four
skinfold
thickness
(biceps, triceps,
subscapular, and
suprailiac)

CRP (mg/L)
Plasma
ELISA
Intra-assay CV
<10%
Inter-assay CV
< 10%
Overnight fast

BF significantly
presented R2 for
CRP (11%) in
both sex. BF
significantly
presented CRP in
men (13%) and
women (7%).

Multiple regression
analyses
CRP (log) (M+F)
BF:
R?- = O.ll(p < 0.001)
B-coefficient (95% CI)
= 0.023 (0.0 16; 0.030)
(p < 0.001)

Multiple
linear
regression
models were
performed for
sex
separately.

Volunteers
from the
Federal
University
ofVi~osa,

BMI (M+F) 22.1 ± 2.8
BF (M+F) 26.1 ± 6.4%
CRP (M+F) (Median
(IQR))
0.83 (0.47-1.58)
mg/dL

Brazil
(MIF=
67/92) and
the
University
of Navarra,
Spain (MIF
= 55/103)

Study
period:
Not
reported
clearly

CRP (log) (M)
BF:
R?- = 0.13(p < 0.001)
B-coefficient (95% CI)
= 0.035 (0.019; 0.051)
(p < 0.001)
CRP (log) (F)
BF:

R?- =0.01(p < 0.001)
B-coefficient (95% CI)
= 0.032 (0.014; 0.042)
(p < 0.001)

Hermsdo
rffet at,
2011,
Spain

To assess the
potential
association of
some selected
plasma
inflammatory
marker
concentrations
with adiposity
(total and
central) and

N= 154
(MIF = 53/101)
Age 21± 3y
BMI (M+F)
22.1 ± 2.7
WHR(M+F)
0.74:1::0.06
BF (M+F)
20.0:1::6.5%
CRP (M+F)

Volunteers
from the
University
of Navarra,
Spain

Crosssection a]
Study
period:
Not
reported
clearly

WC(cm):
measured
midway
between the
lowest rib and
the iliac crest
Hip (em):
Measured at the
maximal hip
circumference,
without gluteal

CRP {mg/L)
Plasma
ELISA
Intra-assay CV
< 10%
Inter-assay CV
< 10%

Those subjects
with higher we
and WHR
(central
adiposity)
Showed higher
CRP and IL-6
(p < 0.05).

IL-6 (pg/mL)
Plasma

Only IL-6
concentration

Multiple linear regression
for trend (r was not
reported p for trend (WC,
WHR, and BF% were
categorized into tertiles to
assess trends.), from linear
regression model adjusted
for co variates)
CRP

we (p = o.ot5)

Adjusted for
age, sex,
smoking, and
physical
activity.

Author,
year,
country

McDade
et al,
2009,
Philipp in
es

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean±SD),
setting/location

metabolic
features in
apparently
healthy young
adults.

(Median (IQR))
0.8(0.6-1.4) mg/1
IL-6 (M+F)
(Median (IQR))
1.1 (0.8-1.5) pg/1

To investigate
the predictors of
CRP in young
adults living in
the Philippines.

N = 1,648
(MIF = 916/732)
Age 20.9 ± 0.3y
BMI (M+F) 20.7 ± 3.2
we (M+F)
70.3 ± 7.8 em
3SF (M+F)
48.5 ±22.3 mm
CRP (M+F) (Median
(IQR))
0.2 (0.1, 0.9) mg!L

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)
contraction.
WHR
BF%:
measured by a
bioelectric
impedance
and sum of
four SF
thickness:
biceps, triceps,
subscapular,
and suprailiac)

The Cebu
Longitudin
al Health
and
Nutrition
Survey
follow up
Cebu,
metropolita
n area

Crosssectional
In 2005

BMI (kg/m2)
WC(cm):
Not reported
3SF thickness:
triceps,
subscapular,
and suprailirac

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV
ELISA
Intra-assay CV
< 10%
Inter-assay CV
< 10%
Overnight fast

CRP (mg!L)
Plasma
Hs-immunoturbidimetric
method
Intra-assay CV
=Not reported
Inter-assay CV
<7.6%
Overnight fast
Cut-off level =
3.0 mg!L
> 3.0 (high)
:5 3.0 (low or
normal)
>10 mg/L:
excluded due to

Results

was positively
associated with
total BF%
(p < 0.05).
Central adiposityrelated indicators
(WC/WHR)
correlated better
than those
assessing total
adiposity with
plasma
pro inflammatory
markers.
In female, BMI
and WCwere
significant
predictors of
elevated CRP (p:
not reported)
although we
was a strong
predictor when
all measures
were considered
simultaneously.
A 1em increase
In WC was
associated with a
6.0% increase in
the likelihood of
CRP>3mg/L

Analysis and significance

Adjustments
for
covariates

WHR (p = 0.020)
BF% (p = 0.053)
IL-6

we (p = o.ool)
WHR (p = 0.002)
BF% (p = 0.001)

A series of maximum
likelihood logistic
regression
:Detailed data were
not reported

No

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean:I::SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV
infectious
diseases

Results

Analysis and significance

Adjustments
for
covariates

Tobit regression model
IL-6 (log)
BMI: B = 0.039
(SE = 0.016,p < 0.05)

Adjusted for
sex

(OR: 1.060, p <
0.001).
In males, SF
thickeness was
significant in
predicting
elevated CRP.
A 1mm increase
in the sum of
3SF measures
was associated
with al.1%
increase in
the likelihood of
elevated CRP
(OR: 1.011, p =
0.09).

McDade
et al,
2011,
Philipp in
es

To report
concentrations
of IL-6 and to
evaluate
adiposity,
infectious, and
socioeconomic
predictors of
individual
variation in IL-6
in young adults.

N = 1,569
(MIF = 8661703)
Age 20.9 :1:: 0.3y
(20-22y)
BMI (M+F) 20.7 ± 3.2
IL-6 (M+F) (Median
(IQR))
1.00 (0.28, 3.21)
pglmL

The Cebu
Longitudin
al Health
and
Nutrition
Survey
follow up
Cebu,
metropolita
n area

Crosssectional
In 2005

BMI (kg/m2 )

IL-6 (pglmL)
Plasma
Hs-multiplex
Immunoassay
Intra-assay CV
=13.3%
Inter-assay CV
for low (14.7%)
and high (12.4%)
Overnight fast

BMI was
positively
associated with
IL-6
concentration
(p < 0.05).

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR,WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Mills et
al, 2008,
USA

To determine
the unique
contributions of
metabolic
factors as
predictors of
CRP and IL-6 in
healthy
younger-aged
adults.

N= 175
(M/F = 83/92)
AA=28
Asian= 56
White= 68
Hispanic = 23
Age 30.4 ± 4.8y
(22-39y)

Crosssectional
(Design:
not
reported)

BMI (kg/m2)
WHRandhip
Not reported

CRP (mg!L)
Plasma
Hs DenkaSeiken assay
Intra-and interassay CV <
10%
Sensitivity <
0.05 mg!L

CRPwas
positively
associated with
BMiandWHR
(p < 0.05).

Univarate correlation
CRP
BMI: r = 0.340
(p<O.Ol)
WHR: r = 0.141
(P< 0.05)

No

BMI(M+F) 24.4 ±3.35
WHR(M+F)
0.823 ± 0.07
CRP(M+F)
0.855 ± 1.24 mg!L
IL-6 (M+F)
0.864±0.75 pg/mL

Consecutiv
e sample,
all
volunteers
were
employed
in full-time
day shifts
at the
University
of
California,
Los
Angeles or
the
surroundin
gLos
Angeles
area

IL-6 (pg/mL)
Plasma
ELISA
Intra-and interassayCV <
10%
Sensitivity<
0.72 pg/m1

IL-6 was positively
associated with
WHR (p < 0.01).

IL-6
BMI: r = 0.070
{p=NS)
WHR: r = 0.306
(p<0.01)

Overnight fast
Morrison
et al,
2011,
USA

To assess hsCRP tracking in
black and white
females from
mid-adolescence
to young
adulthood and to
identify factors
associated with
hs-CRP.

N=392 (F)
Age 26y
Caucasian and AA
BMI, WC, and hsCRP were not reported

The
National
Growth and
Health
Study
(NGHS), a
prospective
ly followed
up

Crosssectional

BMI (kg/m2)
we (em):
Not reported

Hs-CRP (mg!L)
Serum
N hs latex
enhanced
immunenephelometric
assay
CV=Not
Reported
Overnight fast

Hs-CRPwas
Significantly
correlated with
BMiandWC
(p < 0.001).

Bivariate correlation
CRP (log)
BMI: r=0.56
(p < 0.001)
WC: r=0.55
(p < 0.001)

No

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflam matory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Nazmi et
al, 2008,
Brazil

To identifY
factors
associated with
CRP levels in a
young adult
Brazilian
population.

N =3,289
(MIF=
1,919/1,370)
Age22.8y
(21.9-23. 7y)

Crosssectional

BMI (kg/m2)
WC(cm):
measured at the
narrowest girth
of the truck or
halfway between
the costal
margin and iliac
crest

Hs-CRP (mg!L)
Plasma
automated DPC
(Siemens)
Immulite
Cherniluminescent
immunoassay
Intra-assay CV
= 10%
Inter-assay CV
=7%
Sensitivity
<O.lmg!L
Non-fasting

Hs-CRP was
significantly
associated with
BMI and we in
men and women
(p < 0.001).

Crude analyses
{p-values for trend by
linear regression)
Hs-CRP (log)
BMI (M): p (95%CI)
<18.5: p = 0.57
(0.43-0. 75)
18.5-24.9: 1 (reO
25.0-29.9: p = 1.54
( 1.34-1. 76)
~ 30.0: p = 3.03
(2.44-3.76)
(p < 0.001)
we (M): 1 (reO
~ 94:P=2.33
( 1.94-2.82)
(p < 0.001)

Adjusted for
skin color,
age, family
income, and
years of
education

BMI and hs-CRP were
not reported

The 1982
Pelotas
Birth
Cohort
study in the
city of
Pelotas,
prospective
ly followed
up

In 20042005

BMI (F): p (95%CI)
<18.5:P=0.73
(0.56-0.96)
18.5-24.9: 1 (reO
25.0-29.9: p = 1.68
( 1.37-2.05)
~ 30.0: p = 3.34
(2.56-4.34)
(p < 0.001)
WC (F): 1 (ref)
~80:P=2.29

(1.93-2.74)
(p < 0.001)

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

BMI (kg/m2)
WHRand hip:
Not reported in
detail
BF%:
measured
by sum ofSFs

CRP (mg/L)
Plasma
Cardio hs-CRP
assay
CV=Not
reported
Sensitivity
=0.2 mg/L
Overnight fast

CRPwas
positively
correlated with
BMI (r = 0.47, p
< 0.05) and BF%
(r= 0.58,p<
0.05).

Pearson correlation
CRP (log)
BMI: r= 0.47
(p < 0.05)
WHR: r=0.26
(p=NS)
BF%: r=0.58
(p < 0.05)

No

BMI (kg/m2)
WC(cm):
measured
midway
between the
iliac crest and
the lower
portion of the
rib cage
WHRandhip:
Not reported

CRP (mg/L)
Plasma
Cherniluminescent
enzyme-labeled
inmmunometric
assay
CV=Not
Reported
Overnight fast

CRPwas
significantly
correlated with
BMI, WCand
WHR
(p < 0.00001).

Pearson correlation
BMI: r=0.08
(p < 0.00001)
WC: r=O.ll
(p < 0.00001)
WHR: r=0.11
(p < 0.00001)

No

BF%)

Orri et al,
2010,
USA

To determine
the relationship
between CAD
risk factors and
CRPamong
apparently
healthy collegeaged men and
women.

N=30
(M/F = 16114)
Age 22.1 ± 3.1y
BMI (M)
26.5 ±4.4
WHR(M)
0.83 ± 0.05
BF(M)
14.5 ± 6.5%
CRP(M)
0.55 ± 0.51 mg/L

Volunteers
of college
men and
women
(4M and SF
intercollegi
ate
athletes)

Cross
sectional
Over
2week
period

BMI (F)
24.2 ± 1.5
WHR(F)
0.73 ± 0.03
BF(F)
24.3 ±4.5%
CRP (F)
0.77 ± 1.16 mg!L
Perez et
al, 2003,
Colombi
a

To determine
and evaluate the
level of we and
CRP levels in a
Colombian
population.

N= 145 (M)
Age28.9y
(17-38y)
BMI 24.08 ± 3.97
we 83.32 ± 10.11 em
WHR 0.86 ± 0.06
CRP (N=145) was not
reported.

Young
healthy
males
recruited
from
different
levels of
tertiles of
WCthe
health
service of
the

Cross
sectional
Study
period:
Not
reported

Author,
year,
country

Purpose

Participants
(N/sexlage/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Crosssectional

BMI (kg/m 2)
we (em):
Not reported
WHRandhip:
Not reported

CRP (mg/L)
Serum
Hs
turbidimetric
immunoassay
Intra- assay CV
=Not reported
Inter-assay CV
= 3.33%
Overnight fast

CRPwas
significantly
correlated with
BMI, we, and
WHR in men and
women
(p < 0.0001).

Analysis and significance

Adjustments
for
covariates

Linear regression

No

Colombian
army
Raitakari
et al,
2005,
Finland

To investigate
the distribution
of CRP and the
population
determinants of
CRP levels in
young adults.

N =2,120
(MIF = 975/1,046)
Age 31.7 ± 5.ly
(24-39y)
BMI (M)
25.7 ± 4.1
WC(M)
89.6 ± 10.7 em
WHR(M)
0.90±0.06
CRP(M)
1.43 ± 3.26 mg/L
BMI (F)
24.4 ± 4.7
WC(F)
78.8 ± 11.4 em
WHR(F)
0.79± 0.06
CRP {F)
2.01 ± 3.90 mg/L

The
Cardiovasc
ular Risk in
Young
Finn Study,
five centre
follow up

In 2001

p: regression coefficients
CRP (log)
BMI (M): p = 0.0505
(p < 0.0001)
we (M): p= o.oo2o
(p < 0.0001)
WHR (M): p = 2.8674
(p < 0.0001)
BMI (F): p = 0.0498
(p< 0.0001)
we (F): p = o.oo19
(p < 0.0001)
WHR (F): p = 2.0162
(p < 0.0001)

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflam matory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Wanget
al, 2011,
USA

To assess BMI
and BF%as
measures of
overweight and
obesity and to
determine their
relationship to
inflammatory
markers in
university
students.

N = 110
(M: 28.2%,
F: 71.80%)
Age 21.3y
(18-28y)

Crosssectional

BMI (kg/m2)
BF%:
measured by
bioelectric
impedance

CRP {~g/mL)
Plasma
ELISA
CV=Not
reported

CRPwas
significantly
correlated with
BMI (p < 0.01)
and BF%{p<
0.001) in
university
students.

Spearman correlation (r,)
CRP
BMI
M+F: rs = 0.288
(p < 0.01)
M: rs=0.206
{p=NS)
F: rs= 0.422
(p < 0.001)
BF%
M+F: rs = 0.393
(p < 0.001)
M:rs=O.I12
{p=NS)
F: rs= 0.362
(p < 0.01)

No

BMI (M+F)
24.13 ± 4.29
BF (M+F)
25.23 ± 8.64
CRP (M+F)
2.34 ± 2.44 ~g/mL
IL-6 (M+F)
0.97 ± 1.56 pg/mL
TNF-a(M+F)
1.02 ± 0.84 pg/mL

Volunteers
from the
university
students
enrolled at
Texas Tech
University,
Lubbock,
Texas

In 20092010

IL-6 (pg/ml)
Plasma
ELISA
CV=Not
reported
1NF-a {pg/ml)
Plasma
ELISA
CV=Not
reported
Overnight fast

Mvs.F
CRPwasnot
significantly
correlated with
BMI and BF% in
male, whereas
CRPwas
significantly
correlated with
BMI (p < 0.01)
and BF%(p<
0.001) in
females.

IL-6 and TNF-a
were not
significant
correlated with
BMI andBF%
in university
students as well
as both genders.

IL-6
BMI
M+F: rs = 0.090
{p=NS)
M:rs=0.242
(p=NS)
F: rs= 0.108
{p=NS)
BF%
M+F: rs = 0.097

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflam matory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, WC,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

{p=NS)
M: rs= 0.015
{p=NS)
F: rs= 0.054
{p=NS)
TNF-a (log)
BMI
M+F: rs = 0.072
{p=NS)
M: rs = -0.056
{p=NS)
F: rs= 0.140
{p=NS)
BF%
M+F: r5 = 0.105
{p=NS)
M: rs = -0.035
(p =NS)
F: rs = 0.135
{p=NS)

Adjustments
for
covariates

Author,
year,
country

Purpose

Participants
(N/sex/age/adiposity/inflammatory
markers: mean±SD),
setting/location

Design,
study
period

Anthropometric
adiposity
measures
(BMI, we,
WHR, WHtR,
BF%)

Inflammatory
markers
(CRP, IL-6, TNF-a)
measurement site,
assay, CV

Results

Analysis and significance

Adjustments
for
covariates

Williams
et al,
2002,
New
Zealand

To evaluate the
relationship
between ferritin,
metabolic
cardiovascular
risk factors,
CRP, and
anthropometric
measurements in
young men and
women.

N=815
(M/F = 436/379)
Age26y

Crosssectional

BMI (kgP)
we (em):
Measured the
halfway
between the
coastal border
and the iliac
crest

CRP (mg/L)
Serum
Immuneturbidimetric
assay using nonhs assay
Intra-assay CV
=Not reported
Inter-assay CV
= 5.6-12.9%
Non-fasting

CRPwas
significantly
correlated with
BMiand WC in
young men and
women
(p < 0.05).

Univariate correlation
BMI (M): r = 0.11
(p < 0.05)
WC (M): r = 0.10
(p < 0.05)

No

BMI (M)
24.8±4.7
WC(M)
84.2:1:8.3 em
CRP(M)
2.4 ± 4.4 mg/L
BMI (F)
25.2 ± 3.9
WC(F)
75.4 ± 9.3 em
CRP (F)
5.3 :1: 6.8 mg/L

The
Dunedin
Multidiscip
linary
Health and
Developme
nt Study, a
longitudina
I follow up
study,
Dunedin,
New
Zealand

At age
26y

BMI (F): r

=

0.29

(p ~0.0001)

WC (F): r

=

0.27

(p ~ 0.0001)

Abbreviations: N, number; M, male; F, female; BMI, body mass index; WC, waist circumference; WHR, waist to hip ratio; WHtR, waist to height ratio; BF, body fat; CRP, creactive protein; hs, high sensitivity: IL-6, interleukin 6; TNF-a, tumor necrosis factor alpha; log, log transformed (logarithmically transformed); ELISA, enzyme-linked
immunosorbent assay; RIA, radioimmunoassay; y, year; CV =coefficient of variation; OR, Odds Ratio; Cl, confidence interval; NA, not applicable; NS, not significance; CV,
cardiovascular; CVD, cardiovascular disease; HOMA-IR, homeostasis model assessment of insulin resistance; SF, skinfold; wt, weight; min, minimum; max, maximum; MS,
metabolic syndrome; UK, United Kingdom; ref, reference
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Table 3

Quality assessment of included studies in Adolescents
Study, year,
journal

Design:

Sample

Were
study
design
clearly
described?

Were
eligibilit
y criteria
specified
?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

No

El-Wakkad et
al., Cytokine

Not
reported

Herder et al,

Yes

DenneyWilson et al,

Setting:

Measurements

Analyses

Was sample
size clearly
justified and
determined?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammato
ry markers
measured
using valid
instruments
?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/carr
elated/covary?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustment
for
confounding
in the
analyses?

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

8/11

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

8/11

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

9/11

Peer
review
journal:

Quality
lndicat
ors met

Was this
publication
peerreviewed?

2008,
Archives of
Pediatrics and
Adolescent
Medicine

2007,
Journal of
Clinical
Endocrinology
and
Metabolism

-0

Study, year,
journal

Huang et al,
2011,
International
Journal of
Pediatric
Obesity
Jung et al,
2009,
Pediatric
Diabetes
Khan et al,
2010,
Obesity
Research and
Clinical
Practice
MartinexGomez et al,
2010,
International
Journal of
Obesity

Design:

Sample

Setting:

Measurements

Were
study
design
clearly
described?

Were
eligibilit
y criteria
specified
?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

No

Not
reported

Analyses

Was sample
size clearly
justified and
determined?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammato
ry markers
measured
using valid
instruments
?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/carr
elated/covary?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustment
for
confounding
in the
analyses?

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

9/11

Yes

Yes

No

Yes

Not reported

No

Yes

Yes

No

Yes

6/11

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10111

Yes

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

9/11

Peer
review
journal:

Quality
Indicat
ors met

Was this
publication
peerreviewed?

Study, year,
journal

Moon et al,
2004,

Setting:

Measurements

Was sample
size clearly
justified and
detennined?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammato
ry markers
measured
using valid
instruments
?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/carr
elated/covary?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustment
for
confounding
in the
analyses?

Not
reported

No

Not
reported

Yes

Yes

Yes

Yes

No

Yes

7/11

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10111

Yes

No

Yes

No

Yes

Yes

No

Yes

Yes

No

Yes

7/11

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

9/11

Design:

Sample

Were
study
design
clearly
described?

Were
eligibilit
y criteria
specified
?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

Yes

Yes

Analyses

Peer
review
journal:

Quality
Indicat
ors met

Was this
publication
peerreviewed?

Metabolism:
Clinical &
Experimental
Petty et al,
2010,

International
Journal of
Pediatric
Obesity
Serrano et al,
2010,

Arquivos
Brasileiros De
Cardio/ogia
Vikram et al,
2006,

Indian Journal
ofMedical
Research

0

w

Study, year,
journal

Wang,
Christoffel et
al, 2011,

Analyses

Peer
review
journal:

Quality
lndicat
ors met

Setting:

Measurements

Was sample
size clearly
justified and
determined?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammato
ry markers
measured
using valid
instruments
?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/corr
elated/covary?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustment
for
confounding
in the
analyses?

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

9111

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10111

Design:

Sample

Were
study
design
clearly
described?

Were
eligibilit
y criteria
specified
?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

No

Yes

Yes

Was this
publication
peerreviewed?

Journal of
Clinical
Endocrinology
and
Metabolism
Wtimberget
al, 2006,

American
Journal of
Clinical
Nutrition

0

~

Table 4

Quality assessment of included studies in Young Adults
Study, year,
journal

Design:

Sample

Were study
design
clearly
described?

Were
eligibility
criteria
specified?

Were any
sources and
methods of
selection of
participants
clearly
described?

Was
sample size
clearly
justified
and
determined

Setting:

Measurements

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

?

Analyses
Were the
inflammatory
markers
measured
using valid
instruments?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/cor
related/covary

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustme
nt for
confound
ing in the
analyses
?

Peer
review
journal:

Quality
Indicat
ors met

Was this
publication
peerreviewed?

?

Bo et al.,
2004,
Metabolism:
Clinical and
Experimental
Bo et al.,
2004,
Nutrition,
Metabolism
and
Cardiovascul
ar Diseases
Brydon et al.,
2008,
International
Journal of
Obesity

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

9/11

Yes

Yes

Yes

No

Yes

Not reported

Yes

Yes

Yes

No

Yes

8111

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10/11

Study, year,
journal

Hennsdorff et
al., 2012,

Was
sample size
clearly
justified
and
determined
?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammatory
markers
measured
using valid
instruments?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/cor
related/covary
?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustme
nt for
confound
ing in the
analyses
?

Yes

No

Yes

Reported in a
previous
reference

Yes

Yes

Yes

Yes

Yes

10/11

Yes

Yes

No

Yes

Reported in a
previous
references

Yes

Yes

Yes

Yes

Yes

10/11

Yes

No

Yes

No

Yes

Reported in a
previous
references

Yes

Yes

Yes

No

Yes

8/11

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10/11

Were study
design
clearly
described?

Were
eligibility
criteria
specified?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

Yes

Yes

Inflammation
McDade et
al., 2009,

American
Journal of
Clinical
Nutrition
McDadeet
al., 2011,

Peer
review
journal:

Quality
Indicat
ors met

Measurements

Sample

Inflammation
Research
Hennsdorff et
al., 2011,

Analyses

Setting:

Design:

Was this
publication
peerreviewed?

American
Journal of
Physical
Anthropology

0
0\

Study, year,
journal

Design:

Sample

Were study
design
clearly
described?

Were
eligibility
criteria
specified?

Were any
sources and
methods of
selection of
participants
clearly
described?

Mills et al.,
2008,
Obesity
Morrison et
al., 2011,
/SRN
Pediatrics

Not
reported

Yes

Yes

Nazmi et al.,
2008,
Brazilian
Journal of
Medical and
Biological
Research
Orri et al.,
2010,
Journal of
Sports
Medicine and
Physical
Fitness

Analyses

Peer
review
journal:

Quality
lndicat
ors met

Setting:

Measurements

Was
sample size
clearly
justified
and
determined
?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammatory
markers
measured
using valid
instruments?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/cor
related/covary
?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustme
nt for
confound
ing in the
analyses
?

Yes

No

Yes

Not reported

Yes

Yes

Yes

No

Yes

7/11

No

Yes

No

Yes

Not reported

Yes

Yes

Yes

No

Yes

7/11

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10/11

Yes

No

Yes

No

Yes

Not reported

Yes

Yes

Yes

No

Yes

7/11

Was this
publication
peerreviewed?

0
'-l

Study, year,
journal

Perez et al.,
2003,

Design:

Sample

Were study
design
clearly
described?

Were
eligibility
criteria
specified?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

Yes

Yes

Yes

Analyses

Peer
review
journal:

Quality
Indicat
ors met

Setting:

Measurements

Was
sample size
clearly
justified
and
determined
?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammatory
markers
measured
using valid
instruments?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/cor
related/covary
?

Were the
statistical
methods of
data analysis
appropriate
for the levels
of
measurement
of the
variable?

Was the
adequate
adjustme
nt for
confound
ing in the
analyses
?

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

9/11

Yes

Yes

No

Yes

Not reported

Yes

Yes

Yes

No

Yes

8/11

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

No

Yes

9/11

Was this
publication
peerreviewed?

European
Journal of
Cardiovascul
ar Prevention
and
Rehabilitatio
n
Raitakari et
al., 2005,

Journal of
Internal
Medicine
Wang, Reed
et al., 2011 ,

Nutrition
Research

........
0

00

Study, year,
journal

Williams et
al., 2002,
Atherosc/eros
is

Design:

Sample

Were study
design
clearly
described?

Were
eligibility
criteria
specified?

Were any
sources and
methods of
selection of
participants
clearly
described?

Yes

Yes

Yes

Analyses

Setting:

Measurements

Was
sample size
clearly
justified
and
determined
?

Was
setting
clearly
described?

Were
anthropometric
adiposity
variables
reliably
measured and
described?

Were the
inflammatory
markers
measured
using valid
instruments?

Were the
statistical
methods to
infer the
independent
(exposure)
variable and
dependent
(outcome)
variables
associated/cor
related/covary
?

Were the
statistical
methods of
data analysis
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Abstract
Background
Low grade systemic inflammation plays a key role in atherosclerosis, and C-reactive
protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor- alpha (TNF-a),
markers of systemic inflammation, are associated with cardiovascular events and
adiposity. Cardiorespiratory fitness has shown health benefits by reducing circulating
levels of inflammatory markers. However, it remains uncertain whether the negative
association between cardiorespiratory fitness and inflammatory biomarkers is due to
cardiorespiratory fitness itself or results from lower levels of adiposity. Moreover, the
evidence examining the interaction between cardiorespiratory fitness and adiposity in
inflammation in young adults is lacking.

Purpose
The aims of this study were to (1) determine the strength of the associations of
cardiorespiratory fitness and adiposity (body mass index [BMI], waist circumference
[WC]) with circulating levels of plasma hs-CRP, IL-6, and TNF-a; and (2) test the
moderating effect of adiposity on the strength of the association between
cardiorespiratory fitness and circulating levels of plasma hs-CRP, IL-6, and TNF-a.

Methods
A cross-sectional study was conducted with 88 young adults aged 20-34 years without
diagnosed diseases. A submaximal treadmill walking test was used to assess
cardiorespiratory fitness. BMI and WC were measured to assess adiposity. The hs-CRP,
IL-6 and TNF-a were assayed and were log10-transformed. For aim one, a separate
multiple regression analysis was conducted with each ofhs-CRP, IL-6, and TNF-a as
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dependent variables and adjusted for confounders. Analysis of covariance (ANCOVA)
was used and adjusted for confounders for aim two. Confounding variables tested were
sex, ethnicity, oral contraceptive use, and education level.
Results
Aim1: Cardiorespiratory fitness was not significantly associated with log 10hs-CRP after
adjustment for BMI or WC and confounders. Cardiorespiratory fitness was not
significantly associated with log 10IL-6 after adjustment for BMI and confounders.
However, cardiorespiratory fitness was significantly and negatively associated with
log 10IL-6 after adjustment for WC and confounders (Model adjusted R2 =.273,p < .0001;

p = -.341' t = -1.995, p =.049). Aim 2: Cardiorespiratory fitness X BMI or we interaction
was not significantly associated with log10hs-CRP after adjustment for confounders.
Similarly, cardiorespiratory fitness

x

BMI interaction was not significantly associated

with log 10IL-6 after adjustment for confounders. However, cardiorespiratory fitness x
WC interaction was significantly associated with log10IL-6 after adjustment for
confounders (Model adjusted R2 = .258,p < .0001; partial eta2 =.056, F = 4.730,p = .033).
There were no associations of cardiorespiratory fitness, adiposity, and log 10TNF-a.
Conclusions
In young adults, higher cardiorespiratory fitness is significantly associated with lower
levels of IL-6, particularly in young adults with central adiposity. Further studies are
warranted to determine if experimentally induced increases in cardiorespiratory fitness
reduce inflammatory markers in young adults. Longitudinal studies are needed to
understand the underlying inflammatory mechanisms related to interaction between
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cardiorespiratory fitness and adiposity, and its influence on cardiovascular disease risk in
young adults.

Keywords: cardiorespiratory fitness; body mass index; waist circumference; c-reactive
protein; interlukin-6; tumor necrosis factor-a; young adults
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Association of Cardiorespiratory Fitness and Adiposity with Inflammatory Biomarkers in
Young Adults
Atherosclerotic cardiovascular disease (CVD) is a significant public health burden in
the United States (Go et al., 2013). Atherosclerosis, a systemic disease process in which
amassment of plaque builds up in the arterial wall, is the major underlying cause of the
clinical CVD and CVD events (Go et al., 2013; Libby et al, 2009). It has been
demonstrated that low-grade systemic inflammation plays a pivotal role in the initiation
and progression of atherosclerosis (Libby et al., 2009) by impairing endothelial function
(Ferri et al., 2007). Among the many inflammatory biomarkers, high sensitivity Creactive protein (hs-CRP), interleukinkin-6 (IL-6), and tumor necrosis factor -alpha
(TNF-a) are well-recognized markers of inflammation in relation to atherogenesis
(Calabro, Golia, & Yeh, 2009; Haddy et al., 2003).
C-reactive protein (CRP) is a major acute phase inflammatory protein, which is
mainly produced by the liver in response to numerous inflammatory cytokines,
particularly IL-6 (Bajpai, Goyal, & Sperling, 2010). The "high sensitivity (hs)-CRP" term
is defined as "the measurement of CRP in serum or plasma sample using immunoassay
methods with sufficient sensitivity to quantify CRP throughout its normai range" in
asymptomatic individuals (Bajpai, Goyal, & Sperling, 2010, p.191). Hs-CRP detects the
same CRP molecule as CRP test, but it detects substantially lower levels of inflammation
(Bajpai, Goyal, & Sperling, 201 0). Numerous prospective studies have indicated that
plasma level of hs-CRP is a strong independent predictor for future cardiovascular events
in individual with no prior history ofCVD (Buckley, Fu, Freeman, Rogers, & Helfand,
2009; Ridker, 2001; Ridker, 2003).
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IL-6 is a pro-inflammatory cytokine and produced by fibroblasts, endothelial cells,
monocytes, and adipose tissue (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer,
2009). IL-6 plays an important role in controlling hepatic production of inflammatory
proteins, including hs-CRP and fibrinogen (Antuna-Puente, Feve, Fellahi, & Bastard,
2008). A previous prospective study has reported that elevated levels ofiL-6 are
associated with increased risk of future myocardial infarction in 14,916 apparently
healthy men (Ridker, Rifai, Stampfer, & Hennekens, 2000).TNF-a, a pro-inflammatory
cytokine, is secreted by macrophages, lymphocytes, and adipose tissue (Petersen &
Pedersen, 2005). TNF-a activates the production of IL-6 in adipose tissue and blood
mononuclear cells (Petersen & Pedersen, 2005). It has been reported that TNF-a is
associated with degree of early atherosclerosis and correlates with metabolic and cellular
perturbations in atherogenesis (Skoog et al., 2002).
Although clinical symptoms of atherosclerotic CVD, such as chest pain or
discomfort, shortness of breath or fatigue, numbness, and blurred vision are not
commonly detected until adulthood it is a progressive atherosclerotic process that occurs
early in life and has clinical indications for acute coronary syndrome and acute stroke
usually later in life (Franks et al., 201 0; Loria et al., 2007). Hence, young adults could be
an optimal target for preventive endeavors to minimize or delay atherosclerotic process,
which could eventually decrease the incidence of clinical CVD throughout middle and
older adulthood (Loria et al., 2007).
This study is focused on cardiorespiratory fitness and adiposity of young adults in
relation to hs-CRP, IL-6 and TNF-a. Cardiorespiratory fitness refers to "the ability of the
circulatory and respiratory systems to supply oxygen and nutrients during sustained
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physical activity" (Caspersen, Powell, & Christenson, 1985). Cardiorespiratory fitness is
related to "the ability to perform large muscle dynamic, moderate-to-high intensity
exercise for prolonged periods of time" (American College of Sports Medicine [ACSM],
p. 71 ). It has been reported that higher levels of cardiorespiratory fitness are closely
related to higher levels of habitual physical activity (Blair et al., 1995). Maximal oxygen
uptake (V02max) is the gold standard or criterion measure of cardiorespiratory fitness
(ACSM, 2010) and is commonly assessed with either a maximal or submaximal exercise
test, using a treadmill or cycle ergometer (ACSM, 2010). Cardiorespiratory fitness in this
present study was estimated using a submaximal treadmill walking protocol, which
utilizes individual's heart rate (HR) response to submaximal treadmill work rates to
estimate V02max (Ebbeling et al., 1991). Although direct measurement of
cardiorespiratory fitness using a maximal exercise test (with or without collection of
expired gases) is more precise than a submaximal exercise test, the maximal exercise test
is not always feasible or practical in health and research settings due to the need for
expensive laboratory equipment, trained personnel, possible physician oversight,
participant burden, and associated safety considerations (Heyward, 201 0).
Cardiorespiratory fitness has shown health benefits in lowering circulating levels of
inflammatory biomarkers in various populations (Church, Barlow, Earnest, Kampert,
Priest, & Blair, 2002; Kullo, Khaleghi, & Hensrud, 2007, Kuo, Yen, Chen, Y u, & Bean,
2007; Isasi, Deckelbaum, Tracy, Stare, Berglund, & Shea, 2003; Williams et al., 2005).
However, it remains uncertain whether the negative association between
cardiorespiratory fitness and inflammatory biomarkers is due to the health benefits of
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cardiorespiratory fitness itself or results from its association with lower levels of
adiposity (Harmer, 2007).
Adiposity is defined as "the quality or state of being fat" (Merriam- Webster
Dictionary), and a synonym for obesity or fatness (Merriam-Webster Dictionary).

Adiposity has been assessed by anthropometric measures in public health and clinical
practice. Adiposity in this study was assessed by BMI and waist circumference (WC).
BMI (kg/m2 ) has been recommended for the identification of measuring total body fat
and the most widely accepted measures of overall adiposity (Stevens, McClain, &
Truesdale, 2008); however, BMI does not differentiate fat mass from bone and muscle
mass and does not provide any information on the distribution of body fat, particularly
central body fat (Stevens, McClain, & Truesdale, 2008). Thus, this study included WC
for assessing central adiposity (Stevens, McClain, & Truesdale, 2008). Adiposity has
been positively associated with CRP in various populations (Brook, Blaha, &
Blumenthal, 2010; Choi, Joseph, & Pilote, 2013).
Only two studies have reported the association of cardiorespiratory fitness and
inflammation measured by CRP in young adults over the past decade (Kuo et al., 2007;
Williams, Milne, Hancox, & Poulton, 2006). Both studies reported that cardiorespiratory
fitness was negatively associated with CRP in young adults independent of BMI, age,
race, and cardiovascular risk factors, such as blood pressure, smoking, etc. In the study
by Williams et al., investigators measured CRP using a low sensitivity CRP assay, which
may underestimate the strength of the association between cardiorespiratory fitness and
CRP (Williams et al., 2005). In the population-based study by Kuo et al., they included
study participants with CVD risk factors, such as hypertension, diabetes and current
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smokers or participants with anti-inflammatory or CVD medications (Kuo et al., 2007),
which may influence levels of inflammatory biomarkers. Neither study examined
adiposity as moderator of the association between inflammation and cardiorespiratory
fitness, nor the extent to which adiposity influences the association between
cardiorespiratory fitness and inflammation. In addition, neither study assessed central
adiposity in detail. Furthermore, these two previous studies focused only on CRP as a
biomarker of inflammation. It is essential to investigate other inflammatory markers, such
as IL-6 and TNF-a in order to better understand inflammatory processes in relation to
adiposity and cardiorespiratory fitness.
This study aimed to (1) determine the strength of the association of cardiorespiratory
fitness and adiposity (BMI and WC) with circulating levels of plasma hs-CRP, IL-6, and
TNF-a; and (2) test the moderating effect of adiposity (BMI and WC) on the strength of
the association between cardiorespiratory fitness levels and circulating levels of plasma
hs-CRP, IL-6, and TNF-a in young adults aged 20 to 34 years. This study may fill an
important gap in the literature by providing data on the role of adiposity as a moderator of
the strength of the association between cardiorespiratory fitness and three inflammatory
biomarkers.

Methods
Design
This present study utilized a cross-sectional analytic design. Data were collected
on each young adult through cardiorespiratory fitness testing, anthropometric
measurement and blood sampling of inflammatory biomarkers in one session, lasting
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approximately one and halfhours, at the University of Texas Health Science Center at
Houston {UTHSC-H) School ofNursing (SON).

Participant, sampling plan and recruitment
The target population for this study was young adults aged 20 to 34 years residing
in Houston, a large metropolitan city with an ethnically diverse population in southeast
Texas. A sample of the population was accessed using a non-probability quota sampling
approach in order to include approximately equal numbers of males and females of
normal weight (BMI < 25 kg/m2), and overweight or obese (BMI ~ 25 kg/m2). The
estimated sample size was 88 subjects to detect a medium effect size (0.059 ~ R 2 < 0.138)
according to Cohen ( 1998), a power of 80%, and an alpha level of .05 for a two-tailed test
using nQuery Advisor version 7.0 (nQuery, Saugus, MA).
The inclusion criteria were: (1) young adults aged 20-34 years; (2) no diagnosed
diseases; (3) physically capacity for completing the cardiorespiratory fitness testing
safely (ACSM, 2010); and (4) ability to speak and read English. Exclusion criteria were:
(1) current smoker; (2) alcohol dependence or regular consumption of more than 7
servings per week; (3) acute infections, including a current or recent influenza illness, flu
shot recipients within last 4weeks, acute respiratory infection within last 3weeks; (4)
dental infection and problems; (5) cardiometabolic dieseases, such as hypertension,
hyperlipidemia and diabetes mellitus type I or II; (6) rheumatoid arthritis or immune
disorders; (7) history of inflammatory bowel disease, such as Crohn' s disease and
ulcerative colitis; (8) a surgery within the past one month; (9) currently taking
medications, such as use of hormone replacement therapy, antihypertensive medications,
allergy shots or systemic corticosteroids, aspirin, statin, and selective serotonin uptake
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inhibitors (SSRis), and anti-inflammatory medications; (10) history of orthopedic injury
in the past and limitations due to the musculoskeletal demands of cardiorespiratory test ;
and ( 11) other medical conditions and medications that would increase inflammatory
markers or would prohibit cardiorespiratory fitness testing (O'Connor et al., 2009). For
females, additional inclusion criteria were: ( 1) self-reported regular menstrual cycle
length of24-35 days; and (2) self-report of no menstruation at the time of data collection
because menses may affect the levels ofhs-CRP (Gaskins et al., 2012). Additional
exclusion criteria were: ( 1) natural or surgical menopause; (2) current or recent
pregnancy (past 6 months); (3) currently or recently (past 2 months) lactating females
(Williams, Williams & Poulton, 2006); (4) history of gynecologic problems, such as
fibroids, endometriosis, or polycystic ovary syndrome (Escobar-Morreale, LuqueRamirez, & Gonzalez, 2011 ); (5) use of contraceptive hormone patch or vaginal ring
methods of contraception currently or within the past three months; and (6) intrauterine
device (IUD) with hormones or Depo-Provera currently or within the past 12 months
(Gaskins et al., 2011; O'Connor et al., 2009). This study included females who currently
or in the past have taken oral contraceptives, and included as a covariate in the analysis.
Participants were recruited by posting fliers in the UTHSC-H, surrounding communities
of the UTHSC-H, and multiple campuses in Houston. The recruitment began at the end of
March 2013 and continued through December 2013. Individuals interested in the study
contacted the principal investigator (PI) by phone or e-mail and were screened by
interview. Participants that met the selection criteria were invited to a data collection
session.
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Procedures
The data were collected by the PI at the Center for Nursing Research in the
UTHSC-H, school of nursing (SON). The fitness room was maintained between 68 and
76 degrees Fahrenheit, with a humidity level between 20 to 60 percent using a room
temperature thermometer (Q-Track IAQ monitor, TSI Incorporated, Shoreview, MN)
throughout the data collection period (ACSM, 201 0).
To prepare for data collection, participants were instructed (1) to fast from eating
food for 12-hours prior to test but were allowed to drink water only; (2) not to engage in
strenuous exercise, consume alcohol, or use anti-inflammatory drugs 24 hours prior to
blood sampling; (3) to arrive at the UTHSC-H SON bioscience laboratory between 8am
and 10 am; (4) to wear comfortable exercise-type clothing; (5) to avoid caffeine 12- hours
prior to test; (6) to consume plenty of fluids; and (7) to obtain an adequate amount of
sleep the night before the test (ACSM, 2010). The informed consent was obtained from
each participant. All procedures were administered by the PI. Participants received
$10.00 and a free sandwich for completion of data collection protocol. All study
procedures were approved by the Committee for the Protection of Human Subjects at the
UTHSC-H.

Instruments and Data Collection
Assessment of cardiorespiratory fitness. Cardiorespiratory fitness was assessed
by a single-stage submaximal treadmill walking test (SSTWT). The SSTWT was
developed by Ebbeling et al. ( 1991) for estimating V 02max of low-risk, healthy adults 20
to 50 years old. The SSTWT was validated by correlating the indirectly estimated
V02max based on individual's walking speed, heart rate (HR), age and sex and the
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directly measured respiratory gas exchange (V02max) in the cross-validation group (n =
22) (Ebbeling et al., 1991). A correlation (r) of .96 was reported, with multiple
correlation (R2) of .86 (SEE= 4.85 mllkg·mim) (Ebbeling et al., 1991).

Single-stage submaximal treadmill walking test protocol. The SSTWT consisted
of a 4-minute warm-up stage, 4-minute workload stage, and a 2- Sminute cool-down
stage. The treadmill was calibrated before cardiorespiratory fitness test to ensure the
accuracy of the test. Prior to beginning the SSTWT, participants were familiarized with
the treadmill (Precor 956i, Precor, Inc., Woodinville, WA), including a visual
demonstration in order to maximize participant safety. In the first warm-up stage,
participants walked on the treadmill for 4-minutes at 0% incline and a walking speed
(2.0 to 4.5 mph) that brings the HR to between 50% and 70% beats per minute (bpm)
age-predicted maximal HR by the Pl. In workload stage, the treadmill incline was
increased to 5% at the same speed for a 4-to 5-minute period. Following a workload
stage, the participants completed a cool-down stage at a slower walking pace and 0%
incline for a 2-Sminute period. Resting BP and HR using the oscillometric technique
(HEM-907SL, Omron Healthcare, Inc., Bannockburn, IL) was assessed prior to a warmup stage, twice and after a cool-down stage one time. If the participant's resting blood
pressure was ~ 130/90 mmHg or resting HR ~ 100 bpm, the participant was not allowed
to continue with the SSTWT protocol. Polar HR (Vintage NV model, Polar CIC, Inc.,
Port Washington, NY) was recorded during the SSTWT protocol and the Borg Ratings of
Perceived Exertion scale (RPE) was documented at the end of the warm-up stage and the
workload stage. RPE provides a subjective indication of how hard the participant feels he
or she is working with numbers, rating from 6 (very, very light) to 20 (very, very hard)
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(Borg, 1970). Steady-state HR is defined as a HR within 5 bpm during the last 2 minute
of the workload stage. The main outcome of the cardiorespiratory test estimated maximal
oxygen uptake (V02max). The SSTWT prediction equation was used to estimate
V02max based on age, sex, walking speed (mph), and steady-state HR.
Estimated V02 max (ml/kg·min) = 15.1 +21.8 (speed in mph)- 0.327 (steady
state HR in bpm}- 0.263 (speed x age in years)+ 0.00504 (SS HR in bpm age in
years)+ 5.98 (sex; female= 0, male= 1)

Assessment of adiposity. Adiposity was assessed using BMI and WC. BMI was
calculated by dividing the participant's weight in kilograms by the height in meters
squared (kg/m2). Height was measured without shoes to the nearest 0.1 em using a wallmounted stadiometer (Accustat, Genentech Inc.). Weight was measured to the nearest
1/4th lb with a calibrated balance beam scale. Height and weight were measured with
minimal clothing and without shoes and hats (National Health and Nutrition Examination
Survey [NHANES], 201 0). WC was a measure of the degree of central of body fat. WC
was measured to the nearest 0.1 em using a flexible, nonstrectchable tape. The tape
measure was placed just above the uppermost lateral border of the right ilium crest and
was extended around the waist in a horizontal plane (NHANES, 201 0). Height, weight,
and waist circumference were repeated, and the mean of two measures was calculated.

Measurement ofhs-CRP, IL-6, and TNF-a. Blood collection was taken after a
12-hour overnight fast. A 10 ml blood sample was collected from an antecubital vein into
two vacutainers containing ethylene diamine tetra acetic acid (EDTA) by the Pl. The
blood samples were immediately centrifuged at 1,630 relative centrifugal force (ref) at4°C for 30 minutes (Centrifuge5810~ Eppendorf AG Hamburg, Germany). After
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centrifugation, plasma samples were divided into eight aliquots and stored at -80°C until
batch assayed. Plasma hs-CRP was determined by the CRP Ultra Wide Range Reagent
kit (Sekisui Diagnostics, Inc., PE, Canada}, a latex-enhanced turbidimetric in vitro
immunoassay (AU480 automated platform, Beckman Coulter, Marietta, GA) at the
Atherosclerosis Clinical Research Laboratory at the Baylor College Medicine. The
plasma hs-CRP samples exceeding the upper limit of linearity were diluted and repeated.
The new values were multiplied by the dilution factor to generate a final reportable value.
The detectable levels of hs-CRP ranged from 0.05 to 160 mg/L. Intra-assay coefficient of
variations (CV) for hs-CRP was< 3.3%. Plasma IL-6 and TNF-a were determined using
Quantikine high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits (R&D
System, MN, USA) at the Bioscience Laboratory in the UTHSC-H SON. The detectable
levels ofiL-6 ranged from 0.156 to 10 pg/mL, and the detectable levels ofTNF-a ranged
from 0.5 to 32 pg/mL. IL-6 and TNF-a were run on the WorkOut™ software (version
2.5, Perkin Elmer Life and Analytical Sciences). The intra-assay CV and inter-assay CV
for IL-6 were 9.4% and 2.3%, and inter-assay CV for TNF-a were 11.0% and 1.0%
respectively.
Age, sex, ethnicity, education, oral contraceptive use were considered as possible
confounders related to inflammation based on the previous studies (Cauci et al., 2008;
Dreon, Slavin, & Phinney, 2003; Friedman & Herd, 2010; Ferrucci et al., 2005; KelleyHedgepeth et al., 2008; O'Connor et al., 2009; Paalani, Lee, Haddad, & Tonstad, 2011).

Statistical Analysis
Statistical analyses were performed by using statistical software SPSS version
22.0 (SPSS Inc., Chicago, IL). Descriptive data were presented as mean± standard
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deviation (SD), frequency and percentage. Data were checked for normality of
distribution before analyses and were transformed as necessary. The distributions ofhsCRP, IL-6, and TNF-a were positively skewed and were log 10-transformed. All statistical
tests were two-tailed and p-value < .05 was considered statistically significant. Multiple
regression analysis was used to examine aim 1: the strength of the association of
cardiorespiratory fitness and adiposity with inflammatory biomarkers. For aim 2, analysis
of covariance (ANCOV A) was used to examine the association of cardiorespiratory
fitness (continuous variable)

x

adiposity (categorical variables) interaction term with

inflammatory biomarkers (continuous variable) as the outcome variable. Categories for
adiposity were as follows; BMI was divided into < 25 kg/m2 (normal weight) and BMI ~

25 kg/m2 (overweight or obese), and we was divided at the 50th percentile (median value

= 86.4 em); WC < 86.4 em and WC ~ 86.4 em. Separate analyses were conducted with
each of the inflammatory markers (hs-CRP, IL-6, and TNF-a) as the dependent variable.
Analyses for aim 1 and 2 were adjusted for possible confounders including age, sex, or
oral contraceptives (females only), ethnicity and education. The dichotomous variables of
sex and use of oral contraceptives were considered as an interaction term, which resulted
in three categories (males, females without oral contraceptives, and female with oral
contraceptives). Variables that were statistically significantly related to the dependent
variable (p < .05) were included as confounding variables.

Results
Descriptive Characteristics of Participants
One hundred and thirty young adults were assessed for eligibility; 88 participants
completed the study as shown in Figure 1. The descriptive characteristics of the
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participants are presented in Table 1. All participants (n = 88) had complete data for
cardiorespiratory fitness, BMI, WC, hs-CRP, and TNF-a, and 87 participants had IL-6
data. The mean of age of participants was 25.97 ± 3.84 (SD) years (range, 20-34 years),
and 48.9% was males. The anthropometric and health characteristics of the sample are
presented for the sample and for males and females separately in Table 2. Males had
higher mean levels of cardiorespiratory fitness, and W C than females whereas female had
higher mean levels of hs-CRP than males. Males and females had similar mean levels in
BMI, IL-6, and TNF-a.

Associations of Cardiorespiratory Fitness and Adiposity (BMI and WC) with
Logtohs-CRP and LogtoiL-6
Multiple linear regression analysis was used with log 10hs-CRP as the outcome
variable and cardiorespiratory fitness as predictor variables in Table 3. In multiple linear
regression analysis, age, ethnicity, and education were not significant confounding
variables related to logwhs-CRP (p < .20). This study identified sex and oral
contraceptives as important confounders related to log 10hs-CRP (p < .20).
Cardiorespiratory fitness was significantly and negatively associated with logwhs-CRP
after adjustment for sex

x

oral contraceptive interaction term (Modell: adjusted R2 =

.300, F (2, 84) = 13.430,p < .0001; P-coefficient = -.639, t = -4.920,p < .0001).
However, after BMI was added to this model, cardiorespiratory fitness was not
significantly associated with log 10hs-CRP (Model2: adjusted R 2 = .429, F (4, 83) =
17.324,p < .0001;

~-coefficient=

-.178, t = -1.137,p = .259). Likewise, after WC was

added as a predictor, cardiorespiratory fitness was not significantly associated with
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log 10hs-CRP either (Model3: adjusted R2 = .418, F (4, 83) = 16.64l,p <.0001; ~
coefficient= -.202, t = -1.291,p = .200).
In terms of log 10 IL-6, multiple linear regression analysis was used with log 10IL-6

as the outcome variable and cardiorespiratory fitness as predictor variable in Table 4. In
multiple linear regression analysis, age and ethnicity were not significant confounding
variables related to log 10IL-6 (p < .20). Therefore, this study identified sex and education
as confounding variables in the statistical analysis of log 10IL-6 (p < .20).
Cardiorespiratory fitness was significantly and negatively associated with log10IL-6 after
adjustment for sex and education (Modell: adjusted R2 = .216, F (3, 82) = 6.92l,p <
.0001;

~-coefficient

= -.638, t = -4.673, p < .0001 ). When BMI was added to this model,

cardiorespiratory fitness was not significantly associated with log 10IL-6 (Model 2:
adjusted R2 = .283, F (5, 81) = 7.801,p < .0001; ~-coefficient= -.316, t = -1.854,p
=.067). However, cardiorespiratory fitness was significantly and negatively associated
with log 10IL-6 after WC was added to this model (Model3: adjusted R2 = .273, F (5, 81)
= 1.459,p < .0001;

~-coefficient=

-.341, t = -1.995,p =.049).

Interaction between Cardiorespiratory Fitness and Adiposity on Logt0hs-CRP
The results of the analysis of covariance (ANCOVA) to examine the association
of cardiorespiratory fitness (continuous variable) x BMI (categorical variables)
interaction term with log 10hs-CRP (continuous variable) as the outcome variable were
presented in Table 5. There was a statistically significant cardiorespiratory fitness x BMI
interaction term for log 10hs-CRP (Modell: adjusted R2 = .229, F (3, 84) = 9.601,p <
.0001; interaction term, partial eta2 =.051, F (1, 84) = 4.553,p = .036). The interaction
effect is illustrated in Figure 2. For example, young adults with BMI ~ 25 kg/m2 and a
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high cardiorespiratory fitness level (55rnL/kg·min) had a lower level ofhs-CRP (0.60
mg/L) compared with the hs-CRP level (2.39 mg/L) of young adults with BMI ~ 25
2

kg/m and a low cardiorespiratory fitness level (35mL/kg·min). This suggests that higher
levels of cardiorespiratory fitness are associated with lower levels ofhs-CRP in young
adults with BMI in the overweight/ obese range. In contrast, among those with BMI < 25
2

kg/m , the levels ofhs-CRP did not vary by the level of cardiorespiratory fitness. For
instance, as illustrated in Figure 2 young adults with BMI < 25 kg/m2 and a high
cardiorespiratory fitness level (55mL/kg·min) had a hs-CRP (0.45mg/L), which is very
similar to those with BMI < 25 kg/m2 and a low cardiorespiratory fitness level
(35mL/kg·min) hs-CRP (0.49mg/L). This suggests that higher levels of cardiorespiratory
fitness are associated with lower levels of hs-CRP in young adults in the presence of high
BMI ~ 25 kg/m2 group. However, the cardiorespiratory fitness

x

BMI interaction term

was not statistically significant on hs-CRP after adjustment for sex
interaction (p = .127) in model 2, Table 5. This means that the sex

x
x

oral contraceptive
oral contraceptive

interaction has an important confounding effect in relation to cardiorespiratory fitness,
BMI and hs-CRP.
Table 6 shows the analysis of covariance (ANCOV A) to examine the association
of cardiorespiratory fitneSS (continUOUS Variable)

X

WC (categorical Variables) interactiOn

term with logt 0hs-CRP (continuous variable) as an outcome variable. There was not a
statistically significant cardiorespiratory fitness

X

we interaction term on logiOhs-CRP

(Modell: adjusted R2 = .314, F(3, 84) = 14.283,p < .0001; interaction term partial eta2
=.012, F (1, 84) = 1.059,p = .306 in Table 6). Similarly, there was not a statistically
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we interaction term on logtohs-CRP after

oral contraceptive interaction in model 2, Table 6.

Interaction between Cardiorespiratory Fitness and Adiposity (BMI and WC) on
LogtoiL-6
The results of the analysis of covariance (ANCOV A) to examine the association
of cardiorespiratory fitness (continuous variable) x BMI (categorical variables)
interaction term with log10IL-6 (continuous variable) as an outcome variable were shown
in Table 7. Modell shows that there was not a statistically significant cardiorespiratory
fitness x BMI interaction term on log10IL-6 (Modell: adjusted R2 = .190, F (3, 83) =
7.705 p < .0001; interaction term partial eta2 =.033, F (1, 83) = 2.79l,p = 0.099).
Similarly, the cardiorespiratory fitness

x

BMI interaction term after adjustment for sex

and education was not statistically significant on log10IL-6 (Model 2: adjusted R2 = .240,
F (6, 80) = 5.528,p < .0001; interaction term partial eta2 =.022, F (1, 80) = l.820,p =
.181 ).
Table 8 shows the analysis of covariance (ANCOVA) to examine the association
Of Cardiorespiratory fitneSS (continUOUS Variable)

X

WC (categorical Variables) interaction

term with log10IL-6 (continuous variable) as the outcome variable. There was a
statistically significant cardiorespiratory fitness

X

we interaction term on logtoiL-6

(Modell: adjusted R2 = .228, F (3, 83) = 9.456,p < .0001; interaction term partial eta2
=.080, F {1, 83) = 1.254,p = .009). The interaction effect is illustrated in Figure 3. For
instance, young adults with we 2:: 86.4 em and a high cardiorespiratory fitness
(55mL/kg·min) had lower levels ofiL-6 (0.83 pg/ml) compared with the IL-6level (1.83
pg/ml) of young adults with we < 86.4 em and a low cardiorespiratory fitness
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(35mL/kg·min). In contrast, young adults with WC < 86.4cm and a high
cardiorespiratory fitness (55mL/kg·min) had a 0.84 IL-6level, which was similar to the
level of IL-6 (0.88 pg/ml) of young adults WC < 86.4 em and a high cardiorespiratory
fitness (35mL/kg·min). This significant interaction between cardiorespiratory fitness and
WC on log10IL-6 was sustained after adjustment for sex and education (Model 2: adjusted
2

R = .258, F (6, 80) = 5.991,p < .0001; interaction term partial eta2 =.056, F (1, 80) =
4. 730, p = .033). Thus, the association between cardiorespiratory fitness and log 10IL-6
depends on which levels of we are being considered.
TNF-a

There were no associations of cardiorespiratory fitness and adiposity (BMI and
WC) with log10 TNF-a in young adults.
Discussion
The finding of the present study was that cardiorespiratory fitness was not
significantly associated with hs-CRP after adjustment for BMI (WC) and sex

x

oral

contraceptive interaction. Cardiorespiratory fitness was not significantly associated with
IL-6 after adjustment for BMI, sex and education. However, higher levels of
cardiorespiratory fitness were significantly and negatively associated with lower IL-6
levels after adjustment for we, sex and education in young adults aged 20 to 34 years.
For aim two, neither BMI nor we significantly modified the strength of the associations
of cardiorespiratory fitness with hs-eRP levels after adjustment for sex

x

oral

contraceptives interaction. However, we significantly modified the strength of the
association of cardiorespiratory fitness with IL-6 after adjustment for sex and education.
Specifically, young adults with we ~ 86.4cm (median split) and high levels of
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cardiorespiratory fitness had significantly lower levels of IL-6 compared with young
adults with we ;::: 86.4cm with lower levels of cardiorespiratory fitness. This provides
evidence that cardiorespiratory fitness may act as an anti-inflammatory role in lowering
levels of circulating IL-6 particularly in young adults with central adiposity.
In relation to the first aim, the findings of the associations of cardiorespiratory
fitness and adiposity (BMI and WC) with hs-CRP of this present study were inconsistent
with previous two studies (Kuo et al., 2007; Williams et al., 2005). Williams and
colleagues reported that cardiorespiratory fitness levels are negatively associated with
CRP levels after adjustment for BMI, systolic blood pressure, smoking, and combined
oral contraceptive use in 26-year-old young adults (p :S 0.01). This inconsistent result
could be explained by differences between the two samples in mean BMI. The means of
BMI in the previous study were male (25.2kg/m2 ) and females (24.8 kg/m2 ), whereas the
means of BMI in the present study were males (26.06 ± 5.03kg/m2) and females (26.23 ±
6.81kg.m2 ). It has been reported that cardiorespiratory fitness is negatively associated
with fatness (Martinez-Gomez et al., 201 0). Moreover, higher levels of BMI are
associated with high levels ofhs-CRP (Choi, Joseph, & Pilote, 2013). The other previous
study by Kuo and colleagues also reported that a significantly negative association
between cardiorespiratory fitness and CRP after adjustment for age, race, BMI category,
cardiovascular risk factors and anti-inflammatory medication or CVD medications in
1438 adults aged 20-49 from the NHANES 1999-2002. This inconsistent result could be
explained by statistically different adjustment for BMI variable. The previous study
adjusted for BMI as categorical variables whereas this present study adjusted BMI as a
continuous variable. This statistically different adjustment for adiposity (BMI or WC)
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could explain the different results. The findings of present study, however, were
consistent with previous study by Martinez-Gomez et al. (20 10), which showed that
cardiorespiratory fitness was negatively associated with CRP, but this association did not
remain statistically significant after adjustment for body fat in 192 adolescents aged 1317 years (Martinez-Gomez et al., 201 0). Previous review by Hamer (2007) has also
reported that high levels of fitness are associated with lower levels of inflammation,
although the associations were mixed after adjusting for measures of fatness.
In terms of IL-6, no previous studies examined the association of
cardiorespiratory fitness and adiposity (BMI and WC) with IL-6 in young adults aged 2034 years. To our best knowledge, the present study is the first study to examine the
association of levels of cardiorespiratory fitness and adiposity (BMI and WC) with IL-6
levels particularly in young adult aged 20-34 years. The present study found that higher
levels of cardiorespiratory fitness are significantly associated with lower levels of IL-6 in
young adults when controlling for we, sex and education.
In relation to the second aim, this present study is the first to examine the
interactions of cardiorespiratory fitness and adiposity (BMI and WC) in relation to hsCRP and IL-6levels in young adults. For circulating hs-CRP concentration, this present
study did not find significant interactions between cardiorespiratory fitness and either
BMI or we levels with hs-CRP levels after adjustment for sex

X

oral contraceptive

interaction in young adults. This finding may suggest that both cardiorespiratory fitness
and adiposity (BMI and WC) could be independently related to hs-CRP. In a previous
literature review including diverse populations by Hamer (2007) reported that both
fitness and fatness were associated with inflammatory factors although the relative
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contributions of both may be dependent on sex, age, and disease status. Thus, both
maintaining high levels of cardiorespiratory fitness and low levels of BMI and WC could
be important factors for maintaining low hs-CRP levels in young adults.
For circulating IL-6 concentration, however, cardiorespiratory fitness

X

we

interaction was significantly associated with IL-6 after adjustment for sex and education
in young adults. This means that young adults with central adiposity may have lower
levels of IL-6 if they have higher levels of cardiorespiratory fitness, indicating that higher
levels of cardiorespiratory fitness may exert an anti-inflammatory effect and thereby
protect against low-grade inflammation (Wilund, 2007). The mechanisms for the
potential anti-inflammatory roles of fitness are not completely understood. The possible
mechanisms have suggested that regular physical exercise could improve endotheliumdependent vasodilation by enhancing blood flow and shear stress, resulting in increased
the bioavailability of nitric oxide production (Di Francescomarino, Sciartilli, Di Valerio,
Di Baldassarre, & Gallina, 2009). In contrast, this present study did not find a significant
interaction between cardiorespiratory fitness and BMI on IL-6 after adjustment for sex
and education. That is, both cardiorespiratory fitness and BMI could be independently
related to IL-6 after adjustment for sex and education. No previous findings can be
compared with findings of the present study in interaction between cardiorespiratory
fitness and adiposity (measured by BMI and WC) on IL-6 in young adults.
Another important finding of this present study was that there was a significant
interaction between cardiorespiratory fitness and WC with regards to IL-6, but there was
no significant interaction between cardiorespiratory fitness and we with regards to hsCRP. This difference may be explicated by differences in hs-CRP and IL-6 secretion. IL-
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6 is produced in adipose tissue, and induces hepatic production of CRP (Shoelson,
Herrero, & Naaz, 2007). CRP is an acute-phase reactant synthesized mainly in the liver
and is regulated by IL-6 levels (Clearfield, 2005). At rest, approximately 30% of
circulating IL-6 is released from adipose tissue (Mohamed-All et al., 1997), and visceral
adipose tissue secretes 2-3times more IL-6 than subcutaneous adipose tissue (Fried,
Bunkin, & Greenberg, 1998). This present study found that higher levels of
cardiorespiratory fitness were significantly related to lower levels of IL-6 after
adjustment for

we, sex and education. This study also found that higher levels of

cardiorespiratory fitness were significantly associated with lower levels of IL-6,
particularly young adults with WC 2:: 86.4cm. Taken together, IL-6 levels influenced by
visceral adipose tissue and higher levels of cardiorespiratory fitness are significantly
related to reducing IL-6 levels in young adults with WC 2:: 86.4 em.
This present study found that use of oral contraceptive was a significant
confounding variable in relation to hs-CRP. Previous studies also have reported that hsCRP levels are significantly higher among oral contraceptive user versus non-users
(Cauci et al., 2008; Dreon et al., 2003). The underlying mechanisms by which oral
contraceptives induces higher levels of hs-CRP have not been fully clarified (Dreon et al.,
2003). Previous investigations have suggested that exogenous estrogenic hormones may
have directly modulate hepatic synthesis and therefore may affect pro-inflammatory
pathways (van Rooijen, Hansson, Frostegard, Silveira, Hamsten, & Bremme, 2006), but
further investigations are required to clarify the pathways.
In relation to TNF-a, this present study did not find any associations of
cardiorespiratory fitness and BMI (WC) with TNF-a for aim land aim 2.This result is
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possibly due to low concentrations of TNF-a in young adults. In previous studies of the
association between adiposity and TNF-a, Wang and colleagues (2011) reported that
TNF-a was not significantly related to BMI and percent body fat in university students,
and this present study did not find any associations. In contrast, Moon et al and
colleagues (2004) reported that TNF-a was significantly and positively associated with
both BMI (r = .346;p < .005) and WC (r = .525;p < .001) in obese adolescents using a
cross-sectional study.
There are several limitations in this present study. Firstly, it is the inability to
establish causal relationships from data collected cross-sectional time frame. Secondly, a
non-probability quota sampling method in university and community settings limited
generalization of the findings of this study to young adults. Thirdly, indirect estimate of

V02max through HR response to a submaximal single stage treadmill test estimated
V02max instead of direct measurement of V02max through open circuit spirometry during
maximal treadmill test (ACSM, 2010). Lastly, this present study found that 6 participants
who had hs-CRP levels from 10.4 to 21.11mg/L, and these participants were not excluded
from the data analysis. Albeit the American Heart Association (AHA)/Centers for
Disease Control and Prevention (CDC) recommends that an hs-CRP level of > 1Omg/L
should be repeated in 2 weeks due to the possible presence of an acute infection (Pearson
et al., 2003), the 6 participants of this present study were unlikely to have acute
infectious conditions. This present study very carefully assessed an acute infection or any
trauma through inclusion arid exclusion criteria and before blood testing. In addition, the
6 participants were all females that were overweight or obese (BMI from 28 to 44.1
kg/m2). Except for one participant, they all had taken oral contraceptive medications.
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This suggests that more extreme levels of adiposity may be directly associated with acute
chronic inflammation, and oral contraceptives also may contribute to higher levels of hsCRP. However, further study is needed to clarify this association. Moreover, exclusion of
the 6 participants with an hs-CRP > 1Omg/L did not significantly change the findings
(aim 1 and 2) although the data were not shown in this paper.
The main strengths of this present study includes careful selection of participants
using rigorous inclusion and exclusion criteria, and control of important confounders in
relation to each biomarker. In addition, this present study extends previous studies by
including inflammatory biomarkers in addition to CRP, such as IL-6 and TNF-a in young
adults. Furthermore, central adiposity assessed by waist circumference regarding this
association is included, which has not been examined in young adults previously.
Prospective studies are needed to ascertain the influences of cardiorespiratory
fitness and adiposity on inflammatory biomarkers during young adulthood. Exercise
intervention studies for improving cardiorespiratory fitness and weight reduction are also
warranted to reduce hs-CRP and IL-6 and to improve cardiovascular health in young
adults. Moreover, research is needed to investigate the associations of cardiorespiratory
fitness and adiposity with TNF-a in overweight and obese young adults.
In conclusion, cardiorespiratory fitness is significantly and negatively associated
with IL-6 in young adults aged 20-34 years after adjustment for WC, sex, and education.
Moreover, there is a significant interaction between cardiorespiratory fitness and WC in
predicting IL-6levels after adjustment for sex and education in young adults aged 20-34
years old. Therefore, cardiorespiratory fitness may decrease risk of atherosclerosis, CVD
events, and CVD by reducing inflammatory biomarkers. Further studies are warranted to
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determine if experimentally induced increases in cardiorespiratory fitness reduce
inflammatory markers in young adults. Longitudinal studies are needed to understand the
inflammatory mechanisms related to cardiorespiratory fitness and adiposity, and its
influence on cardiovascular disease risk in young adults.
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People who contacted
this study
n=162

Not interested in the study
n=32
Assessed for
eligibility
n=130
,...

Total recruited
D=95

Included in study
n=88

Excluded (Total=3S)
· Smoking (n=8)
·HBP (n=4)
· Chronic diseases (n=2)
· Currently taking medications (n=7)
· Recent surgery (n=2)
· Lowfastingglucose(n=t)
· IUD and hormonal therapy (n=8)
· History of endometriosis and
polycystic ovary syndrome (n=3)

Not showing up (n=6)
Not completed the study protocol
(n=t)

Figure]. Young adult recruitment flow diagram
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Table I
Participant characteristics

All (N = 88)

Age (years)
Sex
Male

Female
Ethnicity
Caucasian
African American
Hispanic
Asian
Mixed Race
Marital status
Married or living
with partner
Single
Occupation
Employee
Doctoral student
Master student
College student
Other
Education
Graduate degree
Undergraduate degree
High school degree
Oral contraceptives
Yes
No

n

%orMean±SD

88

25.97 ± 3.84

43

48.9%
26.30 ± 3.90

45

51.1%
25.66 ± 3.80

24
18
19
20
7

27.3%
20.5%
21.6%
22.7%
8.0%

18

20.5%

70

79.5%

16
9
28
33
2

18.2%
10.1%
31.8%
37.5%
2.3%

17
49
22
45
12
33

19.3%
55.7%
25.0%
26.6%
73.4%
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Table 2
Descriptive statistics for anthropometric and inflammatory biomarkers in young adult aged 20-34 years (N = 88)
All (N = 88)

Mean± SD (Range)

n (%)

Males (n = 43)

Mean± SD (Range)

n(%)

Females (n = 45)

Mean± SD
(Range)

n(%)

Height (em)
Weight (kg)

169.93 ± 9.42
75.66 ± 18.76

176.22 ± 7.49
81.00± 17.52

163.93 ± 6.83
70.55 ± 18.68

BMI (kg/m2 )
Normal weight < 25
Overweight/Obese ~ 25

26.15 ± 5.97
21.90 ± 1.74
30.39± 5.69

44 (SO)
44 (50)

26.06± 5.03
22.42 ± 1.51
29.53 ± 4.76

21 (48.8)
22 (51.2)

26.23 ± 6.81
21.43 ± 1.83
31.25 ± 6.50

23 (51.1)
22 (48.9)

we (em)

90.06 ± 14.30
80.01 ± 4.78
100.11 ± 13.59

44 (50)
44 (50)

91.03 ± 12.96
81.93 ± 4.33
97.59 ± 13.18

18 (41.9)
25 (58.1)

89.12 ± 15.57
78.67 ± 4.69
103.42 ± 13.74

26 (57.8)
19 (42.2)

<86.4
;:::86.4
SBP (mm Hg)
DBP (mm Hg)
HR(permin)

114.31 ± 9.18
73.23 ± 8.66
68.72 ± 11.00

CRF
(V02max(mL/kg· min))
hs-CRP (mg!L)

45.72± 9.03
(15 .42-59.84)
2.16 ± 3.81
(0.067-21.11)
1.26 ± 1.17
(0.33-8.69)
1.09 ± 1.19

IL-6 (pglml)
TNF-a (pg/ml)

119.59 ± 5.89
74.97 ± 7.92
67.14 ± 9.73
88
88
87
88

52.27 ± 5.06
(38.42-59.84)
1.35 ± 1.98
(0.067-9.41)
1.07 ± 0.68
(0.40-3. 70)
1.16 ± 0.99

109.26 ± 8.95
71.57 ± 9.08
70.22 ± 12.00
43
43
43
43

39.47 ± 7.41
(15.42-56.53)
2.69 ± 4.87
(0.085-21.11)
1.45 ± 1.48
(0.33-8.69)
1.03 ± 1.36

45
45
44
45
loo-0

~

\0

(0.42-9.72)
(0.48-5.71)
(0.42-9.72)
Abbreviations: eRF, cardiorespiratory fitness; BMI, body mass index; We, waist circumference; eRP, c-reactive protein; IL-6, interleukin-6;
TNF-a, tumor necrosis factor-alpha; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate.
Note: We was divided into two categories based on the 50th percentile (median value= 86.4cm).
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Table 3
Multiple linear regression ofcardiorespiratory fitness and adiposity with /og 10hs-CRP (N = 88)

Outcomes
Log10hs-CRP (mg/L)

Predictor variables
Models
adjK F
Model I
Intercept
CRF (mL/kg·min)
Sex x OC
Male (ref)
Female (non-OC)
Female (OC)

.324

Model2
Intercept
CRF (mL/kg·min)
BMI (kglm 2)
Sex x OC
Male (ref)
Female (non-OC)
Female (OC)

.455

Model3
Intercept
CRF (mL/kg- 1·min- 1)
we (em)
Sex x OC
Male (ref)
Female (non-OC)
Female (OC)

.445

.300

.429

.418

13.430

17.324

16.641

p

B

SEB

Coefficients
p
t

2.028
-.042

.457
.009

-.639

4.435
-4.920

.000
.000
.000

-.577
.194

.166
.186

-.468
.111

-3.475
1.040

.001
.301

-.838
-.012
.049

.763
.010
.011

-.178
.484

-1.098
-1.137
4.464

.275
.259
.000
.001

-.144
.443

.178
.177

-.117
.255

-.806
2.498

.423
.014

-1.253
-.013
.019

.877
.010
.005

-.202
.462

-1.429
-1.291
4.252

.157
.200
.000
.001

-.125
.484

.185
.183

-.102
.279

-.679
2.647

.499
.010

p

.000

.000

.000

Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; WC, waist circumference;
hs-CRP, high sensitive C-reactive protein; adj, adjusted; B, unstandardized coefficients; SE,
standard error ; ~' standardized coefficients; OC, oral contraceptives; ref, reference.
Model 1: Multiple linear regression predicting CRF from log 10hs-CRP after adjustment for sex x
oral contraceptive interaction term
Model 2: Multiple linear regression predicting CRF from log 10hs-CRP after adjustment for BMI
and sex x oral contraceptive interaction term
Model 3: Multiple linear regression predicting CRF from log 10hs-CRP after adjustment for WC
and sex x oral contraceptive interaction term
Note: hs-CRP was transformed into log10hs-CRP (mg/L). CRF, BMI, and WC, continuous
variables
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Table 4
Multiple linear regression ofcardiorespiratory fitness and adiposity with /oguJL-6 (N = 87)

Outcomes
LogwiL-6 (pglm1)

Predictor variables

If

Models
adjK F

Modell
.252
Intercept
CRF (mL/kg·min)
Sex
Male (ref)
Female
Education
Graduate degree (ref)
Undergraduate degree
High school degree

.216

Model2
.325
Intercept
CRF (mL/kg·min)
BMI (kg/m2)
Sex
Male (ref)
Female
Education
Graduate degree (ref)
Undergraduate degree
High school degree

.283

Model3
.315
Intercept
CRF (mL/kg·min)
we (em)
Sex
Male (ref)
Female
Education
Graduate degree (ref)
Undergraduate degree
High school degree

.273

6.921

7.801

7.459

p

p

Coefficients
t
p

B

SEB

.933
-.020

.185
.004

-.638

5.037
-4.673

.000
.000

-.196

.077

-.346

-2.548

.013
.081

-.162
-.113

.071
.082

-.285
-.175

-2.275
-1.386

.026
.170

.137
-.010
.017

.405
.005
.006

-.316
.361

.337
-1.854
2.952

.737
.067
.004

-.069

.085

-.122

-.810

.421
.160

-.129
-.123

.069
.078

-.226
-.189

-1.868
-1.571

.065
.120

.022
-.011
.007

.465
.005
.002

-.341
.334

.047
-1.995
2.727

.963
.049
.008

-.063

.088

-.112

-.715

.477
.160

-.131
-.120

.069
.079

-.231
-.184

-1.889
-1.517

.062
.133

.000

.000

.000

Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; WC, waist circumference;
IL-6, inter1eukin-6; adj, adjusted; B, unstandardized coefficients; SE, standard error;~'
standardized coefficients; ref, reference.
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Model I: Multiple linear regression predicting eRF from log 101L-6 after adjustment for sex and
education
Model 2: Multiple linear regression predicting eRF from log 101L-6 after adjustment for BMI, sex
and education
Model 3: Multiple linear regression predicting eRF from log 10IL-6 after adjustment for we, sex
and education
Note: IL-6 (pglmL) was transformed into logtoiL-6 (pglmL); eRF, BMI, and we, continuous
variables
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Table 5
Analysis ofcovariance for log10hs-CRP as an interaction ofCRF and BMI (N = 88)

Predictor variables

adjK

p

Model 1
.255
.229
Intercept
CRF(mL/kg·min)
BMI(<25kg/m2 ) (ret)
BMI(~25kg/m 2 )
CRF(mL/kg· min )x BMI(~25kglm 2 )

.000

.385
.348
Model2
Intercept
CRF(mL/kg·min)
BMI(<25kg/m2 ) (ret)
BMI(~25kg/m 2 )
CRF(mL/kg· min)x BMI(~25kg/m 2 )
Sex x OC
Male (ret)
Female (non-OC)
Female (OC)

.000

B

SE
B

-.235
-.002

.506
.010

1.664
-.028

.626
.013

.753
-.020

.666
.013

1.172
-.019

.594
.012

-.400
.293

.172
.184

df

F

p

Partial
eta2

3
1
1

9.607
3.630
5.802

.000
.060
.018

.255
.041
.065

7.061
4.553

.009
.036

.078
.051

5
I
1

10.280
9.257
9.802

.000
.003
.002

.385
.101
.107

I

3.894
2.379
8.662

.052
.127
.000

.045
.028
.174

1
2

Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; hs-CRP; high sensitive Creactive protein; oral contraceptives, OC; adj, adjusted; B, unstandardized coefficients; SE,
standard error; OC, oral contraceptive; ref, reference.
Modell: ANCOV A testing an interaction of CRF and BMI with log 10hs-CRP without adjustment
for sex x OC
Model 2: ANCOV A testing an interaction of CRF and BMI with log 10hs-CRP after adjustment
for sex x OC.
Note: hs-CRP was transformed into log10hs-CRP (mg/L); CRF, continuous variable; BMI was
divided into two categories (normal weight <25; overweight and obese~ 25).
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Figure 2. Modell: ANCOV A testing an interaction of CRF and BMI with log 10hs-CRP
without adjustment for confounders
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Table 6
Analysis of covariance for log whs-CRP as an interaction of CRF and WC (N = 88)

Predictor variables

adjk

p

.3I4

.000

.338

B

SEB

df

F

p

Partial
eta2

.I 53
-.OI2

.440
.009

3
I
1

14.283
6.212
8.745

.000
.015
.004

.338
.069
.094

l.I 09
-.OI2

.568
.OI2

I
1

3.82I
1.059

.054
.306

.044
.012

.753
-.023

.631
.OI2

5
1
I

13.207
7.490
7.456

.000
.008
.008

.446
.084
.083

eRF(mL/kg·min)xWe(~86.4cm)

.626
-.003

.552
.OI2

Sex x oe
Male (ret)
Female (non-Oe)
Female (Oe)

I
I
2

1.287
.079
8.0I5

.260
.779
.001

.OI5
.001
.164

-.244
.406

.173
.178

Modell
Intercept
eRF(mL/kg·min)
we (<86.4cm) (ret)
we (~86.4cm)

eRF(mL/kg·min)xWe(~86.4cm)

Model2
Intercept
eRF(mL/kg·min)
we (<86.4cm) (ret)

.446

.412

we(~86.4cm)

.000

Abbreviations: eRF, cardiorespiratory fitness; we, waist circumference; hs-eRP, high sensitive
e-reactive protein; adj, adjusted; B, unstandardized coefficients; SE, standard error; oe, oral
contraceptive; ref, reference.
Modell: ANeOV A testing an interaction of eRF and we with log 10hs-eRP without adjustment
for sex x oe
Model 2: ANeOV A testing an interaction of eRF and We with log10hs-eRP after adjustment for
sex x oe.
Note: hs-eRP (mg/L) was transformed into logwhs-eRP (mg!L); eRF, continuous variable; We
was divided into two categories based on the 50th percentile (median value= 86.4 em).
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Table 7
Analysis ofcovariance for log10 IL-6 as an interaction ofCRF and BMI (N

Predictor variables

adjK

p

.218
.190
Model 1
Intercept
CRF(mL/kg·min)
BMI( <25kg/m 2) (ret)
BM1(~25kg/m 2 )
CRF(mL/kg·min)xBMI(~25kg/m2 )

.000

.240
Model2
.293
Intercept
CRF(mL/kg·min)
BMI(<25kg/m 2) (ret)
BMI(~25kg/m 2 )
CRF(mL/kg·min)xBMI(~25kg/m2 )
Sex
Male
Female (ref)
Education
Graduate degree (ref)
Undergraduate degree
High school degree

.000

=

87)

B

SEB

df

F

p

Partial
eta2

.080
-.004

.250
.005

3
1
I

7.705
6.533
7.569

.000
.012
.007

.218
.073
.084

.626
-.011

.307
.007

4.154
2.791

.045
.099

.048
.033

5.528
10.644
10.731

.000
.002
.002

.293
.117
.118

6
I
I

.637
-.011

.338
.006

.501
-.009

.305
.006

2.698
1.820

.104
.181

.033
.022

.143

.080

3.195

.078

.038

2.696

.074

.063

-.163
-.127

.081
.070

Abbreviations: CRF, cardiorespiratory fitness; BMI, body mass index; IL-6, interleukin-6; adj,
adjusted; B, unstandardized coefficients; SE, standard error; ref, reference.
Modell: ANCOV A testing an interaction of CRF and BMI with log 10IL-6 without adjustment for
sex and education
Model 2: ANCOV A testing an interaction of CRF and BMI with log 10 IL-6 after adjustment for
sex and education.
Note: IL-6 (pg/mL) was transformed into log10IL-6 (~g/mL); CRF, continuous variable; BMI was
divided into two categories (normal weight <25kg/m ; overweight and obese~ 25kg/m2).
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Table 8
Analysis ofcovariance for logw /L-6 as an interaction ofCRF and WC (N = 87)

Predictor variables

Modell
Intercept
eRF(mL/kg·min)
we (<86.4cm) (ref)
we (~86.4cm)

.255

adjK

p

.228

.000

eRF(mL/kg·min)xWe(~86.4cm)

.258
.310
Model2
Intercept
eRF( mL/kg·min)
we (<86.4cm) (ref)
We(2:86.4cm)
eRF(mL/kg·min)xWe(2:86.4cm)
Sex
Male
Female (ref)
Education
Graduate degree (ref)
Undergraduate degree
High school degree

B

SEB

-.017
-.001

.224
.005

.876
-.016

.287
.006

.000

df

F

p

Partial
eta2

3

9.456
8.596
9.823

.000
.004
.002

.255
.094
.106

9.306
7.254

.003
.009

.101
.080

5.991
10.763
10.918

.000
.002
.001

.310
.119
.120

I

1

6
.511
-.009

.332
.006

.705
-.013

.292
.006

5.818
4.730

.018
.033

.068
.056

.128

.083

2.386

.126

.029

2.039

.137

.048

-.141
-.116

I

1

.070
.080

Abbreviations: eRF, cardiorespiratory fitness; we, waist circumference; IL-6, interleukin-6; adj,
adjusted; B, unstandardized coefficients; SE, standard error; ref, reference.
Modell: ANeOVA testing an interaction of eRF and we with log10IL-6 without adjustment for
sex and education
Model 2: ANeOV A testing an interaction of CRF and we with log10IL-6 after adjustment for sex
and education.
Note: IL-6 (pg/mL) was transformed into logtoiL-6 (pg/mL); CRF, continuous variable; WC was
divided into two categories based on the 50th percentile (median value= 86.4cm).
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Figure 3. Model 1: AN COV A testing an interaction of cardiorespiratory fitness and WC
with log 1olL-6
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Appendix A
Study Flyers

16 1

ATTENTION!!
Individuals between the ages of 20 and 34 are needed to
participate in a new research study!!

We are seeking individuals without heart disease, respiratory
conditions and chronic disease for a study of young adults.
During one visit to the research center participants in this study will:
• Treadmill walk test to monitor heart rate
• Have a blood test
• Answer some basic questions about yourself.
• Be compe nsated for your participation in this study.
If you are inreresred or have fmtber questions please call

716-909-4121 or email: Eunduck.Park@uth.tmc.edu
Eunduck Park, MSN, ANP, RN
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ATTENTION!!
Individuals between the ages of 20 and 34 are needed to
participate in a new research study!!
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We are seeking young males and females
who are in the green color (Body Mass
Index (BMI) > 25) without smoking, heart
disease, respiratory conditions and other
chronic diseases.
During one visit to the research center.
participants in this study will:

Have treadmill walk test.
I
Have a blood test.
'
-.,
/1
Answer some basic questions about yourself.
'
, Pound•
•
Be compensated for your participation.
If you are interested or ha,·e further questions please call e mail:
Eunduck.Park@uth.tmc.edu or call 716-909-4121
=m= UTHealth I
:n·

:·

,

n·

I I I

~

I I

I

I

•
•
•

Eunduck Park, MSN, RN, ANP, The University of Texas School of
Nursing
:::l
"0
<:.1

u

:::l

'0
QJ

u

;f11: IRB ~mER: HSC-SN- 12-0323
UTHcalth IRB APPROVAL DATE: I0/03/20 13
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AppendixB

Eligibility Criteria Check List
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Participants' Initial Eligibility Checklist
Identification
2. Date (lllllllddlyy)

1. futerviewers name

3. Participant Initials:

-First

-Last

Inclusion Criteria
(A check ··No" in any of following questions (Q4-Q8) indicates that the potential pa11icipant is
not eligible for the study)

If tile participa11t "Do11 't k11ow", clleck "F" 0111VO.

Yes
4. ·y·otmg adults aged 20-34
5. Is capable of canliorespiratory fitness test (Treadmill walk test)?
6. Is able to speak. read. comprehend and respond in English?

For JVotllell OIIIJ'
7. !\1enstrual cycle length of 24-35 days dtumg the last 2 months

8. Are you having yotu· period now?
(If a participant is on a period now. she \Vill be scheduled a day when
she is not on her tuenstruating period).

No
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Exclusion Criteria
(A check ..yes" in any of flowing questions (Q9-Q27) indicates that the potential participant is
not eligible for the sntdy)

If tile participant "Doll 't k11ow", clleck "F" 011 JVO.

Yes
9. Acute sn1oking. current smokers or smoking cessation less than 1 year
10. Alcohol dependence or regular alcohol consumption> 7 servings
per week
11. Acute infection. a cmTent or recent influenza illness or a
recent flu shot recipient. acute respiratory infection within 2weeks
12. Dental infection or problem within 2 weeks

13. Chronic diseases: cardiovascular diseases: hypertension. lipidenua.
and type 2 diabetes
14. hnmtme disorders: rheumatoid arthritis
15. History of osteoporotic injury and limitations due to the
musculoskeletal demands of cardiorespiratory fitness test. or other bone
diseases
16. History of osteoporosis
17. Recent surgery within 1 month
18. C'tm·ently taking medications: hormone replacement therapy. antihype11ensive medications. anti-platelet or coagulation medications.
allergy shots or systenlic corticosteroids. or selective serotonin uptake
inllibitors
19 ..Anti-inflammatory medications: statin. aspirin or had taken these
medications in the past 48 hours
20. Other medical conditions or medications that would prohibit
participation in exercise and blood sampling
(If yes. please list below)

No
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Yes

For wome11 Ollly,

21. ~Ienopausal status
22. Use ofh01mone replace therapy
23. Is ClUTently pregnant
2-t. Lactating female
25. History of gynecologic problems. such as endometriosis or
polycystic ovary syndrome
26. Hormonal contraception use except oral contraception: patch. depoprovera
27. Intra Uterine Devices with hormones and Depo-Provera within past
12 months

Participant's Eligibility: Yes_ _ _ _ __

~o

_________

No
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AppendixC
Informed Consent
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Scientists h:we debated w hether fi tness is more associated with intlallllllarory markers 0 1 it
body wei!ilit is more associated with iuflaunnatory m arkers in your body. Hi!ili lew is or
inflnnuuation bnve been shown to be rclnted to bean disease. ll1e fi ndings of this smdy may
hdp to improve health care nud to design programs to m aintain nud improve the health of
y01mg adults. However. the tests ped ormed m this study nrc not dtnguostic nud will not predict
1f you Will get heart disease
TI1ic.

IS

a loca l c,htcly tha t will em oil a total o f liS subject~ in l k •ILC.Inn .

PROCEDllU::
Jfy,m ag1ee ami ;-u e ahle to take pml in t h i~ s tudy. yon wi ll uudel gn the foll,1wiug pwcedule,
aite1 sigui11g thi~ iufunu ed l'UU ~ell t ·

•

Yon will be asked to fill out a pre-assessment health questionnaire to !demit)· 1f it is
sate for yon to take the fitness test. If tt is not safe to test your fi tness. you will be
excluded from this sntdy. The demoll:r.lphic questiom1nire mcludes age. gender.
etlmicity. m.mia l stai11S. and educntion . You will also be inten·iewed abom your health
conditions.

•

lf you are eligible to prut icipate m tlus st11dy. you Wi ll be scheduled for blood testing.
body measuremen ts. such as height 11nd weight. m1d physic il l fitness test. Tills test mll
he perfon necl one d11y at the rm JSC -IT. School o f~nr-;;ing anclraken ahont 3 hPnr~

•

fl1l yuu1 ~dt~uled test day, you are asked uot 10 eat aftet S pw tl!e uightbefme the te~ t.
_-\dditiuually. you are asked not to do streuuons exeu:ise m J.lh~ ~ical acti' 11~. iliiill.
alcohol. or us e anti-iu1lallllll:-ti01Y dmgs 2-l hom s prior to the blood draw. You are
asl.:.ed to aniw at the laboratory at the School of1\m ~iu~ l>etwee11 Saw aud !Oaut io1
l>lood test We \\ill draw 10 ll1l (al>out 2 teas)Xlou~) ofuhx.1d for iuflaunnatio11 1e tiug .
F or the iimess test, you are asked to wear comfortable ~xercise-type clothing. 11nd a\·oid
tobacco and caffeine 3 hours prior to test. Yon are also asked to haw an adequate
amomu s leep the night before the tesl.

•

"\ ft~r

•

After the'ie mea~urement~. ynn will be gi-·en 11 lighr !Tee lunch with juice 01 wnter

•

After bilviug 11 light lunch and brief r~st mg period. the im·estigator will test your fi mess.
T his test assesses how your body handles p hysical activity. Tllis rest will rake 20-30
minmes of walking on rhe n·eadmjl! with w:mn-up and cool down stages. You will be
asked to w~ar a bean ra te mo1litor around your chest. Smdy staff will guide you dming
the test.

blood test. study professiOnal staff will measure your height. weight and wmst
eircumfercuce. Th.?Sc rncnsm cs nrc to nssess your body s ize. You Wi ll be asked to
tcmo\·e at~y outer clothlllg. such as a sweater. :15 well 35 hat and shoes.

.. __.. ··---.. -

t:Tf ft·.tilh
,

, __
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AppendixD
Pre-Assessment Health Questionnaire

171
Pr e-assessment Health Questionnaire
Pre-assessment Health Questionnaire consists of two sec tions: section l. demographic
infomwtion and section 2. pre-assessment questi01maires. Section 1 demographic iufonuation
includes infonnation on age. gender. etlmicity. marital status. and education. Section 2 preassessment health questiOJmaire will be used to determine the i.ndiYidnar s risk related to
cardiorespiratory fitness participation. The questi01maire is designed to identify whether the
pa11icipants are appropriate and safe to test for cardiorespiratory fitness.
The obj ectiws of the pre-assessment health questionuaire are:
• To identify those with a medica l contraindication.
• To identify those with other health risk!meclical concems that may influence the decision
about petfomung a cardiorespiratory fitness test (sub-maximal treadnull test).
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Pre-Health Assessment Questionnaire

futerviewer's name:

Study tmit identifier:
Date of futerview:

l _ l__l / ~__l __l /
(rvionth)

(Date)

(Year)

Item

Question
#

Section 1: Demographic Information (Q1-Q6)

1

Respondent· s gender:

_ _ ~L.U.E [ 1 ] _ _ FEl\,IALE [ 2 ]

2

··How old did you ttlfll on your last birthday?"
._I_ _ .I _ _ _ I

years old
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3

""\Vhat is your etlmicity?''
___ Caucasian [ 01 ]
_ _ _ Afiican American [ 02 ]
_ _ Hispanic [ 03 ]
___ Native American [ 04 ]
_ _ Asian [ 05 ]
___ Pacific Islander [ 06 ]
_ _ ~Iixed Race

[ 07 ]

_ _ DON'T KNO\V [ 97 ]

-t

..\Vhat is your martial stants?"
___ ~Jarried or living with partner [ 01 ]
_ _Single [ 02 ]
___Divorced or \Vidowed [ 03 ]
_ _ Refitsed [ 97 ]

5

""\Vhat is yotu· education level?"
___ Post doctoral--~Skip question #6 [ 01]
_ _.....PhD

-~Continue

with question #6 [ 02]

_ _.....~~laster's degree -•Continue with question #6 [ 03]
___Bachelor's degree-. Continue with question #6 [ 04]
___High school's degree _ _.....:tvfiddle school's degree
___.Don't know
6

~skip

~skip

question #6 [ 05 ]

-~Skip

question #6 [ 06 ]

question #6 [ 07 ]

..If you are sntdent. what year are you in?"
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Section 2: Pre-Assessment Questionnaires
Reference: American College of Spot1s Medicine (b). ACS!vl's health-related physical fitness
assessment manual. 3rd ed. Philadelphia (PA): Lippincott. Williams & \Vilkins: 2010 (p.20-21

Please provide responses (YES or NO) co the
symptoms you have had:

followin~

concern in~ family history, your own history, and any

PERSONAL HISTORY
Have you ever had:

FAMILY HISTORY
H<~vP ;~ny•mmPc1:1tP ~mllymPmhPrc;

YES NO

had a:
~eart

attack
~cart surgery
coronary ste:-lt

YES

NO

0

c

0

u

0

c

cardiac catheterization
congPnir;~l hP:t'"t dPft>Cr

0

0

0

0

srroke

0

0

Odler chronic Ciseasc:

SYMPTOMS

Have you e\'er had:

High blood pressure
High chole~terol
DiabrtP<;.
Any heart problems
Oisea:oe of a.ncries
I hyroid disease
lung disease

Asthma

YES NO

0

0

Chest pain

0

0

0

0

Shortness ofbrea:h

0

0

0

0

Heart palpitaticns

0

0

;::)

0

Skipped heartbears

0

0

0

0

Heart murmur

0

0

0

0

lmermittent leg pam

0

0

0

0

0

0

Dizziness or fainting
Fatigt;e - usual activities

0

0

0

0

0

0

0

0

Ce1ncc:r

0

0

~n01·ins

Kidrey disease
Hepatitis

0

0

Bac~

0

0

Orthofcdic problems
Orher:

Other:---~---- --~~

0

pain

STAFF COMMENTS: _____________________________________________________

Have you ever had your cholesterol measured?

Yes 0

No U

If yes, value _ _ Where: _ _ _ __

1\re you raking any prescription (include birth control pills) or nonprescription medications? Yes 0

No 0

For each of your current medications, provide the following information:
MEDICATION

Dosage-times/day

Time taken

Years on medication

Reason for taking

175

HOSPITALIZATIONS: Plt"ase

li~r

recent hospitalizations (Women: do not list normal pregnancies)
Reason

Location

Yes D

Any orh~r medrcal prohlems/concerns not already identifrcd?

No 0

If so, please list: ____ _

LIFESTYLE HABITS
Do you e\'er have an uncomfortable: shortness of breath during exercise or when doing activities?
YesD

NoD

Do you ~·cr have chest drscomfort during e><ercise?
If so, does it go away with rest?

--------------

No 0

No U

If so, what? Cigarettes 0

How long have you smoked?

How much per day:

Yes IJ

No 0

~~------~

Yes 0

Do you currently smoke?

Yes D

Crgars 0

< 'h pack C

Have you ever quit smoking?

Pipe 0

years

fi to 1 pack 0 1 to 1 Y.! packs 0
Yes 0 No 0 \\/hen? - - - - -

> 2 packs 0

1 h to 2 packs 0

How many years and how much did you smoke? - - - - - - - Do you drink an)' alcoholic beverages?
Beer _ _ (cans)

Yes :J

\Vine _ _ (glasses)

Do you dnnk an)' caffeinated beverages?
Coffee _ _ (cups)

No 0

If yes, how much in 1 week? (indicate below)

Hard liquor _ _ (drinks)

Yes 0

Tea _ _ (glasses)

If yes, how much in 1 wt:ek? (indicale below)

No 0

Soft drinks _ _ (cans}

Are you currently following a weight reduction diet plan?

Yes 0

No 0

No 0

If yes, how often and what type? _ _

If so, how long have you been dieting? _ _ months
Is the plan prescribed by your doctor?

Yes 0

No 0

Have you used weight reduction diets in the past?

Yes 0

~E.VALUllli<JJ'I{

What is your occupational activity level?

Sedentary r:

Lighr r J

Moderate 0

Do you., currently engage in vigorous physical activity on a regular basis?

<15 min 0

15-30 min 0

How long have you engaged in this type of activit~·?

Do

)'OU

No 0

How many days per w e e k ? - - - - - - -

If so, what type(s)?
How much time per day?

Yes 0

Heavy 0

31-60 min 0

<3 rnonths 0

>60 min 0
3-12 months 0

engage in any recreational or leisure-time physical activities on a regular basis?

> 1 year 0
YcsO

NoD

If so, what activities? - - - - - - - - - - - - On average: How often? _ _ _ timesjwcck;
for how l o n g ? - - - - - - rime/session

How long have you engaged in this type of activity?

< 3 months

3- i 2 months

> 1 year
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AppendixE
Flow Chart for Sampling and Data Collection
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Screening cubjccts:'
eligibilit y usi ng o telephone:
Interview a nd email

No

r_

YU

Expl,.ln tho d etailed study
purposes, proced u ru, benefitc,
risks, and d iscomforts, "nd
confidentiality ot the School of
Nursing, UTHSC-H

No

Yes

Obtain Informed
a m sen ts

Pro-asso.ssmant c.c:rccning for

CR fitnaos and blood s ample
test (health history and
dc:mogrophlc information)

No

Yes
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Give instructions of blood
test, CR fitness test,
adiposity and schedule a

date

Blood test at UT SON
Bioscience Lab

Lunch and Break

Adipostiy /CR fitness at
UT SON center for
Nursi ng Research

Collected data

Data entry,
validation, editing

Analyze Data

Data save
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AppendixF
Time Frame for Project 2012-2013
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Tim~ Fram~

for

Proj~<'t

2012-2013

Jun

Aug

Sep

Oct

No\·

Dec

Setting study room
and equipment

Feb

Mar

Apr

May

Jun

July

Aug

2013

2012
Human subJects
approval

Jan

X

X

X

X

X

Recruit
participants

X

X

X

X

X

X

X

X

X

X

Data
Collection

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Data Entry
Analyze data
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AppendixG
Notification Approval

182

UTH~ili

Committee tor th• Prot•cuon of Human SubJects

The University of Texas

--,'It,

Health Science Center at Houston

NOTICE OF APPROVAL TO IMPLEMENT REQUESTED CHANGES
May 28, 2013
HSC-SN-12-0323- Association of Cardiorespiratory Fitness and Adiposity with Inflammatory
Biomarkers in Healthy Young Adults
PI: Eun Duck Park
Reference Number: 096182

PROVISIONS; Unless otherwise noted, this approval relates to the research to be conducted under
the above referenced title and/or to any associated materials considered at this meeting, e.g. study
documents, informed consent, etc.
APPROVED:

By Expedited Review and Approval

CHANGE APPROVED: Posting CPHS approved flyers at Harris County Community College and
University of Houston
REVIEW DATE:

May 27, 2013

APPROVAL DATE:

May 28,2013

CHAIRPERSON:

John C. Ribble, MD

Upon receipt of this letter, and subject to any provisions noted above, you may now implement the
changes approved.
CHANGES : The principal investigator (PI) must receive approval from the CPHS before initiating
any changes, including those required by the sponsor, which would affect human subjects, e.g.
changes in methods or procedures, numbers or kinds of human subjects, or revisions to the
informed consent document or procedures. The addition of co-investigators must also receive
approval from the CPHS. ALL PROTOCOL REVISIONS MUST BE SUBMITTED TO THE
SPONSOR OF THE RESEARCH.
INFORMED CONSENT: Informed consent must be obtained by the PI or designee(s), using the
format and procedures approved by the CPHS. The PI is responsible to instruct the designee in the
methods approved by the CPHS for the consent process. The individual obtaining informed consent
must also sign the consent document. Please note that if revisions to the informed consent
form were made and approved. then o ld blank copies of the ICF MUST be destroyed. Only
copies of the appropriately dated. stamped approved informed consent form can be used
when obtaining consent.
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UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The PI will immediately
inform the CPHS of any unanticipated problems involving risks to subjects or others, of any serious
harm to subjects, and of any adverse drug reactions.
RECORDS: The PI will maintain adequate records, including signed consent documents if required,
in a manner that ensures subject confidentiality.
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..!IL

UTH~th

Comm1tteo tor tho Ptoteetton of Human Suhjoct.s

The Unive rsi ty o f Te xes

'

"II

Health Sci en ce C e nter at Houat on

r'

II'

"'

NOTICE OF APPROVAL TO IMPLEMENT REQUESTED CHANGES

October 31 , 2012
HSC-SN-12-0323 - Association of Cardiorespiratory Fitness and Adiposity with
Inflammatory Biomarkers in Healthy Young Adults
PI : Dr. Eunduck Park
Reference Number: 088871

PROVISIONS: Unless otherwise noted, this approval relates to the research to be
conducted under the above referenced title and/or to any associated materials
considered at this meeting, e.g. study documents, informed consent, etc.
APPROVED: By Exped ited Review and Approval
CHANGE APPROVED: Revised Protocol Version 1.4. (dated 9/29/2012)
And Consent Document Version 1.1 (dated 10/31 /2012)
REVIEW DATE:

October 30, 2012

APPROVAL DATE:

October 31 , 2012

CHAIRPERSON:

Richard Kirkeeide, PhD

Upon receipt of this letter, and subject to any provisions noted above, you may now
implement the changes approved.
CHANGES: The principal investigator (PI) must receive approval from the CPHS before
initiating any changes, including those requ ired by the sponsor, which would affect
human subjects, e.g. changes in methods or procedures, numbers or kinds of human
subjects, or revisions to the informed consent document or procedures. The addition of
co-investigators must also receive approval from the CPHS. ALL PROTOCOL
REVISIONS MUST BE SUBMITIED TO THE SPONSOR OF TH E RESEARCH.
INFORMED CONSENT: Informed consent must be obtained by the PI or designee(s),
using the format and procedures approved by the CPHS. The PI is responsible to
instruct the designee in the methods approved by the CPHS for the consent process.
The individual obtaining informed consent must also sign the consent document. Please
note that if revisions to the informed consent form were made and approved, then
old blank copies of the ICF MUST be destroyed. Only copies of the appropriately
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dated. stamped approved informed consent form can be used when obtaining
consent.
UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The PI will
immediately inform the CPHS of any unanticipated problems involving risks to subjects
or others, of any serious harm to subjects, and of any adverse drug reactions.
RECORDS: The PI will maintain adequate records, including signed consent
documents if required, in a manner that ensures subject confidentiality.
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Eunduck Park, MSN, RN
EDUCATION
The University of Texas
Health Science Center
at Houston (UTHSC-H)

2010-2014

PhD

The State University ofNew York
at Buffalo

2008-2010

MS
Nursing
Adult Nurse Practitioner

The State University ofNew York
at Buffalo

2005-2007

BS

Nursing

Suwon Women's College
Suwon, South Korea

1993-1996

AD

Nursing

Nursing

LICENSURE & CERTIFICATION
State

Active or Inactive

Nurse Practitioner in Adult Health
New York State

Inactive
May 2010- May 2013

Registered Nurse
Texas State

Active
2010-Present

Registered Nurse
New York State

Active
2003-Present

Registered Nurse
Republic of Korea

Active
1996-Present

Basic Life Support for Health Care Provider, 2008-Present
Collaborative IRB Training Initiative (CITI), 2009-Present
HIPP A Certificate, 2009
Teacher's Certificate, School Nurse in Republic of Korea, 1996-Present
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PROFESSIONAL EXPERIENCE
Institution
Dates

Position Title

Inclusive

ST. Mary's Hospital
CATHOLIC UNIVERSITY
Seoul, South Korea
Medical Unit

Registered Nurse
(Full time)

May 1996-July 2001

Buffalo General Hospital
Orthopedic Unit
Buffalo, New York

Registered Nurse
(Full time)

August 2007-July 2008

The University of Texas
Health Science Center at Houston
School ofNursing

Teaching Assistant

May 2013-August 2014

HONORS AND AWARDS
Award

Award Organization

Date

National Nursing Honor Society

Sigma Theta Tau
International,
Gamma Kappa Chapter
The State of New York at Buffalo
School ofNursing

March 2007

Zeta Pi Chapter
TheUTHSC-H
School ofNursing

March 2011

TheUTHSC-H
School ofNursing

August 20 I 0-May 2013

James T. and Nancy B. Willerson The UTHSC-H
Endowment Scholarship
School of Nursing

August 2013

PARTNERS Scholarship
Full tuition support for
Three years of the PhD program

Sigma Theta Tau International
Zeta Pi Chapter,
PhD Excellent Award

The UTHSC-H
School ofNursing

May 2014
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RESEARCH GRANTS
Association of Cardiorespiratory Fitness and Adiposity with Inflammatory Biomarkers in
Young Adults (Dissertation), Principal Investigator

Sigma Theta Tau International, Zeta Pi Chapter, $2,000, May 2012
Center for Nursing Research (Treadmill Equipment), October 2012
The UTHSC-H, School ofNursing

Global Korean Nursing Foundation (GKNF)-US, $2,000, August 2013
Dr. Meininger's Professorship Research Support (Assay kits), December 2013
The UTHSC-H, School ofNursing

PUBLICATIONS AND PAPERS
Park, E., Meininger, J. C., Kang, D., & Gabriel, K. P. Association of cardiorespiratory
fitness and adiposity with inflammatory biomarkers in young adults. In
preparation for submission.

Park, E., Meininger, J. C., Baun, M., & Kang, D. Anthropometric adiposity measures
and inflammatory biomarkers in adolescents and young adults: A systematic
review. In preparation for submission.

Park, E. & Meininger, J. C. Effects of exercise interventions on inflammatory markers in
healthy adults: A systematic review. In preparation for submission.
Master Thesis: The prevalence of cardiovascular risk factor in type 2 diabetes in an innercity primary care practice, The State University of New York at Buffalo.

PRESENTATIONS
Park, E., Meininger, J. C., Kang, D., & Gabriel, K. P. (August 2013). Association of
cardiorespiratory fitness and adiposity with inflammatory biomarkers in young adults.
Presented at the Sigma Zeta Pi conference, The UTHSC-H, School of Nursing (podium
presentation).
Park, E. & Meininger, J. C. (April2012). Effects of exercise interventions on
inflammatory markers in healthy adults: A systematic review. Presented at the Nursing
Research Day, The UTHSC-H, School of Nursing/Sigma Zeta Pi (poster presenter).
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Tukov, M.S., Park, E., & Rejman, K. P. (April2010).The prevalence of cardiovascular
risk factors in type 2 diabetes in an inner-city primary care practice. Presented at the
Sigma Xi Research Day, The State University of New York at Buffalo (poster presenter).

PROFESIONAL MEMBERSHIPS
Sigma Theta Tau International Society ofNursing, Zeta Pi Chapter, 2011-Present
Sigma Theta Tau International Society ofNursing, Gamma Kappa Chapter, 2007-2011
American College Nurse Practitioner (ACNP), 201 0-Present
Southern Nursing Research Society (SNRS), 2012-Present
Council for the Advancement ofNursing Science (CANS), 2012-Present
Preventive Cardiovascular Nursing Association (PCNA), 2011-Present
American Heart Association (AHA), 2012-Present
American College of Sports Medicine (ACSM), 2014-Present
Obesity Society, 2014-Present

COMMUNITY SERVICE
Volunteer, ST. JOSEPH'S OFFICE, May 1996- July 2001, Seoul, South Korea
-Nonprofit organization
-Provided comprehensive health care and support services to homeless
-Presented nursing care and emotional support for those living on the margins of
society or are forsaken by society as a registered nurse volunteer

RESEARCH EXPERIENCE AND TRAINING RELEVANT PROJECTS
Ph.D. Dissertation, "Association of Cardiorespiratory Fitness and Adiposity with
Inflammatory Biomarkers in Young Adults"
-Trained for Biological Laboratory Practicum for Biobehavioral Research,
the UTHSC-H, School ofNursing, Biological Laboratory, May 2012-Present
-Trained for Sub-Maximal Cardiorespiratory Fitness Testing, the UTHSC-H,
Health Recreation Center, Houston, Texas, January 2012-Present
Master Thesis, "The Prevalence of Cardiovascular Risk Factor in Type 2 Diabetes in an
Inner-City Primary Care Practice"
-Data Collector, JUDGE METTINA COMMUNITY HEALTH CENTER,
Buffalo, New York, May 2009-December 2009
-Collected data using chart reviews on patients with Type 2 diabetes
-Data coding and entering using SPSS soft program

Nursing Research Day: Moderator in Community Section
The UTHSC-H, School of Nursing/ Sigma Zeta Pi

April2013
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Cardiometabolic Journal Club
Chair: Dr. Meininger, Co-chair: Dr. Gallagher
The UTHSC-H, School ofNursing

January 2011-June 2013

TEACHING EXPERIENCE
Teaching Assistant, Department of Acute and Continuing Care, The UTHSC-H, School
ofNursing, May 2013-August 2014
Management Patients in High Acuity Settings
May 2013-August 2014
Adult Health Care I
May 2013
Teaching Activities
Curriculum Planning and Development
Fall2013
-Presented and demonstrated "Providing Tracheostomy Care" to peers and
faculty

